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Thesis Abstract 
Chlamydia trachomatis (Ct), the most common sexually transmitted bacterium, 
has been associated with adverse pregnancy outcomes including controversial 
data on miscarriage, intrauterine growth restriction and low birth weight, 
however the causative mechanisms are unknown. A successful pregnancy 
requires normal endometrial stromal cell (ESC) decidualisation and trophoblast 
invasion, processes that involve chemokine action and lead to successful 
implantation. My objectives were to determine whether Ct infection impacts 
upon ESC decidualisation and chemokine secretion on human primary ESC in-
vitro, to investigate the role of Ct infection in pregnancy in-vivo using a murine 
model of pregnancy and to investigate the role of Ct in miscarriage in a 
statistically powered case control study.  
A novel finding is that Ct can infect and proliferate in ESC, resulting in 
suboptimal decidualisation as measured by decidualisation marker prolactin’s 
reduced mRNA and protein levels in infected ESC. Furthermore, the altered 
secreted chemokine profile of decidualised ESC suggests an attenuated innate 
immune response from infected ESC. Focusing on chemokines C-X-C motif 
chemokine 12 (CXCL12) and CXCL16, important for trophoblast invasion, 
decreased mRNA and protein concentrations were detected in infected 
decidualised cells.  
From the in-vivo mouse model of past Ct infection in pregnancy, it was 
demonstrated that Ct infection did neither affect the fertility of the mice, 
pregnancy or resorption numbers in C3H mice nor alter embryonic and 
placental weight on e12 embryos. However, Ct infection caused reduction of 
embryo and placenta weight on e14 embryos.  
Finally, preliminary data from the case control study indicate that past Ct 
infection is not associated with miscarriage. Our in house PGP3 ELISA that 
detects past Ct infection was more sensitive than a commercially available 
MOMP ELISA. 
  vii 
My data suggests that Ct infection affects pregnancy during the implantation 
stage by impairing decidualisation and altering chemokine secretion 
predisposing for adverse pregnancy outcomes that include growth restriction 
during later gestation.   
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Lay abstract 
Chlamydia trachomatis (Ct) is the most common sexually transmitted bacterial 
disease worldwide. Controversial research data indicates that it may be a cause 
of pregnancy complications including miscarriage, growth restriction of the 
embryo during pregnancy and decreased birth weight. It is not yet known how 
Ct infection can cause this, however it is known that a successful pregnancy is 
determined during the first days, when the embryo attaches itself to a receptive 
womb, a process called implantation. A womb is not receptive to an embryo 
throughout the menstrual cycle, it has to prepare during every cycle for a 
possible implantation, a process called decidualisation. Decidualisation 
happens in a specific part of the womb that consists of cells called endometrial 
stromal cells (ESC) and following decidualisation the functional role of ESC is 
to allow and assist the implantation of an embryo. In combination with 
generation of new blood vessels and invasion of the embryonic trophoblast (the 
cells that will form the placenta) in the womb, these processes are essential for 
a successful pregnancy. Signalling molecules of the immune system called 
chemokines play an important role in regulating and coordinating all the above 
processes. My assumption was that Ct infection interferes with decidualisation 
resulting in pregnancy complications.  
To investigate the effect of infection in decidualisation, I showed for the first 
time that Ct can infect the ESC of the womb. The infected ESC seem to not be 
able to undergo a decidualisation-like process they were subjected on as 
efficiently as non infected ESC. This was measured by reduced levels of 
molecules known to be essential for decidualisation and implantation, 
including chemokines that guide foetal trophoblast cells during implantation.  
Furthermore, to clarify whether maternal Ct infection that has been cleared 
(past Ct infection) can affect pregnancy outcome and embryo growth I used a 
mouse model of Ct infection. The mice were infected with Ct and a month later 
were impregnated. The results from the Ct infected mice were compared to 
pregnancy outcomes of mice that had not been infected. My experiments 
showed that past infection did not affect the pregnancy rate of the mice and did 
  ix 
not result change the number of miscarried pups when the pregnancy outcome 
was examined on day 12 (e12) of mouse pregnancy. Also, there was no change 
in the weight of the pups and the placentas on e12, however pups and placentas 
from e14 of mouse pregnancy weighed less compared to their e14 counterparts 
from mice that were not infected with Ct. 
Finally, I examined women that miscarried compared to women with healthy 
pregnancies to see if they had Ct infection in the past to verify whether this 
increases the miscarriage incidence in women. Even though the study is not yet 
complete, preliminary data suggest that past Ct infection is not likely to 
increase miscarriage incidence. The same samples were tested using a 
commercially available ELISA that proved to be less accurate at detecting past 
infection in patients. 
To summarise, the present study suggests that changes caused by Ct infection 
in the womb can potentially disrupt delicate and strictly regulated processes 
during early pregnancy that could lead to pregnancy complications such as 
restricted embryonic growth. Since Ct is treatable but difficult to diagnose, 
screening for Ct infection in high-risk populations could decrease these 
incidents.  
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1. Chapter 1: Literature review  
1.1 Chlamydia trachomatis (Ct) 
Chlamydia trachomatis (Ct) is the most common sexually transmitted pathogen 
worldwide (Howie et al., 2011).  
1.1.1 Taxonomy 
Ct’s taxonomical lineage is: Chlamydiae/Verrucomicrobia group; Chlamydiae; 
Chlamydiia; Chlamydiales; Chlamydiaceae; Chlamydia/Chlamydophila 
group; Chlamydia. Ct serovars (bacterial strains that have different antigenic 
properties as determined by a microimmunofluorescence test) A, B, Ba and C 
infect mainly the conjunctiva and are associated with trachoma (Monroy and 
Villalba-magdaleno, 2012). Serovars D, Da, E, F, G, Ga, H, I, J and K are 
predominantly isolated from the urogenital tract and are associated with 
sexually transmitted diseases (STDs), inclusion conjunctivitis or neonatal 
pneumonitis in infants born to infected mothers (Clarke, 2011; Klint et al., 
2007; Monroy and Villalba-magdaleno, 2012). Serovars L1, L2, L2a and L3 
can be found in the inguinal lymph nodes and are associated with 
lymphogranuloma venereum (Clarke, 2011; Klint et al., 2007; Monroy and 
Villalba-magdaleno, 2012).  
1.1.2 Prevalence, symptoms, diagnosis, treatment, 
persistence and vaccine  
Ct prevalence is high, estimated at 97 million new cases in 2005 worldwide 
(World Health Organisation (WHO), 2011). The most recent data from Public 
Health England for 2015 show that the most commonly diagnosed sexually 
transmitted infection was Ct as 200,288 infections were diagnosed, a small 
decrease from 206,774 diagnoses made during 2014 (Health Protection Report, 
2016). More specifically, 1.5 million young people aged 15 to 24 years old 
were tested, the target population for the National Chlamydia Screening 
Programme (Health Protection Report, 2016).  
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Though untreated Ct infection is often asymptomatic in women, it can result in 
mucopurulent cervicitis (Brunham et al., 1984), acute urethral syndrome 
(Stamm et al., 1980) and pelvic inflammatory disease (PID, Paavonen and 
Lehtinen, 1996). Reinfection with Ct can result in a strong adaptive immune 
response and the increased inflammation may cause further damage to the 
reproductive tract, as it is presumed to be the case in chronic PID (Hillis et al., 
1997; Price et al., 2013). 
Diagnosis is carried out by PCR on swab samples. Treatment includes 
administration of antibiotics, such as tetracyclines, azithromycin, or 
erythromycin (Brocklehurst and Rooney, 2000; MedlinePlus, 2014). 
Following infection, Ct can under specific conditions convert into a dormant 
form that remains undetected by the immune system of the host. This form 
does not multiply although continues to survive in the cell for 6 months up to 5 
years (Meijer et al., 2005; Morré et al., 2002). In-vitro data have demonstrated 
that exposure to penicillin and interferon-γ (IFN-γ) can result in “persistent” Ct 
infection (Beatty et al., 1993; Lambden et al., 2006). Persistence also depends 
on the serovar causing the infection, as it has been shown that serovar E has 
lower clearance rate compared to other serovars (Meijer et al., 2005; Morré et 
al., 2002). 
There is no vaccine available for Ct yet, despite many attempts at developing 
one (Cambridge et al., 2013; Peterson et al., 1999; Schautteet, Stuyven, et al., 
2011; Singh et al., 2006; Stary et al., 2015). These attempts often resulted in 
partial to non prophylactic protection from Ct reinfection. However, even when 
protection against reinfection has been demonstrated by a study (Brunham and 
Rey-Ladino, 2005), there is significant serovar to serovar variation between 
characteristic surface proteins such as major outer membrane complex 
(MOMP) that hinders the development of a universal vaccine of the host 
against any future infection. Furthermore, persistent Ct infection that results in 
sophisticated mechanisms of avoiding detection from the host immune system 
is an additional challenge that needs to be addressed (Brunham and Rey-
Ladino, 2005). Recent vaccines tend to shift towards prevention of disease 
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rather than protection from reinfection, however an effective vaccine has not 
yet been developed (reviewed in Brunham and Rey-Ladino, 2005; Schautteet, 
De Clercq, et al., 2011).  
1.1.3 Life cycle of Ct  
Ct has two developmental stages, the infectious but metabolically inactive 
elementary body (EB) and the metabolically active intracellular reticulate body 
(RB). EBs measure from 200 to 400 nm in diameter, are susceptible to 
penicillin and are resistant to mechanical shock. In contrast, RBs are between 
500 and 1500 nm in diameter, are not infective or affected by penicillin 
however they are susceptible to mechanical shock (Monroy and Villalba-
magdaleno, 2012). Ct is known to infect epithelial cells of mucosal tissues 
(Hossain, 1989; Monroy and Villalba-magdaleno, 2012; Rödel, Grosse, Yu, 
Wolf, Otto, Liebler-Tenorio, Forsbach-Birk, Straube, et al., 2011). Briefly, as 
seen in Figure 1.1, a Ct EB enters a host epithelial cell, transitions to RB that 
multiplies by binary fission and approximately 24-48 hours later the RBs 
transform to EBs, the host cell is lysed and the EBs are released to infect 
nearby healthy cells. 
 
Figure 1.1. Life cycle of Ct in the female genital tract. The Ct infectious elementary body 
(EB) enters a host epithelial cell of the female genital tract and transforms to the metabolically 
active reticulate body (RB). RBs multiply by binary fission utilising host cell nutrients within a 
protective membrane called inclusion and approximately 24-48 hours later the RBs transform 
to EBs. The host cell is lysed and the released EBs are able to infect nearby healthy cells. 
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1.1.3.1 Molecular mechanisms of Ct infection  
The infectious process begins with attachment of an EB to an eukaryotic 
epithelial cell (Dautry-Varsat et al., 2005). Ct serovars utilise slightly different 
mechanisms of entry to host cells (Dautry-Varsat et al., 2005). Serovars such 
as L1-L3 utilize a surface heparan-sulfate-like ligand that binds to a specific 
host cell receptor that facilitates bacterial entry into the cell (Chen and 
Stephens, 1997; Jian Ping Zhang and Stephens, 1992). Serovar E attachment to 
the HEC-1B epithelial cell line was not affected by heparin or heparan 
sulphate, indicating it enters host cells via another mechanism (Davis and 
Wyrick, 1997). It has been suggested that serovar E uses lipid microdomains in 
the host cell plasma membrane that are known as detergent insoluble 
glycolipid-rich domains or lipid “rafts” (Stuart et al., 2003), however a more 
recent study reported that serovar E is not using this mechanism (Gabel et al., 
2004). Although the paper by Gabel et al. does not show data from several 
results, both studies appear to have conducted very similar experiments 
including same concentration of drugs used to inhibit Ct infection of HeLa 
cells. Another study has implicated the protein disulfide isomerase, a 
component of the estrogen receptor complex, to attachment of serovar E to 
endometrial epithelial cells (Davis et al., 2002). The precise entry process of 
serovar E EBs remains therefore unclear to date. 
Following internalization, a vacuole called inclusion forms from Ct-originating 
vesicles in the infected cell. Ct, as an obligate intracellular bacterium, requires 
host nutrients to proliferate whilst it modifies the cell defence mechanisms to 
avoid destruction. All such interactions are facilitated by the inclusion 
membrane. It was originally thought that Ct depends completely on the host 
cell’s energy molecules ATP, GTP, CTP and UTP to acquire energy, however 
it was later revealed that Ct can synthesize CTP (Tipples and McClarty, 1993). 
Immediately after cell entry, Ct protein synthesis produces inclusion proteins 
(Li et al., 2008; Scidmore-Carlson et al., 1999). Sphingomyelin and cholesterol 
are both examples of materials required by the growing RBs and are 
transported from the Golgi apparatus, a process that has been shown to involve 
Ct encoded proteins such as the Ct inclusion membrane protein (IncA) and is 
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promoted by microtubule trafficking (Carabeo et al., 2003; Hackstadt et al., 
1995, 1999; Richards et al., 2013). 
As seen in Figure 1.2, it is believed that the Ct developmental cycle is 
regulated at a transcriptional level and is divided in three stages (Nicholson et 
al., 2003). Very little is known regarding the transformation of EBs to RBs that 
occurs within the first 2-6 hours following internalisation. During early 
differentiation of stage I, genes that are expressed are involved in transcription 
or nutrient transport, genes inhibiting fusion of the Ct inclusion with the host 
cell lysosomal pathway and inclusion membrane proteins (AbdelRahman and 
Belland, 2005; Belland et al., 2003). Stage II, 18 hours post infection, is when 
RB proliferation has reached a plateau (Nicholson et al., 2003; Stephens et al., 
1998). Genes upregulated during this stage include “cell envelope biogenesis 
components (18%), energy metabolism (11%), protein folding (3%), and DNA 
replication, modification, repair, and recombination (4%)” and some genes that 
are in common with stage III (Nicholson et al., 2003). During stage III of the 
developmental cycle, RBs transition to EBs, therefore proteins specific for EBs 
are expressed among other genes (Nicholson et al., 2003). It is known that the 
Ct cell envelope becomes rigid and septated at the time of transition from RB 
to EB (Peterson and de la Maza, 1988).  
Finally, at the end of a Ct life cycle, RBs transform back into EBs and EBs are 
released by host cell lysis or extrusion (packaged EB release that leaves host 
cell intact, Hybiske and Stephens, 2007). 
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Figure 1.2. The three stages of Ct developmental cycle within the cell. Early differentiation 
during the first 12 hours that is characterised by transformation of an EB to RB and 
transcription of early stage genes that are involved in Ct growth and protection from host cell 
defence mechanisms. During stage II, up to 18 hours post infection, the RBs proliferate and 
divide. Finally, 24 hours post infection the first RBs begin to transform to EBs that will infect 
nearby cells when the cell is lysed 48 hours post infection. (Image adapted from open access 
article Nicholson et al., 2003). 
1.1.3.2 Host immune response to Ct infection 
The host immune response to Ct has two stages: an early response caused by 
the innate immune system and a more delayed response of the adaptive 
immune system. The innate immune system acts both as a first barrier against 
pathogens and as an activator of the adaptive immune system (Iwasaki and 
Medzhitov, 2010). 
The innate immune system is the first line of defence against pathogens. It 
includes physical barriers such as the epithelial cell barrier, the complement 
system (a number of proteins found in the blood that enhance the ability of 
phagocytes and antibodies to eliminate pathogens) as well as specialised cells 
including mast cells, macrophages, neutrophils, dendritic cells (DC), basophils, 
eosinophils and natural killer (NK) cells circulating throughout the whole 
body.  
Host–pathogen interactions are induced via host recognition of conserved 
molecular structures of the pathogen that are known as pathogen-associated 
molecular patterns (PAMPs). PAMPS are sensed by the host’s pattern 
recognition receptors (PRRs). Several classes of PRRs recognize distinct 
microbial components and directly activate immune cells (reviewed in 
Uematsu and Akira, 2008). PRRs are expressed on innate immune cells such as 
DCs, neutrophils, NK cells and macrophages. These receptors include among 
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others the highly conserved among species family of transmembrane Toll-like 
receptors (TLRs), the Scavenger receptors and the NOD-like receptors 
(Dempsey et al., 2003; Iwasaki and Medzhitov, 2010; Kumar et al., 2011; 
Meylan et al., 2006). 
Ct is a Gram-ve bacterium that has an inner and outer membrane similar to 
Gram-ve bacteria and a lipopolysaccharide (LPS) but does not have a 
peptidoglycan layer (Monroy and Villalba-magdaleno, 2012). However, it does 
not contain peptidoglycan (Hatch, 1996). As demonstrated in Figure 1.3, Ct is 
known to contain unique PAMPs including MOMP (Caldwell et al., 1981) and 
rough LPS (Heine et al., 2003). Ct LPS has been reported to be recognised by 
both TLR2 (Erridge et al., 2004) and TLR4 (Heine et al., 2003). Another 
known antigen of Ct that induces a strong immunological response is 
Chlamydia heat shock protein 60 (Hsp60) that is located on the inclusion 
(Raulston et al., 1998) and is recognised by TLR4 (Sasu et al., 2001).  
 
Figure 1.3. Notable antigens of Ct include Lipopolysaccharides (LPS), Major outer 
membrane protein (MOMP) and secreted plasmid protein PGP3. LPS is targeted by 
pattern recognition receptors (PRRs) of the innate immune system whereas MOMP and PGP 
are recognised by antibodies and memory cells of the adaptive immune system. These antigens 
are also commonly used to detect presence of Ct in diagnostic and laboratory techniques. 
If a PAMP is successfully recognised, signalling pathways that activate host 
immune responses mediated by various cytokines and chemokines are 
mobilised, including immune cell recruitment (Dempsey et al., 2003; Iwasaki 
and Medzhitov, 2010; Kumar et al., 2011). These processes aim to eradicate 
the pathogens from the host organism. One such chemokine that is known to be 
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strongly induced by Ct infection in epithelial cells is C-X-C motif chemokine 8 
or interleukin 8 (CXCL8 or IL8, Buckner et al., 2013; Das et al., 2010; 
Natividad et al., 2009). CXCL8 attracts neutrophils to the cite of infection 
(Buckner et al., 2013; Das et al., 2010; Natividad et al., 2009). As seen in 
Figure 1.4, other innate immune cells recruited in response to Ct infection 
include macrophages and DCs. DCs secrete Interleukin 12 (IL-12) that acts as 
an attractant to NK cells (Bas et al., 2008; Hook et al., 2004; Lu and Zhong, 
1999).  
The NACHT, LRR, and pyrin domain-containing (NALP) protein family are a 
subtype of the NOD-like receptor family. NALP proteins have an important 
role in activation of proinflammatory caspases through formation of a complex 
called “inflammasome”. NALP2/NALP3 inflammasomes contain the proteins 
NALP2, NALP3, CARDINAL, the adaptor protein ASC and caspase 1. The 
NALP1 inflammasome consists of NALP1, ASC, caspase 1 and caspase 5. 
Both inflammasomes control the activation of proinflammatory cytokines IL-
1β and IL-18 (van de Veerdonk et al., 2011). 
 
Figure 1.4. Host immune response to Ct infection is facilitated by both the innate and the 
adaptive immune system. 
    28 
Following the innate immune response, defensive mechanisms of the adaptive 
immune system are activated by antigen-presenting cells including 
macrophages and DCs.  
The adaptive immune system has two arms, humoral (antibody mediated) and 
cellular (cell mediated). T-cells and B-cells are the main effector and memory 
cells of adaptive immunity. In the thymus, naive T-cells that encounter self-
antigens are deleted (central tolerance). Mature T-cells that exit the thymus can 
also become tolerant to antigens at other anatomical sites (peripheral 
tolerance). T-cells are divided into distinct populations characterised by 
specific cluster of differentiation (CD) markers expressed on each population: 
CD4+ T-cells mediate the innate immune response by secreting various 
cytokines and this group includes include T-helper 1(Th1), T-helper 2 (Th2), 
T-regulatory cells (Treg) and other subtypes. Cytotoxic CD8+ T-cells are the 
cells that have the potential to that “kill” infected cells, cancer cells and 
generally damaged cells. T-cell activation is a highly complex process 
(reviewed in Smith-Garvin et al., 2009). Briefly, to activate a cytotoxic or 
helper T-cell to proliferate and differentiate into an effector cell, an antigen-
presenting cell provides a signal by an antigen bound to a MHC protein on the 
surface of the presenting cell and a second signal provided by co-stimulatory 
proteins. This process is known as antigen presentation. Following activation, 
T-cells are believed to migrate from the thymus to other areas in the body. B-
cells, following activation via T-cells or APCs produce antibodies and interact 
with various T-cell subtypes in a complex network that mediates the innate 
immune response (Dempsey et al., 2003). 
At the site of infection there is a strong inflammatory reaction mediated mainly 
by activated CD4+ T-cells with a Th1 phenotype aiming to clear the Ct 
infection (Hafner et al., 2008). Despite the fact that this dual response of innate 
and adaptive immune systems is usually effective in clearing the pathogens, in 
several cases Ct evades eradication resulting in a persistent infection. Ct uses a 
plethora of mechanisms to evade the host immune response. It has been 
established that Ct can infect macrophages and this results in cytotoxic effect 
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of the macrophages on the T-cells via tumour necrosis alpha factor (TNFα) 
secretion (Jendro et al., 2000, 2004). However, one of the most known 
mechanisms is IFN-γ mediated persistence (Perry et al., 1997). Th1 cells 
produce IFN-γ, which is known to inhibit Ct reproduction (Perry et al., 1997). 
The resolution of infection depends on the concentration of IFN-γ. It is known 
that high levels of IFN-γ are associated with the clearance of infection whereas 
in low levels the bacteria stop replicating however they survive within the cells 
resulting in a persistent infection (Beatty et al., 1993).  
1.2 Ct and adverse pregnancy outcomes 
As Ct infects the female genital tract, its role in adverse pregnancy outcome 
has been a subject of research interest during the past decades. Studies indicate 
a strong association with ectopic pregnancy supported by mechanistic data 
(Bakken et al., 2007; Shaw et al., 2011). However, the data on miscarriage 
(Baud et al., 2011; Wilkowska-Trojniel et al., 2009; Nigro et al., 2011), low 
birth weight (Berman et al. 1987; Johnson et al., 2011; Blas et al., 2007), 
intrauterine growth restriction (Investigators of the John Hopkins Study of 
Cervicitis and Adverse Pregnancy, 1989; Vedmedovska et al., 2010) and 
preterm labour (Hollegaard et al., 2007; Blaset et al., 2007; Silveira et al., 
2009; Johnson et al., 2011) are the subject of on-going debate.  
Controversial data exist due to the many confounders that can affect pregnancy 
outcomes in humans as well as issues with study design, including 
underpowered sample size, difficulty in recruitment, variable diagnostic test 
sensitivity that can differ significantly from study to study. Further research 
into the potential association between Ct and these adverse pregnancy 
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1.2.1 Ct and miscarriage 
1.2.1.1 Miscarriage definition and statistics 
Miscarriage is the spontaneous loss of pregnancy during the first 24 weeks of 
gestation (Figure 1.5), with the majority noted during the first 12 weeks. For 
the majority of women, a miscarriage is an isolated event and is followed by a 
successful pregnancy (“spontaneous miscarriage”, termed “miscarriage” from 
this point onwards). A smaller number (0.5-1%) of women may experience 
three or more successive miscarriages, a condition known as “recurrent 
miscarriage” (Bulletti et al., 1996). “Early miscarriage” is defined as 
pregnancy loss during the first trimester of pregnancy (less than 12 weeks of 
gestation) and occurs in up to one in five pregnancies. A “late miscarriage” 
during the second trimester (12-24 weeks of gestation) is less common, 
occurring in 1-2% of pregnancies (Hay, 2004). Foetal death from the 25th week 
of gestation onwards is defined as stillbirth (Figure 1.5).  
 
Figure 1.5. Adverse pregnancy outcomes throughout gestation. (Image from Giakoumelou 
et al., 2015, reproduced with publisher's permission). 
Although miscarriage is considered the most common adverse pregnancy 
outcome, worldwide figures are not available. It is generally accepted that 
miscarriage occurs in 20% of all pregnancies (Everett, 1997; Hure et al., 2012). 
Measurements from a recent Australian prospective cohort study including 
14,247 women aged 18-23 years, indicate a miscarriage rate between 11.3 to 
86.5 per 100 live births amongst different groups. Miscarriage occurred in 25% 
of the women in the study when the women were 31-36 years old (Hure et al., 
2012). Contributing to the inaccuracy of miscarriage statistics is the fact that 
many miscarriages remain unreported and are managed at home.  
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Miscarriages are associated with physical and psychological morbidity. An 
early miscarriage is managed expectantly, medically or surgically often with no 
complications, however 2-3% of patients may develop an infection (Trinder et 
al., 2006). Bleeding due to miscarriage can lead to haemodynamic shock and 
maternal death (Everett, 1997). The emotional response of a woman to 
miscarriage can include depression and anxiety (Blackmore et al., 2011). It was 
reported that 25% of women one month after miscarriage display symptoms of 
post-traumatic stress disorder (PTSD) and depression. Four months after the 
occurrence, PTSD symptoms were reduced to 7% of the population, however 
depression rates remained similar, an indication as to how seriously an adverse 
pregnancy outcome can affect the psychological health of a woman (Engelhard 
et al., 2001). 
1.2.1.2  Aetiology of miscarriage 
Approximately 50% of early miscarriages are attributed to chromosomal 
aberrations such as a structural alteration or abnormal chromosomal numbers 
of the foetus (Eiben et al., 1990; Suzumori and Sugiura-Ogasawara, 2010). 
Several other factors have been associated with increased risk of miscarriage. 
The age of both parents has a significant role as the risk of an adverse 
pregnancy outcome is increased if the parents are 35 years old or older and it is 
50% higher if the mother is 42 years of age (Fretts et al., 1995; de la 
Rochebrochard and Thonneau, 2002; Maconochie et al., 2007; Nybo Andersen 
et al., 2000; Slama et al., 2005). In addition, factors such as ethnic origin, 
psychological state of the mother, very low or very high pre-pregnancy BMI, 
feelings of stress, use of non-steroidal anti-inflammatory drugs, smoking and 
alcohol consumption have also been associated with significantly higher rates 
of miscarriage (Coste et al., 1991; Lashen et al., 2004; Maconochie et al., 
2007; Nielsen et al., 2001; Sopori, 2002). Moreover, it has been reported that 
women whose first pregnancy resulted in miscarriage are at a higher risk of the 
second pregnancy resulting in miscarriage compared to women who had a live 
birth (Kashanian et al., 2006).  
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1.2.1.3  The role of infection in miscarriage 
Maternal infection causes 15% of early miscarriages and 66% of late 
miscarriages (Baud et al., 2008; Srinivas et al., 2006). It has been reported that 
78% of 101 tissue samples from miscarriage were infected with bacteria 
(chorioamnionitis), whereas all the control samples from medically-induced 
abortions were uninfected in the same study (Allanson et al., 2010). Studies 
published in the last five years suggest that infections such as bacterial 
vaginosis, malaria, cytomegalovirus, dengue fever, brucellosis and HIV may 
result in miscarriage (reviewed in Giakoumelou et al., 2015, Appendix 2). On 
the contrary, there is no evidence to support that Coxiella burnetii, adeno-
associated virus, Bocavirus, Hepatitis C and Mycoplasma genitalium are 
associated with miscarriage. More importantly though, there are contradicting 
data regarding the effects of Ct, Toxoplasma gondii, Human papillomavirus, 
human herpes virus 1&2, Polyomavirus BK, Hepatitis B and B19V infection. 
The study quality and results reported in each individual study have been 
assessed in the review included in Appendix 2 (Table 1.1,from Giakoumelou et 
al., 2015). 
Table 1.1. Pathogens and their association with miscarriage (from Giakoumelou et al., 
2015, reproduced with publisher's permission). 
 
1.2.1.4  The role of Ct infection in miscarriage  
Several studies have been published regarding the association of Ct with 
miscarriage and they will be discussed in more detail in Chapter 5. Briefly, 
active infection has been shown to be associated with miscarriage in two 
studies (Vigil et al., 2002, Arsovic et al., 2014), however a number of studies 
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reported no association between active infection and miscarriage (Baud et al., 
2011; Grönroos et al., 1983; Munday et al., 1984; Sozio and Ness, 1998). On 
the contrary, studies have been published in support of the association of past 
Ct infection with miscarriage, with Ct prevalence ranging between 11%-69% 
in miscarriages compared to 2-7% in healthy pregnant controls (Arsovic et al., 
2014; Baud et al., 2011; Licciardi and Grifo, 1992; Wilkowska-Trojniel et al., 
2009), a fact disputed only by one study (Paukku et al., 1999). 
1.2.2 The role of Ct infection in low birth weight, 
premature labour and intrauterine growth 
restriction 
1.2.2.1 Definitions, prevalence statistics and aetiology 
Low birth weight is defined by the World Health Organisation (WHO) as birth 
weight below 2,500g and is a significant cause of neonatal mortality and 
childhood morbidity (Kramer, 1987; McCormick, 1985). The most recent 
prevalence data from the US show that 8.0% of babies born in 2014 were born 
with low birth weight, a percentage that remains unchanged since 2013 
(National Vital Statistics Reports, 2015). In England and Wales in 2015, 7% of 
babies had low birth weight, a percentage that remains unchanged since 2011 
(Low birth weight of term babies, 2015). Low birth weight infants have been 
shown to have decreased motor development and have moderate-to-severe 
deficits in academic achievement, attention problems and internalising 
behavioural problems that continually hinder these individuals compared to 
their peers up to early adulthood (Aarnoudse-Moens et al., 2009; de Kieviet et 
al., 2009). Low birth weight can be attributed to either premature delivery or 
intrauterine growth restriction commencing as early as the first trimester 
(Kramer, 1987; Smith et al., 1998).  
Labour can be termed “preterm” or premature if the onset of labour is prior to 
37 weeks of gestation (CDC - Centre for Disease Control and Prevention, 
2013). Cases are classiffied as “extremely preterm” when gestational age is less 
than 28 weeks, “very preterm” when gestational age is between 28 and 32 
weeks and as “moderate to late preterm” from 32 to less 37 gestational weeks. 
The most recent prevalence data from the US show that 11.4% of babies born 
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in 2013 were born prematurely (CDC - Centre for Disease Control and 
Prevention, 2013). Premature labour has been associated with intrauterine 
growth restriction (Ananth et al., 2001).  
Intrauterine growth restriction (IUGR) is most commonly defined as 
embryonic weight decreased by 10% compared to the expected weight at any 
gestational age and it occurs in approximately 10% of pregnancies (American 
College of and Gynecologists, 2013). IUGR is a significant cause of morbidity 
and mortality among premature neonates (Garite et al., 2004). The aetiology of 
IUGR is attributed to maternal, placental and foetal causes (reviewed in Suhag, 
A & Berghella, 2013). Known maternal risk factors for IUGR include parity, 
maternal age, a history of preterm delivery, smoking, short stature, low weight, 
low weight gain (Horta et al., 1997; Wen et al., 1990) and many more. IUGR 
caused by placental insufficiency occurs in up to 3% of all pregnancies (Suhag, 
A & Berghella, 2013). The most common causes include abnormal 
implantation such as placenta previa, reduced uterine blood flow and reduced 
placental nutrient transport (Ananth et al., 2001; Battaglia, 2003; Laurini et al., 
1994). Similar results identifying these parameters have been previously 
demonstrated by IUGR animal models such as sheep and rat (Block et al., 
1990; Gilbert and Leturque, 1982). Furthermore, disruptions of the innate 
immune system in the fetomaternal interface including the lack of dendritic cell 
activation in the maternal decidua have also been demonstrated in IUGR 
pregnancies (Cappelletti et al., 2013). Common foetal factors known to result 
in IUGR are often genetic such as chromosomal abnormalities (Snijders et al., 
1993). Additionally, preeclampsia is a serious condition that can occur in 
pregnancy after 20 weeks and is associated with premature labour and IUGR 
(Srinivas et al., 2009). Finally, it has been suggested that maternal infection 
with some pathogenic factors might result in IUGR, however the data is sparse 
and further studies are required identify potential risk factors (reviewed in 
Vedmedovska et al., 2015). 
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1.2.2.2 The role of Ct infection in low birth weight, premature 
labour and intrauterine growth restriction 
A prospective study of 801 women within 22 to 30 weeks of gestation 
examined the role of several pathogens including Ct in IUGR and preterm 
delivery (Investigators of the John Hopkins Study of Cervicitis and Adverse 
Pregnancy, 1989). Active Ct infection was significantly associated both with 
intrauterine growth retardation (odds ratio = 2.4, 90% Confidence Interval (CI) 
1.32-4.18) and preterm delivery (odds ratio = 1.6, 90% CI 1.01-2.50) after 
adjustment for confounding factors (Investigators of the John Hopkins Study of 
Cervicitis and Adverse Pregnancy, 1989). Conversely, in a 1994 cohort study 
of 13,914 women, active Ct infection was not associated with IUGR (Germain 
et al., 1994). The above studies both used cell culture as a detection method for 
Ct infection. New diagnostic tests with higher sensitivity than cell culture have 
been developed such as PCR detection (Centers for Disease Control and 
Prevention., 2014) and a new study should be carried out to investigate the 
association of Ct infection and IUGR utilising modern detection methods. 
A strong association of Ct infection with premature birth is supported by data 
from several case control, cohort, retrospective or prospective studies 
(Andrews et al., 2000; Baud et al., 2015; Folger, 2013; Hollegaard et al., 2007; 
Martius et al., 1988; Rours, de Krijger, et al., 2011; Rours, Duijts, et al., 2011). 
Ct was detected in 25% of IUGR placentae and was shown to induce placental 
inflammation (Rours, de Krijger, et al., 2011). 
There is little evidence regarding the role of Ct infection with low birth weight. 
Among women with diagnosed Ct infection, recent Ct infection was identified 
as a risk factor for low birth weight compared to persistent Ct infection 
(Berman et al., 1987). A study associated maternal Ct infection with 
bronchopulmonary dysplasia in very low birth weight babies (Da Silva et al., 
1997), however another study reported zero prevalence of Ct infection in low 
birth weight babies (Garland and Bowman, 1996).  
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1.3 The role of the maternal environment in 
successful pregnancy 
A receptive uterus and successful implantation are crucial factors for normal 
pregnancy development.  
1.3.1 Endometrial decidualisation and embryo 
implantation  
 
1.3.1.1 Anatomy of human endometrium  
The human endometrium is the innermost layer of the human uterus (Figure 
1.6). It undergoes cyclic remodelling in response to sex steroid hormones 
during the menstrual cycle. The endometrium is comprised of luminal 
epithelial cells and beneath them lies a stromal compartment that contains 
endometrial fibroblasts/stromal cells (ESC), blood vessels created by 
endothelial cells, secretory epithelial cells forming glands and several types of 
immune cells including the uterine natural killer cells (uNK), DCs and 
macrophages (Aplin et al., 2008a). 
 
Figure 1.6. Anatomy of the human uterus. 
The endometrium is composed of two layers; the basalis or basal layer and the 
functionalis or functional layer. The basal layer is located over the 
myometrium and does not alter significantly during the menstrual cycle. The 
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functional layer contains the stromal compartment and the luminal epithelium 
that are affected cyclically by the steroid hormones during the menstrual cycle 
(Aplin et al., 2008a).  
1.3.1.2 Endometrial decidualisation 
A 28-day menstrual cycle has three distinct phases: 
• Proliferative phase (days 5–14 of a 28-day menstrual cycle)  
During the proliferative phase, the functional layer including the stromal 
compartment and the luminal epithelium regenerate, recovering from the 
previous menstrual phase. The main hormone of this phase is estrogen whose 
actions are mediated via various receptors. The endometrial thickness is 
increased from 1mm to 3-4 mm by ovulation (Figure 1.7, Aplin et al., 2008a).  
• Secretory phase: Decidualisation (days 14–28 of a 28-day menstrual 
cycle) 
Around day 14 of a 28-day menstrual cycle, under the influence of anterior 
pituitary gland hormones luteinising hormone (LH) and follicle-stimulating 
hormone (FSH), ovulation occurs. During the secretory phase, the dominant 
hormone in the endometrium is progesterone that is secreted by the corpus 
luteum that in the ovary from a follicle following oocyte ovulation (Aplin et 
al., 2008a; Graham and Clarke, 1997). In early secretory phase, the 
endometrial glands proliferate and, at a later stage, angiogenesis occurs whilst 
the stromal compartment undergoes decidualisation increasing in thickness.  
Endometrial decidualisation is the process whereby, under the influence of 
estrogen and progesterone (P4), the stromal compartment of the endometrium 
proliferates and differentiates during the mid secretory phase of the menstrual 
cycle (Figure 1.7, Aplin et al., 2008a). This process ensures that the 
endometrium transiently becomes receptive to a blastocyst during a brief 
period called the “window of implantation” at days 18-22 of a 28-day 
menstrual cycle (Gellersen and Brosens, 2014a). The ESC undergo structural 
changes as they become rounder and bigger as well as functional changes 
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displayed by secretion of decidualisation-specific markers such as prolactin 
(PRL, Gellersen and Brosens, 2014). Primary cells isolated from human 
endometrium have been used in in-vitro studies as a model for investigating the 
molecular events that occur during decidualisation, discussed further in section 
1.3.6. 
The molecular pathways of decidualisation are analysed in section 1.3.1.3. 
• Menstrual phase (days 1–5 of a 28-day menstrual cycle)  
If there is no blastocyst implantation, progesterone secretion ceases and as a 
result of progesterone withdrawal the functional layer of the endometrium is 
shed during the menstrual phase as the cells undergo apoptosis (Figure 1.7, 
Aplin et al., 2008a). 
 
Figure 1.7. The menstrual cycle is governed by ovarian estrogen and progesterone 
secretion. It has three phases; proliferative, secretory and menstrual phase. During the 
proliferative phase, the functional layer of the endometrium regenerates under the influence of 
estrogen. When secreted estrogen levels drop, due to an increase in progesterone the stromal 
compartment commences decidualisation during the secretory phase. The stromal cells become 
bigger and rounder and increased angiogenesis is observed as the endometrium prepares of a 
possible blastocyst implantation (termed ‘decidualisation’). In the event of no implantation, 
progesterone levels drop and the functional layer is shed during the menstrual phase. (Image 
drawn by T Pinner and obtained from Prof Philippa Saunders). 
 
1.3.1.3 The fetomaternal interface during implantation 
In humans, the embryo enters the uterine cavity at 72–96 hours after 
fertilization. Hatching of the embryo (escape from the zona pellucida) occurs 
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by day 5 (about 110–120 hours after ovulation). The embryo is prepared to 
implant, however whether this occurs depends on maternal receptivity and 
whether implantation occurs during the window of implantation (Gellersen et 
al., 2010).  
A successful pregnancy depends upon maternal receptivity during the 
implantation window. The importance of conception timing and ovulation has 
been of interest for several years. In a prospective study of 221 women 
attempting to get pregnant, it was shown that 84% of implantations occurred 8-
10 days post ovulation and late implantation was associated with early 
pregnancy loss (Wilcox et al., 1999). Implantation is a process that involves 
maternal and embryonic participation and interaction, however as the above 
study highlights, a healthy embryo is unlikely to survive in a non receptive 
uterus (Lessey, 2000).  
Placenta formation begins as the embryonic trophoblast cells come into contact 
maternal epithelium (blastocyst apposition) and differentiate further into 
syncytiotrophoblast cells that invade the epithelial layer during blastocyst 
adhesion (Figure 1.8A). Syncytiotrophoblasts, supported by the decidualised 
stroma (Godbole et al., 2011), penetrate the endometrium and surround the 
embryo, whilst it embeds itself in the stromal compartment at the final stage of 
implantation (blastocyst invasion/embedment). A second trophoblast layer, the 
cytotrophoblast, is an inner layer without contact with the maternal cells. At 
days 10-12 of gestation, the embryo is completely embedded in the 
endometrium, the epithelium has grown over it and the implantation process is 
complete (Figure 1.8B). The maternal decidua is not “passive” during the 
invasion process as it was widely believed for many decades; on the contrary it 
was recently shown that the ESC acquire invasive capabilities in response to 
trophoblast-derived signals and ESC migration is essential to facilitate 
implantation (Gellersen et al., 2010; Grewal et al., 2008).  
Trophectoderm in the blastocyst gives rise to the trophoblast lineages of the 
placenta, whereas the placental stroma and vasculature rise from the 
extraembryonic mesoderm. 20-22 days post conception, vasculogenesis 
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commences as the first placental villi appear. The foetal heart begins beating 
around day 22 of gestation, the embryonic circulatory system is formed around 
day 32 and by day 45 blood begins to circulate in the placenta (Gellersen et al., 
2010; Godbole et al., 2011; Grewal et al., 2008). 
Cytotrophoblast invasion of the uterine wall begins after implantation until 
week 18 of gestation. As a result, cytotrophoblast cells infiltrate the maternal 
decidua and spiral arteries, reaching as far as the uterine myometrium during 
the second semester. The invasion of the maternal spiral arteries is essential for 
the transformation of the vessels during pregnancy, that includes the loss of 
vascular smooth muscle that results in reduced blood flow typical of the 
fetomaternal interface during pregnancy (Gellersen et al., 2010; Godbole et al., 
2011; Grewal et al., 2008). 
 
Figure 1.8. Blastocyst implantation in receptive human uterus during the window of 
implantation. (A) The trophoblast comes into contact with the epithelium and differentiates 
further into syncytiotrophoblast that invades the epithelial layer. (B) Syncytiotrophoblasts, 
supported by the decidualised stroma penetrate the endometrium and surround the embryo, 
whilst it embeds itself in the decidual stroma. The implantation process is complete by day 12 
of gestation, rendering the embryo completely embedded in the endometrium (from 
Giakoumelou et al., 2015, reproduced with publisher's permission).  
The process of implantation is highly complex and, although many key 
pathways involved have been identified, new discoveries are still made 
(reviewed in Salamonsen et al., 2015). P4 is an important regulator of 
endometrial receptivity during the menstrual cycle and can also negatively 
regulate trophoblast invasion via regulation of the matrix metalloproteinases 
(MMPs, reviewed in Halasz and Szekeres-Bartho, 2013). MMPs mediate 
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extracellular matrix degradation and are involved in several normal and 
pathological processes, including implantation (reviewed in Nardo et al., 
2003). The blastocyst also utilises adhesion proteins, called integrins, during 
the implantation window (Merviel et al., 2001). In addition, the blastocyst has 
been shown to regulate apoptosis of the maternal epithelial cells in-vitro via the 
Fas ligand pathway (Galán et al., 2000). Several studies confirm heparin-
binding epidermal growth factor (HB-EGF) is required for trophoblast cell 
survival, in particular during hypoxic conditions (Armant et al., 2006; Imudia 
et al., 2008). The action of HB-EGF is known to impact on decidual ESC 
polyploidy and was shown to be mediated by cyclin D3 (Tan et al., 2004). 
Increased HB-EGF levels were reported in maternal decidual cells and 
placental stromal cells from miscarriages compared to normal pregnancies 
(Ozbilgin et al., 2015). Finally, deregulation of serum and glucocorticoid-
inducible kinase 1 (SGK1) were shown to interfere with implantation and 
predispose to pregnancy complications such as RPL (Salker et al., 2011). 
1.3.2 Molecular pathways of endometrial decidualisation  
Several molecular cues, pathways and cell types are involved in stromal cell 
transformation to decidualised ESC. Decidualisation in humans will be 
discussed first, followed by decidualisation in mice. 
1.3.2.1 Endocrine signalling  
As mentioned in paragraph 1.3.1 estrogen and P4, the ovarian steroid 
hormones, predominantly control uterine physiology (Gellersen and Brosens, 
2014a). The postovulatory rise in circulating progesterone, produced by 
luteinizing granulosa cells, dictates the onset of decidualisation of estrogen-
primed endometrium (Aplin et al., 2008b).  
1.3.2.2 Autocrine and paracrine signalling 
The endometrial microenvironment is crucial to decidualisation; autocrine 
signals from ESC and paracrine cues from neighbouring cell populations such 
as epithelial cells, immune cells and endometrial vasculature cells all 
contribute to successful decidualisation (Gellersen and Brosens, 2014a).  
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1.3.2.2.1 Prolactin (PRL) 
PRL is a peptide hormone and its levels are correlated with the progression of 
ESC decidualisation (Bole-Feysot et al., 1998), hence its extensive use as a 
decidualisation marker in in-vitro studies (Telgmann and Gellersen, 1998). 
PRL expression is regulated by P4 (Brosens et al., 1999). The role of PRL in 
decidualisation and early pregnancy, though crucial, is not completely known 
yet. It is has been reported that PRL has an active role in epithelial cell 
differentiation, as it has been shown to promote epithelial cell growth via 
crosstalk with the epidermal cell factor. It is known to be implicated in immune 
cell regulation, to induce angiogenesis and promote trophoblast cell growth and 
invasion (Corbacho et al., 2002; Montgomery, 2001; Reuwer et al., 2012; 
Stefanoska et al., 2013). PRL also plays an important role in implantation and 
early pregnancy as it has been demonstrated that prolactin receptor (PRLR) 
knock-out mice have implantation failure (Lucas et al., 1998). PRLR has also 
been shown to increase cell proliferation, implantation, angiogenesis, 
trophoblast cell growth and immune regulation during early pregnancy 
(Jabbour and Critchley, 2001). More recently it was shown that this effect 
attributed to ovarian not uterine PRLR (Reese et al., 2000).  
1.3.2.2.2 Growth factors 
Decidualisation induces the expression of soluble and transmembrane HB-
EGF, which has many roles in pregnancy. It facilitates embryo development, 
mediates implantation and is thought to have a function in endometrial 
receptivity and maturation (as reviewed in Iwamoto and Mekada, 2000; Raab 
and Klagsbrun, 1997).  
Regarding in-vitro decidualisation, HB-EGF and its receptors EGFR and 
ERBB4/HER4 are increased in ESC after cAMP treatment and its expression is 
regulated by TNFα and TGFβ, which suggests that it inhibits stromal cell 
apoptosis whilst a decidualisation signal is present. Inhibition of HB-EGF 
results in reduction of PRL and IGFBP1 (Chobotova et al., 2005).  
 Members of the transforming growth factor β (TGFβ) superfamily, including 
activins, inhibins and follistatin, play a major role in the paracrine/ autocrine 
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regulation of the decidual process (as reviewed in Jones et al., 2002). TGFβ is 
a multifunctional modulator that is involved in processes ranging from 
apoptosis promotion to cell differentiation both in health and disease in various 
cell types and tissues (as reviewed in Wajant et al., 2003). It has three 
isoforms, TGFβ1-3. TGFβ1 is induced by progesterone by endometrial 
epithelial cells in-vitro and acts on stromal cells to commence PRL secretion 
(Kim, 2006). Another autocrine modulator, a TGFβ family member, is 
LEFTY2, an important inhibitor of the NODAL signalling pathway (Derynck 
and Zhang, 2003; Saijoh et al., 2000). LEFTY2 is increased during 
decidualisation and is activated by pro-protein convertase 5/6 (PC5/6, Okada et 
al., 2005; Tang et al., 2005). PC5/6 also activates vascular endothelial growth 
factor (VEGF, Siegfried et al., 2003). VEGF, a known proangiogenic 
modulator (as reviewed in Ferrara et al., 2003) is known to be activated by 
cAMP (Popovici et al., 1999) and was shown to be increased in an in-vitro 
decidualisation model (Matsui et al., 2004). Endothelial growth factor (EGF) is 
another angiogenic factor that was recently shown to be increased during the 
secretory phase together with VEGF (Möller et al., 2001), however its role in 
decidualisation has not been further investigated. 
Furthermore, activin and inhibin pathways as well as notch and lipid signalling, 
such as endocannabinoids and phosphatidic acid are also involved in 
decidualisation (as reviewed in Gellersen and Brosens, 2014). 
1.3.2.3 Regulation of endometrial decidualisation  
Progesterone and cAMP signalling pathways are crucial for successful 
decidualisation and both are required for the process to be completed (Brosens 
et al., 1999). 
P4 acts by binding and activating progesterone receptor (PGR). Two main PGR 
isoforms act in the endometrium, PGRA and B, which are both regulated by 
estrogen (Kastner et al., 1990). PGRA and PGRB regulate different genes and 
pathways and PGRA even acts as a suppressor of PGRB (Gao et al., 2000; 
Kastner et al., 1990; Lockwood et al., 2000). Progestin-dependent activation of 
the MAPK pathway through c-Src is mediated by PGRB (Migliaccio et al., 
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1998). PGRB together with the estrogen receptor B also induce MAPK and 
AKT activation in response to progestin signalling (Vallejo et al., 2005).  
PGRA is the main PGR isoform in the endometrial stromal compartment (Mote 
et al., 1999). It was also shown to be a stronger activator of insulin-like growth 
factor-binding protein 1 (IGFBP1) and decidual PRL promoters than PGRB 
(Christian, Pohnke, et al., 2002; Gao et al., 2000). 
Cyclic adenosine monophosphate (cAMP) is a ubiquitous second messenger 
produced upon binding of extracellular ligands to Gs protein coupled receptors. 
Subsequent activation of membrane-bound adenylyl cyclase leads to generation 
of cAMP from adenosine triphosphate (ATP). A major target for cAMP is 
protein kinase A (PKA), a holoenzyme composed of two regulatory and two 
catalytic subunits. Binding of two cAMP molecules to each regulatory subunit 
leads to dissociation of the catalytic subunits, which in turn catalyse 
phosphorylation of various cytoplasmic target proteins (as reviewed in 
Skalhegg and Tasken, 2000). Catalytic subunits also phosphorylate and 
activate nuclear targets like cAMP response element (CRE) binding protein 
(CREB) or the related CRE modulator (CREM) (as reviewed in Lamas et al., 
1996; Mayr and Montminy, 2001) that act as activators of a plethora of genes.  
Together, cAMP and progesterone are known to significantly induce 
expression of decidualisation markers IGFBP1 and PRL in-vitro decidualised 
ESC, thus providing a reliable in-vitro model of decidualisation (Brosens et al., 
1996, 1999). Many other genes are induced or suppressed during 
decidualisation and some of them have been identified in a microarray analysis 
of human decidualisation (Brar et al., 2001). 
Crucial to the decidualisation process, downstream of PI3K/AKT pathway are 
the Forkhead box (FOXO) subfamily of Forkhead transcription factors that are 
involved in cell cycle arrest, senescence, and apoptosis as well as cellular 
differentiation (as reviewed in Accili and Arden, 2004; Downward, 2004; 
Greer and Brunet, 2005). Phosphorylation in response to SGK1 or AKT results 
in the cytoplasmic retention of FOXO3A resulting increased proliferation 
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(Brunet et al., 2001). FOXO1 is significantly upregulated in the human 
endometrium during decidualisation in-vivo, an effect also seen in-vitro 
(Christian, Zhang, et al., 2002; Labied et al., 2006). FOXO1 is required to 
activate IGFBP1 and PRL in ESC (Gao et al., 1999; Kim et al., 2005). 
IGFBP1 and PRL are also regulated by HOX transcription factors, proteins that 
bind DNA through a conserved sequence, the homeobox. HOXA10 and 
HOXA11 both can induce these two classic decidualisation markers (Godbole 
and Modi, 2010; Lynch et al., 2009). 
A plethora of other signalling pathways, molecules and transcription factors are 
involved in decidualisation, an indication of how tightly regulated this process 
is in humans (reviewed in Gellersen and Brosens, 2014b).  
1.3.3 Decidualisation and early pregnancy in mice 
1.3.3.1 Anatomy of the mouse uterus and estrous cycle 
The mouse (Mus musculus) reproductive tract is bilateral as it consists of two 
ovaries, a bicornuate uterus (two oviducts, two uterine horns), one cervix and 
one vagina (Figure 1.9). All these organs respond to hormonal changes due to 
the mouse estrous cycle and are very dynamic as they undergo many 
morphological changes during estrous cycles and gestation (Bertolin and 
Murphy, 2014).  
The mouse uterus consists of the perimetrium, myometrium, endometrium, 
lumen, endometrial epithelium, stromal compartment that contains several 
immune cells and the uterine glands (Figure 1.9E). The mesometrium (the part 
that is closer to the abdominal cavity and contains uterine vessels and nerves) 
when decidualised contributes to the formation of placenta. The 
antimesometrial region (opposite the mesometrium) decidua supports the 
embryo during early pregnancy (reviewed in Groothuis et al., 2007).  
In female mice, similarly to women, gonadotropin-releasing hormone (GnRH) 
released by the hypothalamus causes secretion of LH and FSH from the 
gonadotrophs of the anterior pituitary, leading to ovulation (Bertolin and 
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Murphy, 2014). Ovarian follicles secrete estrogen, the action of which is 
followed by progesterone to render the endometrium receptive to implantation 
(Groothuis et al., 2007).  
 
Figure 1.9. Mouse uterus during the four phases of the estrous cycle. (A–D) Female 
internal reproductive tract, (O - ovary, OV - oviduct, U – uterus, C – cervix). Scale bars 
represent 2 mm. (E–H) Bright field microscopy images of hematoxylin–eosin stained sections 
of the mouse uterus (P – perimetrium, M – myometrium, E – endometrium, L – lumen, Ep - 
endometrial epithelium, St - stromal compartment, Ug - uterine glands) Scale bars represent 0.1 
mm. Image adapted from Bertolin and Murphy, 2014. 
The equivalent of the menstrual cycle in rodents is called the estrous cycle, 
lasts approximately 4-5 days and has many similarities to the menstrual cycle 
(reviewed in Groothuis et al., 2007).  
The estrous cycle in mice consists of four stages: 
• Proestrus (day 1) 
This stage corresponds to the proliferative phase of the menstrual cycle, 
characterised by follicle and uterine growth. During this stage, a Prl surge 
occurs following the LH and FSH surge (Figure 1.9A,E, reviewed in 
Bertolin and Murphy, 2014; Groothuis et al., 2007).  
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• Estrous (day 2) 
This stage is similar to the early secretory phase of the menstrual cycle; 
following ovulation there is a shift from estrogen to progesterone secreted by 
the corpus luteum as the main hormone influencing the murine endometrium. 
During this phase the female is receptive “in heat”. Furthermore, observed Prl 
concentrations peak during this phase (Figure 1.9B,F, reviewed in Bertolin and 
Murphy, 2014; Groothuis et al., 2007).  
• Metestrous (day 3) 
Corresponds to late secretory phase of humans. Progesterone secretion inhibits 
LH and thus prevents further ovulation. Towards the end of metestrous of an 
unmated mouse, the corpus luteum ceases progesterone secretion as it becomes 
non functional (Figure 1.9C,G, reviewed in Bertolin and Murphy, 2014; 
Groothuis et al., 2007).  
• Diestrous (day 4) 
Similar to late secretory/ menstruation phase. Regression of the corpus luteum, 
followed by reabsorption of the endometrium in the uterus instead of menstrual 
shedding. Finally, estrogen levels start to increase preparing for the next 
proestrous phase. (Figure 1.9D,H, reviewed in Bertolin and Murphy, 2014; 
Groothuis et al., 2007). 
1.3.3.2 Decidualisation, implantation and early pregnancy in mice  
Another major similarity between humans and mice is that implantation is 
critical to a successful pregnancy and occurs only during an “implantation 
window” during which the endometrium is receptive to the embryos (Favaro et 
al., 2014; Yoshinaga, 1988). 
Trophoblast differentiation in the mouse begins with the embryo polarisation at 
the 8-cell stage (reviewed in Sutherland, 2003). The outer polarised cells form 
the epithelial trophectoderm layer of the trophoblast that at the time of 
implantation transform to the invasive population called trophoblast giant cells. 
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These cells mediate embryo invasion in the uterus and vasculogenesis, as seen 
in Figure 1.10. This transformation includes morphological changes such as 
cytoskeleton modifications and is a complex process that involves factors such 
as Oct3/4 and Cdx2 (Carney et al., 1993; Niwa et al., 2005; Parast et al., 2001; 
Ralston and Rossant, 2008; Strumpf et al., 2005). Once the giant trophoblast 
cells adhere to the uterine epithelium, the epithelial cells undergo apoptosis and 
the giant trophoblast cells contact first the epithelial membrane and then the 
decidualised stromal cells as they invade the uterus (Favaro et al., 2014; Parr et 
al., 1987; Sutherland, 2003). Maternal receptivity is mediated mainly by 
estrogen and P4 action in the endometrium through a highly complex and 
tightly regulated process leading to decidualisation (reviewed in Ozturk and 
Demir, 2010). The blastocyst growth stage also known to influence maternal 
receptivity (Paria, Huet-Hudson, et al., 1993).  
 
Figure 1.10. Transition of the trophectoderm to an invasive phenotype. The hatched 
blastocyst has a polarized, transporting, epithelial trophectoderm layer (TE), which exhibits no 
motility. The trophectoderm can be divided into two regions based on proximity to the inner 
cell mass (ICM): the polar TE (in green) and the mural TE (in yellow). As the blastocyst 
becomes competent to implant, the TE cells alter their polarity and begin to extend apical 
protrusions. During implantation in-vivo, these protrusions aid in displacement and 
phagocytosis of the apoptotic uterine epithelial cells, and give rise to the laminar extensions 
that ultimately form the blood sinuses of the yolk sac placenta. Figure from open access article 
(Sutherland, 2003). 
Hb-egf is the first marker of embryo implantation in the mouse. It is expressed 
in the luminal epithelium prior to implantation at the site of blastocyst 
apposition on day 4 of gestation (Das et al., 1994). Hb-egf was also shown to 
activate the epidermal growth factor receptor (Egfr, Das et al., 1994) that is 
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known to be expressed by the blastocyst trophectoderm and its expression is 
regulated by maternal steroid hormones (Paria, Das, et al., 1993). Hb-egf was 
later shown to be also expressed by the mouse uterus at the site of 
implantation, therefore suggesting involvement in foeto-maternal cross-talk 
during implantation (Hamatani et al., 2004). Furthermore, Hb-egf-/- mice 
display reduced litter size as a result of defective implantation.  
The prolactin homologue in the mouse (Prl) has multiple roles during 
decidualisation and early gestation. It is also responsible for the mammary 
gland development during early pregnancy (reviewed in Mizoguchi et al., 
1997). 
1.3.4 The role of the immune system in endometrial 
decidualisation and implantation 
1.3.4.1 Innate immune system in early pregnancy  
Evidence has emerged in the past few years supporting multiple roles of 
immune system regulators in decidualisation, angiogenesis and implantation 
during early pregnancy (Bowen et al., 2002; Nagamatsu and Schust, 2010). 
Whilst the immune tolerance of the semi-allogeneic foetus is maintained, 
several components of the immune system fulfil their designated roles in 
preparation for implantation as well as during gestation (Chaouat et al., 2004; 
Entrican, 2002).  
NK cells, macrophages and DCs have all been detected in the foeto-maternal 
interface and there is strong evidence of the critical role of the maternal innate 
immune system in early pregnancy (Gardner and Moffett, 2003; Guleria and 
Pollard, 2000; Moffett-King, 2002).  
Approximately 40% of cells in the decidua are uNK (CD56brightCD16- NK 
cells) that are in immediate contact with invading extravillous trophoblasts 
(Bulmer et al., 1991; Hanna et al., 2006) CXCL12 expression by invasive 
trophoblasts induces the specific migration of CD16- human NK cells, human 
placental cytotrophoblasts attract monocytes and CD56bright NK cells via the 
actions of MIP1a (Wu et al., 2005). Hanna et al demonstrated in-vitro and in-
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vivo that decidual NK cells regulate trophoblast invasion by production of the 
interleukin-8 (CXCL8/IL8) and interferon-inducible protein–10 chemokines 
(Hanna et al., 2006) 
Macrophages in the placental bed have been shown to induce apoptosis of 
extravillous trophoblast via tumour necrosis factor α (TNFα) secretion, that 
resulted in limited extravillous trophoblast invasion of spiral arterial segments 
in-vitro (Reister et al., 2001).  
1.3.4.2 Adaptive immunity in early pregnancy  
Cytotoxic immune cells, including T-cells and B cells are not entirely absent 
during gestation. Gestation is not immunologically privileged; rather the 
maternal immune system is accepting a semi-allogeneic foetus. Several aspects 
of the processes governing maternal acceptance have been investigated and it is 
now known that multiple mechanisms are involved, making this process highly 
complex and tightly regulated (Chaouat, 2007; Entrican, 2002). 
The traditional view of maternal acceptance was a shift in the ratio of Th1/Th2 
cells in the uterus towards the Th2 during gestation, suggesting that Th1 
population decrease is essential for the maternal acceptance of the semi-
allogeneic foetus (Chaouat, 2007). Women with recurrent miscarriage 
displayed non-pregnancy Th1/Th2 ratio, indicating the shift to Th2 did not 
occur post conception (Reinhard et al., 1998). However, research emerging 
during the past few decades has revealed several other mechanisms and cell 
types involved in maternal acceptance. 
Decidualised ESC have been shown to actively ensure that the foeto-maternal 
interface is populated by CD56bright NK cells and macrophages but not CD56dim 
NK cells, T-cells, B cells or uterine DCs (uDCs, Silasi and Mor, 2012; Volchek 
et al., 2010). Normally, DCs initiate T-cell responses to antigens they present 
in lymph nodes. However, uDCs have been shown in mice studies to be 
“entrapped” in the decidua and thus unable to present antigens in lymph nodes 
(Collins et al., 2009; Tagliani and Erlebacher, 2011). Another mechanism via 
which T-cell recruitment in the uterus is minimised is epigenetic silencing of 
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chemokines that attract T-cells (Nancy et al., 2012). Inflammatory cytokines 
such as IFN-γ and TNFα are not usually expressed in the placenta and have 
been associated with miscarriage in mouse models (Entrican, 2002).  
Treg cells control immune homeostasis and immunosuppression (Saito et al., 
2010). Studies have demonstrated that unexplained infertility, miscarriage and 
preeclampsia are often associated with deficit in Treg cell number and function 
while normal pregnancy selectively stimulates the accumulation of maternal 
forkhead-box-P3+ (FoxP3+) CD4+ Treg cells with foetal specificity (reviewed 
in La Rocca et al., 2014; Roncarolo and Battaglia, 2007). Interleukin-10 (IL-
10), a chemokine that mediates immunosuppression, is known to be highly 
expressed during early pregnancy until before the onset of labour, assisting in 
maternal acceptance and cross-talk between the placenta and decidua 
(reviewed in Thaxton and Sharma, 2010). Finally, the newly discovered 
immune effector cells, T-helper 17 cells (Th17) have also been associated with 
maternal acceptance and their role is still under investigation (Saito et al., 
2010). 
1.3.4.3 Chemokines of particular importance in early pregnancy  
Chemokines are a family of small secreted chemotactic cytokines. The 
chemokine superfamily consists of a large number of ligands and receptors 
with an important role in the immune system (Soares, 2004). According to the 
motif displayed by the first two cysteines at the amino end, they have been 
classified into four families: CXC, CC, XC and CX3C, named due to their 
ability to induce chemotaxis not only on immune cells but also on various other 
cell types (Luster, 1998; Rossi and Zlotnik, 2000).  
1.3.4.3.1 Stromal derived factor 1 (SDF-1/CXCL12)  
Stromal derived factor 1 (SDF-1/CXCL12) is a proliferative and chemotactic 
factor for cells as well as endothelial cells and is also involved in 
haematopoiesis, germ cell development, cardiogenesis and neurogenesis 
together with its receptor CXCR4 (Nagasawa, 2014).  
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Estrogen induces expression of CXCL12 in ESC (Tsutsumi et al., 2011) and 
promotes the survival of secretory phase ESC via CXCL12/CXCR4 up-
regulation-mediated autophagy inhibition (Mei et al., 2015). However, 
CXCL12 levels were not found to be different throughout the menstrual cycle, 
in contrast to CXCR4 levels which were higher in proliferative phase (Laird et 
al., 2011). Laird et al also reported strong immunostainning of CXCL12 and 
CXCR4 in the glandular epithelium and no staining of CXCL12 in stromal 
cells, whereas CXCR4 seemed present in low levels (Laird et al., 2011). 
CXCL12 mRNA was detected in stromal and in decidual endothelial cells and 
its levels in stromal cells were not altered due to progesterone or estrogen 
treatment in another study (Carlino et al., 2008). Another study reported few 
patient samples staining positive for CXCL12 during secretory phase and 
researchers were unable to detect any CXCL12 in cell supernatants in-vitro in 
response to 17β-estradiol or progesterone treatment (Kitaya et al., 2004).  
The CXCL12/CXCR4 axis is involved in the maintenance of Th2 bias at the 
maternal/foetal interface in early human pregnancy (Piao et al., 2012). More 
importantly, CXCL12 controls over-invasion of trophoblasts via upregulating 
CD82 expression in DCs at maternal-foetal interface of human early pregnancy 
in a paracrine manner (Li et al., 2011) and promotes the cross-talk between 
trophoblasts and decidual stromal cells in human first-trimester pregnancy 
(Zhou et al., 2008). This is potentially mediated by recruitment of 
CD56brightCD16- NK cells into decidua due to CXCL12 secretion by 
trophoblast cells (Carlino et al., 2008; Hanna et al., 2003; Wu et al., 2005). 
CsA was shown to increase trophoblast invasiveness through strengthening the 
cross-talk of trophoblasts and decidual stromal cells mediated by CXCL12 and 
CD82 in early pregnancy (Meng et al., 2012). Finally, human cytomegalovirus 
infection was shown to result in trophoblast invasion failure due to CXCL12 
inhibition (Warner et al., 2012).  
In mice, Cxcr4+ DCs were shown to promote angiogenesis during embryo 
implantation (Barrientos et al., 2013). DCs are known to be crucial for mouse 
implantation as depletion of uterine DCs causes implantation impairment that 
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resulted in embryonic resorptions (Plaks et al., 2008). Cxcl12 has also been 
shown to enhance exogenous CD4+CD25+ T-cell migration in the uterus and 
thus prevent embryo loss in non-obese diabetic mice (Lin et al., 2009). 
1.3.4.3.2 CXCL16/ SRPSOX 
CXCL16/ SRPSOX is a recently characterised chemokine (Matloubian et al., 
2000) that together with its receptor CXCR6 (Bonzo/STRL33/TYMSTR) has 
been associated with Th1 cells (Kim et al., 2001), DCs and CD4+ T-cells 
(Tabata et al., 2005) as well as NK cells (Unutmaz et al., 2000). CXCR6 was 
found to be critical for activation, homeostasis and recruitment of natural killer 
T (NKT) (Germanov et al., 2008; Kim et al., 2002). CXCL16 mRNA is 
activated by IFN-γ and TNFα (Abel et al., 2004). Soluble CXCL16 
(chemokine domain) induces chemotaxis of activated T-cells and bone marrow 
plasma cells via its receptor CXCR6, but the transmembrane molecule 
functions as a scavenger receptor for OxLDL, phosphatidylserine, dextran 
sulphate and bacteria and can uptake OxLDL and phagocytose bacteria as well 
as adhere to CXCR6-expressing cells (Abel et al., 2004; Shimaoka et al., 2004; 
Shimaoka et al., 2004 (1)). The CXCL16/CXCR6 pathway has been associated 
also with cancer (Darash-Yahana et al., 2009; Deng et al., 2010), angiogenesis 
(Isozaki et al., 2013) and juvenile idiopathic arthritis (Martini et al., 2008). 
Human trophoblast- recruited T-cells and monocytes into decidua by secretion 
of chemokine CXCL16 and interaction with CXCR6 in the first-trimester 
pregnancy (Huang et al., 2008). Furthermore, CXCL16 has been reported to 
induce proliferation and invasion of first-trimester human trophoblast cells in 
an autocrine manner (Huang, Zhu, et al., 2006).  
In mice, the role of Cxcl16 and its receptor Cxcr6 in pregnancy remains 
unknown. 
1.3.4.3.3 Interleukin 8 (IL8/CXCL8)  
CXCL8 is a proinflammatory chemokine that has many identified roles. It acts 
as a chemoattractant and activator for neutrophils (Das et al., 2010; Himmel et 
al., 2011; Loos et al., 2009) and T-cells (Larsen et al., 1989). It is 
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proinflammatory (as reviewed in Huang et al., 2006), proangiogenic 
(Heidemann et al., 2003) and has also been associated with cancer and 
response to drugs (as reviewed in Gales et al., 2013). It acts via surface 
receptors CXCR1 and CXCR2. 
CXCL8 is expressed in perivascular cells and glandular epithelium and 
increases in late secretory phase endometrium and decidua during early 
pregnancy (Arici et al., 1998; Caballero-Campo et al., 2002; Critchley et al., 
1994; Milne et al., 1999). This effect seems to be induced via lysophosphatidic 
acid (LPA) signalling in ESC through the LPA receptor and Nuclear Factor-
κB-Dependent Pathway (NF-κΒ, Chen et al., 2008). CXCL8 has furthermore 
been reported to increase proliferation of ESC (Arici et al., 1998). CXCL8 
expression in endometrial epithelial and stromal cells is induced by IL-1α and 
TNFα and its mRNA is slightly increased due to progesterone, even though 
there is no significant change in protein levels (Arici et al., 1996). Stable 
protein levels throughout the menstrual cycle were also reported by another 
study that further demonstrated inhibition of CXCL8 secretion by P4 in 
endometrial explants (Kelly et al., 1994). 
Finally, CXCL8 secretion by uNK cells is reported to increase the invasiveness 
of extravillous trophoblast cells treated with conditioned supernatants in an in-
vitro model (De Oliveira et al., 2010). Decidual CXCL8 was shown to enhance 
trophoblast invasion by increasing MMP2 and MMP9 and integrins α5 and β1 
(Jovanović et al., 2010). The human blastocyst does not secrete measurable 
amounts of CXCL8, CCL2 and CCL5, however it does upregulate mRNA and 
protein levels of CXCL8 within endometrial epithelial cells whilst inhibiting 
protein secretion (Caballero-Campo et al., 2002).  
1.3.5 Abnormal decidualisation, implantation and 
placentation in adverse pregnancy outcomes  
As presented above, extensive research indicates that decidualisation and 
implantation are inextricably associated and normal completion of both 
processes is essential for the establishment of a successful pregnancy.  
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1.3.5.1 Abnormal early gestation and miscarriage 
The maternal endometrium plays a very important role to pregnancy outcome. 
It has recently been demonstrated that maternal decidualised ESC actively 
select blastocysts that are of good quality and this ability is not displayed by 
non decidualised stromal cells (Salker et al., 2010; Teklenburg, Salker, 
Molokhia, et al., 2010). Furthermore, both undifferentiated and decidualised 
endometrium has been shown to be altered compared to normal pregnancies in 
women with spontaneous miscarriage (Plaisier et al., 2009). Additionally, 
impaired decidualisation, measured by a reduction in the decidualisation 
marker PRL in the endometrium, has been associated with recurrent 
miscarriage (Salker et al., 2010) and in rodent models decidual cell prolactin 
production is essential for successful pregnancy (Bao et al., 2007).  
The timing of implantation is crucial for pregnancy outcome (Mahendru et al., 
2012). Among the pregnancies examined in this study, from 102 that implanted 
on day 9 after ovulation, 13% ended in early miscarriage. This proportion was 
increased to 26% with implantation on day 10, 52% on day 11, and 82% when 
implantation occurred after day 11 (Mahendru et al., 2012). 
1.3.5.2 Premature labour, low birth weight, IUGR and abnormal 
early gestation  
IUGR has also been linked to abnormal implantation and placentation. Delayed 
implantation was also associated with decreased foetal size in the first trimester 
measured by smaller crown-rump length of the foetus (Mahendru et al., 2012). 
It has been shown that smaller crown-rump length during the first trimester 
correlates with lower birth weight and subsequently IUGR (Salomon et al., 
2011). Furthermore, abnormal implantation that leads to defective placentation, 
such as in the case of placenta praevia, has been linked to low birth weight due 
to premature delivery and IUGR (Ananth et al., 2001). The role of 
decidualisation to development of IUGR, low birth weight and premature 
labour has not yet been elucidated. 
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1.3.6 Studying decidualisation and early pregnancy: in-
vitro and in-vivo models 
In-vitro models have been used in research for many decades. They are 
generally faster and easier to use than in-vivo models. Furthermore, they allow 
for experimentation on primary cells and small tissue samples, thus enabling 
scientists to investigate if certain mechanisms and effects could exist in a living 
subject (Wu and Swartz, 2014). Importantly, they can replace certain in-vivo 
studies and preliminary data from in-vitro studies can inform on subsequent in-
vivo experiments, thus reducing the number of animals required for research. 
As a result, they have a significant ethical advantage over in-vivo studies (Balls 
and M., 2002). However, as in-vitro models consist of the study of either 
individual cells or few cell types in co-culture (primary cells, cell lines or 
combination), they do not represent the complex microenvironment of a tissue 
or organ (James, Carter, et al., 2012). Moreover, in several cases primary cells 
in single cell culture display different behaviour and transcriptional profiles 
due to the lack of interaction with other cell types (James, Carter, et al., 2012). 
The advantages of immortalised cell lines are the ease of obtaining a culture 
stock, ease of handling and culture manipulation and generally faster cell 
proliferation compared to primary cells. However, they can significantly differ 
from their primary cell counterparts (Kaur and Dufour, 2012). Despite these 
limitations, in-vitro experiments are used to test whether a hypothesis is 
plausible prior to progressing to more complex in-vitro experiments or studies 
in humans such as clinical trials.  
Several in-vitro models have been used to study decidualisation of primary 
ESC (reviewed in Gellersen and Brosens, 2014). ESC can be decidualised in-
vitro when treated with medroxyprogesterone acetate (MPA) combined with 
enhancer cAMP for 4 to 10 days (Brosens et al., 1999). When using MPA 
alone culture of ESC can last between 10-20 days (Tseng et al., 1992). On the 
contrary, using cAMP alone was shown to induce decidualisation in a cell line 
derived from immortalised ESC within three days (Samalecos et al., 2009). 
Estrogen followed by P4 can induce decidualisation of ESC in-vitro, however 
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it is a long protocol as it lasts 10-14 days (Hess et al., 2007; Popovici et al., 
2000). Treatment of primary ESC using P4 and cAMP results in decidualised 
phenotype from day 4 of treatment (Gibson et al., 2016). All of the above 
protocols induce mRNA and protein expression of classic decidualisation 
markers such as PRL and IGFBP1.  
Mice have a number of advantages as research model organisms. The mouse 
genome is similar to the human genome (99%) and mouse biology has been 
well characterised due to years of extensive research (Peters et al., 2007). Mice 
have short gestation period (less than 20 days), produce plenty of offspring and 
their reproductive biology is similar enough to humans to allow extrapolation 
of conclusions of animal studies to humans, often followed by validation of 
identified mechanisms (Lim and Wang, 2010). Mouse models have been 
developed utilising genetic manipulations such as gene deletion (Woods et al., 
1996). In addition, as a result of their small size and short life span, the 
financial cost of murine studies is often significantly less compared to larger 
organisms, such as sheep. However, important factors taken into consideration 
when using mouse models are that mice have several differences with humans: 
an estrous cycle, decidualisation occurs after fertilisation only, they usually 
produce multiple offspring per gestation, they have bicornuate uteruses, 
gestation lasts 20 days whereas the human gestation is much longer and some 
human genes may not have a mouse homolog or the mouse gene may have a 
different function to the human (Arck and Hecher, 2013).  
Extensive gestational studies are conducted in other species, such as sheep and 
cows, due to similarities to human gestation and the industrial use of these 
animals. Several observational studies have been carried out in ruminants (Wu 
et al., 2006). A comparison of human and sheep gestation and advantages of 
using sheep as an animal model is reviewed in (Barry and Anthony, 2008). 
Due to the limitations in studying reproductive outcomes with relation to 
Chlamydia infection in humans, several mouse models have been established 
and used to investigate whether infection has a causative role. These include 
Chlamydia psittaci (C. psittaci, Buzoni-Gatel and Rodolakis, 1983), C.abortus 
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(de Oca et al., 2000), C.muridarum (Habbeddine et al., 2013) and various 
serovars of Ct (de la Maza et al., 1994; Pal et al., 1999, 2001). Detailed 
analysis of the above studies can be found in Chapter 4, section 1. 
When the focus of research is human health and disease, in-vitro and in-vivo 
studies can inform on potential mechanisms involved as well as the potential 
efficacy of a treatment, however further investigation on humans in the form of 
a study is required to confirm each hypothesis. When designing a study, 
statistical power is calculated based on previous studies that inform on 
prevalence or predictions of the extend of the effect under investigation if this 
is a novel investigation (Concato et al., 2000). Following strict ethical rules, 
prospective and retrospective large-scale studies can be used to investigate 
prevalence of a disease and whether it is associated with a certain outcome. 
These allow for direct extrapolation of results regarding patient health and can 
impact upon health policies (Song and Chung, 2010). Limitations of these 
studies include adequate sample size and inclusion bias that can lead to 
conclusions that are not representative for the whole population. Due to the 
complexity of humans biology, multiple factors can result in the same outcome 
(Saeidnia et al., 2015). Suboptimal study design that does not take into account 
all confounding factors can be a serious limitation for many studies (Saeidnia 
et al., 2015). However, carefully designed studies that investigate issues 
regarding human health are one of the pillars of current research. 
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1.4 Hypothesis and aims of PhD 
The hypothesis of the work presented in this thesis is that Ct infection of the 
maternal endometrial stromal compartment has a detrimental effect on 
decidualisation leading to adverse pregnancy outcomes including miscarriage 
and IUGR. To address this hypothesis, the aims of my PhD were:  
1.  To determine whether Ct infection impacts upon decidualisation and 
chemokine secretion in a human model of endometrial stromal cell 
decidualisation 
2.  To investigate the role of Ct infection on adverse pregnancy outcome in 
a murine model of pregnancy  
3. To determine the association of Ct in miscarriage in a case-control 
study  
  
    60 
2. Chapter 2: Materials and Methods 
Unless otherwise stated all chemicals and reagents were purchased from Sigma 
(Sigma- Aldrich Company Ltd, Dorset, UK). 
2.1. Chlamydia trachomatis (Ct) stock 
production 
2.1.1. Production of Ct stocks for in vitro and 
in-vivo experiments 
Ct serovar E was used for both in-vitro and in-vivo infection studies. Stocks 
were produced at the Moredun Research Institute, with the generous help and 
guidance of Dr Nick Wheelhouse, Dr Sean Wattegedera and Prof. Gary 
Entrican.  
2.1.2. Ct elementary bodies (EBs) growth and 
purification 
Ct serotype E stock was produced in HEp2 cells using well established 
protocols. Sub-confluent flasks of HEp2 cells were inoculated with Ct. Infected 
cells were cultured for 48-72 hours in Iscove’s Modified Dulbecco’s Medium 
(IMDM, Life Technologies, Paisley, UK) supplemented with 2% heat 
inactivated foetal calf serum (FCS) and 1 µg/ml cycloheximide (Sigma, Cat. 
No C4859, PAA laboratories Ltd, Yeovil, Somerset, UK) until high numbers of 
mature inclusions were observed by optical microscopy. The cell monolayers 
were disrupted with glass beads and the medium containing cell debris was 
briefly sonicated (Vibracell, Sonics & Materials, Connecticut, USA) and 
centrifuged at 50 x g for 5 minutes at 4°C to remove intact cells. The 
supernatant was removed and centrifuged at 12,000 x g using a J-LITE JLA-
16.250 rotor (Beckman Coulter Ltd. High Wycombe, UK). The pellet was 
resuspended by sonication in Tris/KCl and 25ml of inoculum was layered onto 
10ml 40% Gastrografin® (Bayer plc, Berkshire, UK) and centrifuged at 20,000 
rpm at 4°C for 45 minutes using a SW 32Ti rotor on Optima L-90K 
ultracentrifuge (Beckman Coulter Ltd). The pellet was re-suspended into 1ml 
Tris/KCl and layered onto discontinuous gradient (54%, 44%, 34% 
Gastrografin®) and centrifuged at 20, 000 rpm as above at 4°C for two hours. 
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The interface between the 44% and 54% layers, containing the EBs was 
carefully removed. The EBs were washed by resuspension in 10ml Tris KCl 
and centrifuged at 20, 000 rpm as above at 4°C for a further 45 minutes to 
remove residual traces of Gastrografin®. The final pellet was resuspended by 
sonication in 10ml of Chlamydia Transport Medium (218mM Sucrose, 3.76 
mM KH2P04, 7.1 mM K2HPO4, 4.9 mM L-glutamic acid, 10% FCS, 0.05 
mg/ml Gentamycin, 0.1mg/ml Streptomycin, 150U/ml Nystatin) and the 
aliquots stored at -80OC. 
2.1.3. UV inactivation of Ct elementary bodies 
To UV inactivate Ct EB’s, 500 l of inoculum was exposed to 2J UV-C. 
The successful inactivation of Ct was confirmed by culturing HeLa cells, 
known to be infected by Ct (Rödel, Grosse, Yu, Wolf, Otto, Liebler-Tenorio, 
Forsbach-Birk, and Straube, 2011), with UV inactivated bacteria for 96 hours 
without the development of any inclusions.  
2.1.4. Titration of Ct stock 
To determine the titre of the Ct stock, HEp2 cells were plated at 105 per 
well in 8 well glass chamber slides, infected with serial tenfold dilutions of Ct 
inoculum (Multiplicity of infection [MOI] 1 – 10-8) and cultured for 48 hours. 
The cells were fixed in ice-cold acetone for 5 minutes, left to air dry and stored 
at -20°C. After thawing, the slides were rehydrated in phosphate-buffered 
saline (PBS) and incubated with the primary antibody (mouse monoclonal anti-
C. abortus LPS, Santa Cruz Biotechnology, Cat. No. 13/4) for 1 hour at room 
temperature. Following PBS washes, the slides were incubated with a 
fluorescein isothiocyanate (FITC)-conjugated anti-mouse IgG antibody 
(Sigma) for 60 minutes at room temperature in a light-tight humidity chamber. 
Slides were mounted using ProLong® Gold Antifade Mountant with 4',6-
diamidino-2-phenylindole (DAPI) nuclear counterstain (lifeTechonologies, 
Cat. No. P36930). The total number of inclusions per well was counted at serial 
dilutions 10-5-10-7 and the titre of stock was calculated. The titre is a 
measurement of EBs that can form inclusions and are called inclusion-forming 
units (IFU). 
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2.2. RNA extraction, quantification and 
quality assessment  
To assess changes in expression levels of genes of interest, total ribonucleic 
acid (RNA) extraction was performed using RNeasy® Mini (Qiagen, Crawley, 
UK, Cat. No. 74104) and RNeasy Micro (Qiagen, Cat. No. 74004) kits for 
RNA extraction from tissue and cells respectively.  
2.2.1.  RNA extraction from cultured cells 
Cultured cells were grown as monolayers in six-or 12-well plates, as described 
in Chapter 3, section 2. Per well of each plate, 350 μl of RLT lysis buffer 
containing 0.01% β-mercaptoethanol were added following PBS washes to 
remove cell media. The cell lysates were immediately stored at -80°C until 
extraction. Frozen lysates were defrosted, mixed at 1:1 ratio with 70% ethanol 
and the sample was added to an RNeasy MinElute® Spin Column. Following a 
series of wash steps with wash buffers provided in the kit and on-column 
DNaseI digestion to remove contaminating DNA (Qiagen, Qiagen RNAse-Free 
DNase kit, Cat. No.79254), 80% ethanol was added to the samples and the 
column membranes were dried using centrifugation. During the final step, the 
samples were eluted in 15 μl RNase-free H2O. 
2.2.2. Tissue RNA extraction 
To extract RNA from mouse tissue (model described in Chapter 4) a 
phenol/chloroform protocol provided by the RNeasy® Mini Kit was used. 
Tissue samples weighing 5-10 μg were transferred in sterilized 2ml tubes 
containing a steel bead and 1 ml TRI-Reagent® (Cat. No.T924, Sigma). 
Samples were lysed for three minutes at 25 Hz twice using a tissue lyser. 
Lysates were transferred to 1.5 ml PhaseLock Heavy GelTM tubes and 200 μl of 
chloroform was added. Following mixing of the two phases in each tube by 
shaking and room temperature incubation for five minutes, samples were 
centrifuged at 14,000 g at 4°C. The aqueous top layer was poured into new 
tubes and 1:1 volume 70% ethanol was added. The mixture was transferred to 
RNeasy mini spin columns and the manufacturer’s protocol was followed. 
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Briefly, after a series of wash steps and on-column DNaseI digestion, samples 
were eluted in 30 μl RNase-free H2O. 
2.2.3. Quantification and quality assessment of 
RNA samples 
Quantification of all RNA samples was done using a Nanodrop® ND-1000 
Spectrophotometer (Nanodrop Technologies, Wilminton, DE, USA). All 
extracted samples were stored at -80°C.  
To assess the efficacy of the RNA extraction protocol and the quality of the 
extracted RNA, the Agilent RNA 6000 Nano Kitsystem was used (Agilent, 
CA, USA, Cat. No. 5067-1511). The manufacturer’s protocol was followed - 
briefly, the gel-dye mix was prepared and added to the chip provided from the 
specified well. The RNA marker was loaded in all wells, followed by the 
ladder and the samples. The chip was then vortexed and run on the Agilent 
2100 Bioanalyzer.  
2.3. Quantitative-Real Time PCR 
Quantitative-Real Time- polymerase chain reaction (qPCR) is widely used to 
investigate changes in transcription levels of genes of interest, the expression 
level compared to genes that are known to be stably expressed across all 
experimental conditions, called ‘housekeeper’ genes (relative expression). 
Furthermore, qPCR can be used to quantify levels of a target in samples 
utilising a standard curve of samples with known levels (absolute 
quantification).  
2.3.1. Preparation of complementary DNA 
(cDNA) using SuperScript® VILOTM Synthesis 
Kit 
First-strand complementary DNA (cDNA) synthesis was carried out using a 
SuperScript® VILOTM Synthesis Kit (InVitrogen, Paisley, UK, Cat. No. 
11754050) according to the manufacturer’s protocol, as summarised in Table 
2.1.  
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Table 2.1. Reaction mix for cDNA synthesis using SuperScript VILO Synthesis Kit for a 
20 μl reaction. 
Stock Final concentration Volume per 20 μl  
5x VILO Reaction mix 1 x 4 μl  
10x Superscript Enzyme Mix 0.125 x 0.25 μl  
RNA (100 ng/μl ) 100 ng 1 μl  
Nuclease Free H2O  14.75 μl  
 
Samples were incubated in a thermo-cycler (MJ Research PTC-200 Thermo 
Cycler, BC-MJPC200) under the following conditions:  
• 25°C for 10 minutes 
• 42°C for 60 minutes 
• 85°C at 5 minutes 
The samples were stored at –20°C until use. 
2.3.2. Housekeeping gene assay 
The choice of housekeeping genes is an essential first step to ensure the results 
of each qPCR experiment are accurate and reproducible. To determine how 
many and which genes were appropriate, a housekeeping gene assay was 
performed for both the in-vitro human cell studies and the in-vivo mouse 
model (Primerdesign, Southampton, UK, Cat. No. ge-SY-12). Candidate 
housekeeping genes included in the geNorm housekeeping assay kit were 18S, 
RPL13A, EIF4A2, YWHAZ, ACTB, GAPDH, CANX, UBC, SDHA, CYC1 
and ATP5B. The optimal amount of genes and the best housekeeping genes 
were selected by analysing the data using the qbase+ program.  
This qPCR assay was based on the TaqMan probe method, whereby the gene 
specific probes are bind to single stranded DNA and are separated from the 
attached fluorophore only if the specific gene sequence is amplified by the 
DNA polymerase. The fluorophore is then cleaved and omits light when 
excited by the qPCR cycler. 
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Samples from all treatments derived from four different patients and five 
different mice were used. The assay was carried out in 384-well clear optical 
pates (Applied Biosystems, Cat. No.4309849) plates at 10 μl/ well final 
reaction volume, as described in Table 2.2. 
Table 2.2. Sample preparation for geNorm Housekeeping gene qPCR assays (TaqMan 
method) 
Stock Final concentration Volume per 10 μl  
2X Taqman universal 
master mix 
1 X 5 μl  
Primer pair 20 μM 0.5 μl  
Nuclease free H2O  3.5 μl 
cDNA 5 ng 1 μl  
 
The experiments were carried out using ABI7900 thermal cyclers (instruments 
that employs precise temperature control and rapid temperature changes to 
conduct PCR) under standard conditions. 
 The results were analysed using qbase+ (Biogazelle), which contains the 
geNorm program that: “calculates the gene expression stability measure M for 
a reference gene as the average pairwise variation V for that gene with all other 
tested reference genes. Stepwise exclusion of the gene with the highest M 
value allows ranking of the tested genes according to their expression 
stability”(geNorm manual). The principles on which this analysis is based are 
widely accepted (Vandesompele et al., 2002). 
2.3.3.  Quantitative-Real Time-PCR using SYBR 
green 
SYBR green is a cyanide dye which only binds to double stranded DNA, the 
result of amplification of the double-stranded DNA due to gene-specific 
primers (Zipper et al., 2004). The resulting complex, when excited with blue 
light, omits green light that is detected by the qPCR thermal cycler machine.  
All reactions were carried out in 384-well plates at a final reaction volume of 
10μl per sample, as seen in Table 2.3. The samples were mixed by repeat 
pipetting and centrifuged in a mini plate spinner (Applied Biosystems, 
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Warrington, UK) at 1000 g for 20 seconds to remove any bubbles. A standard 
curve of cDNA made from standardised placenta RNA (Ambion, Cat. No 
AM7950) was used on every plate to ensure comparability between all plates. 
Table 2.3. qPCR sample using SYBR green  
Stock Final concentration Volume per 10 μl  
2x Brilliant III SYBR 
Mix 
1 X 5 μl  
Primer pair 10 uM 0.5 μl  
Diluted Reference Dye  0.15 μl 
Nuclease Free H2O  3.35 μl 
cDNA 2.5 ng 1 μl  
 
Plates were assayed using the cycle conditions described in Table 2.4. 
Table 2.4 qPCR cycling protocol on ABI 7900 using Brilliant III ultra-fast SYBR green 
master mix 
Cycles Temperature Time 
1 cycle 95°C 180 seconds 
 
40 cycles 
95°C 5 seconds 
60°C 15 seconds 
 
1 cycle 
95°C 15 seconds 
60°C 15 seconds 
95°C 15 seconds 
 
All primers were predesigned KiCqStart® SYBR® Green Primers (Cat. No. 
KSPQ12012). Furthermore, all primers were validated using a standard curve 
of placental RNA with known concentration (Ambion, Cat. No AM7950). The 
placental RNA sample was used as positive control sample across all plates to 
further assess the variability of the assay among plates. Dissociation curves 
were used for every primer, as shown by a single peak, to confirm specific 
products. Quantification was performed using the 2-ΔΔCt method.  
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3.  Chapter 3: Chlamydia trachomatis 
infection of human endometrial stromal 
cells induces defective decidualisation 
and chemokine release.  
3.1. Introduction and aims 
The development of a successful pregnancy depends upon maternal receptivity. 
This is largely established during decidualisation, and the normally 
decidualised endometrium plays a crucial role in successful pregnancy. It has 
recently been demonstrated that decidualised ESC actively select blastocysts 
based on quality and this ability is not exhibited by non decidualised stromal 
cells (Salker et al., 2010; Teklenburg et al., 2010). Decidualised ESC in the 
presence of arresting embryos in an in-vitro co-culture displayed suppression 
of important factors for implantation such as HB-EGF, an effect not seen in 
when embryos were cultured with non decidualised ESC (Teklenburg et al., 
2010).  
In women with spontaneous miscarriage, decidualised endometrium is altered 
compared to normal pregnancies as it displayed decreased vascularisation 
evident by fewer blood vessels presented and accompanied by decreased 
expression of pro-angiogenic factors such as VEGF-A (Plaisier et al., 2009). 
Novel findings highlight that endometrial stem cells may also impact in the 
establishment of a receptive endometrium. Specifically, ESC from patients 
with recurrent miscarriage have been recently discovered to be in a premature 
status of senescence that results in impaired decidualisation response, a fact 
attributed to the absence of stem cells in the uteri of women with recurrent 
miscarriage (Lucas et al., 2016). Furthermore, impaired decidualisation, 
measured by a reduction in the decidualisation marker PRL in the 
endometrium, has also been associated with recurrent miscarriage (Salker et 
al., 2010) and in rodent models decidual PRL production has been shown to be 
critical for successful pregnancy (Bao et al., 2007). Moreover, in endometrial 
biopsies of women with miscarriage, use of electron microscopy revealed a 
reduction in intracellular communication gaps compared to healthy women 
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(Kara et al., 2007). However, it is not specified whether the samples were from 
recurrent or spontaneous miscarriage cases (Kara et al., 2007). 
The maternal immune system impacts significantly upon decidualisation, 
implantation and pregnancy maintenance, with immune cells and chemokines 
being involved in processes such as the menstrual cycle, trophoblast invasion 
and spiral artery remodelling among many others (Critchley et al., 2001; Lash 
et al., 2010; Smith et al., 2009). Secretion of appropriate chemokine signals by 
decidual cells contributes to the recruitment of predominantly anti-
inflammatory leukocyte subpopulations necessary for pregnancy maintenance 
(He et al., 2012), and prevent recruitment of potentially damaging Th1-cells in 
response to inflammation (Nancy et al., 2012). A Th1 response was associated 
with recurrent miscarriage in a small study (Jenkins et al., 2000). Furthermore, 
chemokines are also involved in trophoblast invasion and angiogenesis during 
early pregnancy (Du et al., 2014). As discussed in Chapter 1, important 
chemokines shown to induce trophoblast invasion include CXCL12, CXCL16 
and CXCL8 among others. 
The maternal immune response to miscarriage associated infections can have 
detrimental effects on pregnancy maintenance, a characteristic example of 
which is seen when malaria pathogens are detected in the placenta (reviewed in 
Giakoumelou et al., 2015).  
Ct is the most common sexually transmitted bacterial disease and its potential 
association with adverse pregnancy outcomes such as miscarriage is discussed 
in Chapter 1. However, even studies that suggest an association between Ct and 
miscarriage (Baud et al., 2011; Licciardi et al., 1992; Vigil et al., 2002) have 
not yet identified the mechanism(s) responsible. 
It is well established that Ct infects endometrial epithelial cells (Buchholz and 
Stephens, 2006; Rasmussen et al., 1997; Rödel, Grosse, Yu, Wolf, Otto, 
Liebler-Tenorio, Forsbach-Birk, and Straube, 2011), but the effect of Ct 
infection on ESC function and decidualisation is yet undetermined and may 
have a role in the association of Ct infection with adverse pregnancy outcomes. 
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Ct is known to cause endometritis, namely inflammation of the endometrium 
that can be asymptomatic, in non-pregnant women (Tait et al., 1997). Data 
from animal studies indicate that in mice, C. abortus induces the murine 
equivalent of miscarriage without foetal harm, likely due to decidual damage 
(Buendía et al., 1998). In cattle C. psittaci associated chronic endometritis is a 
recognised cause of infertility (strain now known as C.pecorum, (Wittenbrink 
et al., 1993). To my knowledge, no study to date has identified why Ct can 
cause endometritis in women or how infection of the stromal compartment of 
the endometrium might alter the function of human ESC. 
The hypothesis of the work presented in this Chapter was that Ct can infect 
ESC and impact on decidualisation and immune response. 
To address this hypothesis I aimed:  
1. to determine whether Ct can infect human ESC in-vitro  
2. to examine the effect of Ct infection on decidualisation and chemokine 
secretion in an in-vitro model of human ESC decidualisation.   
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3.2. Materials and methods 
Details of Ct elementary bodies (EBs) growth, purification and detection by 
immunohistochemistry, UV inactivation of Ct elementary bodies, titration of 
Ct stock, RNA extraction, quantification and quality assessment and Real time 
PCR have been described in Chapter 2. All cell lines were Mycoplasma free. 
3.2.1. Patients and Samples 
3.2.1.1. Primary human endometrial stromal cells (ESC)  
The ESC used in this study were isolated from endometrial tissue samples from 
women undergoing hysterectomy for benign gynaecological conditions 
collected after informed written consent (kindly supplied by Professor Hilary 
Critchley; LREC10/S1402/59). Samples from women in the proliferative phase 
of the menstrual cycle (determined by the last menstrual period and 
measurement of serum estradiol and progesterone levels) were selected for the 
experiments described in this Chapter. The tissue underwent dissociation using 
enzymatic digestion with 1 mg/ml of collagenase type IV for two hours at 
37°C, (Sigma C5138), followed by mechanical break down using a 70 μm and 
subsequently 40μm filters (Falcon, Corning, Cat. No 352350 and 352340 
respectively), allowing the dissociated stromal cells to pass through the filter 
pores, while the partly digested epithelial-containing glands were discarded. 
Single cells were plated in RPMI 1640 medium (Sigma, Cat. No. R0883) 
supplemented with 10% heat inactivated foetal calf serum (HIFCS, Gibco, Cat. 
No 10082147), 1% L-glutamine (Sigma, Cat. No G-7513) and 1% penicillin/ 
streptomycin (Sigma, Cat. No. P4333), prepared under sterile conditions. The 
medium was maintained for a maximum of seven days after which fresh 
medium was prepared. The cells were monitored on a daily basis, cultured until 
confluent, harvested and stored in medium containing 0.5% FCS and 15% 
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3.2.2. Cell culture 
3.2.2.1. ESC 
Proliferative phase ESC isolated as detailed in section 3.2.1.1 were thawed and 
re-suspended in RPMI 1640 medium supplemented as described above. The 
medium, containing DMSO, was changed following cell attachment to the 
flasks and culture was maintained until sufficient cell numbers were reached 
for up to five passages. Prior to any treatments, cells were transferred to phenol 
red-free RPMI 1640 (Sigma, Cat. No R7509) containing 10% charcoal stripped 
foetal calf serum (CSFCS, prepared in house from FCS), 1% L-glutamine and 
0.5% gentamycin (Sigma, Cat. No. G1272) for 48 hours prior to use. The 
antibiotic gentamycin was used instead of penicillin/ streptomycin, because it 
does not inhibit Ct growth (Bowie et al., 1978). Cells were incubated at 37°C 
in 5% CO2. Treatments were performed in duplicate per experiment and cells 
from 2-7 different patients were used per experiment, as detailed in individual 
sections of this chapter. 
3.2.2.2. Immortalised trophoblast cell line (SW71) 
Swan-71 (SW71) is a first trimester human trophoblast cell line that has been 
telomerase immortalised (Straszewski-Chavez et al., 2009). Cell stock aliquots 
were stored in liquid nitrogen. After being thawed, cells were cultured in 
Dulbecco's Modified Eagle Medium (DMEM, LifeTechnologies, Cat. No. 
11966-025) with 10% HIFCS, 1% L-glutamine and 0.5% gentamycin.  
3.2.2.3. HeLa cell line 
The HeLa cell line was a kind gift from Professor Sarah EM Howie, Centre for 
Inflammation Research, University of Edinburgh. HeLa cells were cultured in 
RPMI 1640 media containing phenol, supplemented with 10% HIFCS, 1% L-
glutamine and 0.5% gentamycin. 
3.2.3. In-vitro decidualisation 
To assess the effects of infection on the decidualisation of primary ESC 
treatment with P4 and cAMP for 6 days (Gibson et al., 2016) was selected 
from the published models of in-vitro decidualisation (discussed in 1.3.6) as an 
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optimal protocol length for ESC decidualisation and survival, as it was to be 
followed by a 48 hour Ct infection.  
Cells were trypsinised, centrifuged for 3.5 minutes at 115 g and resuspended in 
phenol red-free RPMI 1640 with 10% CSFCS. They were then plated at 2x105 
cells per well in a six-well plate or 105 cells per well in a 12-well plate for a 
minimum of 24 hours. Before the decidualisation protocol commenced, cells 
were serum starved in 2% CSFCS medium for 24 hours, supplemented as 
previously described. The cells were treated with 10-6 M P4 (Sigma, Cat. No. 
P0130) and cAMP (Sigma, Cat. No. A9501) at a final concentration of 0.1 
mg/ml. The medium was changed every 48 hours over a six-day period (Table 
3.1).  
To assess the decidualisation of ESC, levels of the secreted classic 
decidualisation marker PRL were measured using ELISA according to the 
manufacturer’s protocol (R&D, Cat. No. DY682). Consistent with PRL 
secretion, morphological changes of the cells (cells became bigger, rounder and 
multinuclear) were observed as the protocol was progressing. 
3.2.4. In-vitro Ct infection of decidualised ESC 
ESC, decidualised as described in 3.3, were infected with multiplicity of 
infection (MOI) 0.001, 0.01, 0.1, 1, 2 or 3 on day 6 of the decidualisation 
protocol to determine optimal Ct concentration for ESC infection as described 
in Table 3.1. For example, infection with MOI 1 was conducted by adding 105 
Ct EBs on 105 decidualised ESC in 2% CSFCS medium for 48 hours. 
Following infection, the cells were fixed in ice cold methanol for 20 minutes, 
air dried and stored at -20°C until further use.  
Table 3.1. Decidualisation protocol for ESC. Treatments of progesterone (P4) and cyclic-
AMP (cAMP) were administered in the cell media on days 1, 3 and 5. On day 6 the cells were 
infected with Ct or vehicle control and 48 hours later samples were collected. 
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3.2.4.1. Counting Ct inclusions and cell numbers 
To visualise ESC infection, ESC fixed on plates were stained for 10 minutes 
using Giemsa stain (Sigma, Cat. No. 48900) diluted at 0.04 % (w/v) in pH6 
buffer followed by a wash with distilled water. When air-dried, pictures were 
immediately taken using an Axiovert 200 Zeiss microscope to analyse the 
infection status of cells. 
When performing cell and Ct inclusion counts, 15 images were taken for each 
well at random locations of the well by the author and were subsequently 
analysed using ImageJ. The numbers of both inclusions (infected) and 
uninfected cells were counted in all 15 images and the mean was used in 
calculating the different cell and inclusion numbers as a response to Ct 
infection, treatment with UV-Ct or uninfected media control.  
3.2.4.2. Detection of Ct inclusions using 
Immunofluorescence  
To stain the Ct inclusions, ESC and HeLa cells were grown on round glass 
coverslips (FisherScientific, Cat. No015) that were sterilised in 70% ethanol 
and then transferred in six-well plates. ESC and HeLa cells were grown at 104 
cells/coverslip on glass slides coated with Matrigel (Corning, Cat. No 354248). 
Matrigel is a solubilized basement membrane preparation extracted from the 
Engelbreth-Holm-Swarm mouse sarcoma, a tumour rich in proteins such as 
laminin (a major component), collagen IV, heparin sulphate proteoglycans, 
entactin/nidogen, and a number of growth factors that improves cell adhesion 
and survival. 
An antibody for lipopolysaccharide (LPS), a protein found on the outer wall of 
Gram-ve bacteria (anti- C.abortus LPS, Santa Cruz Biotechnology, Cat. No. sc-
101593) was tested. The second antibody tested was an anti-Ct MOMP 
antibody (ThermoFisher, Cat. No MA1-7334). Several concentrations and 
antigen retrieval conditions (1 μg/ml - 100 ng/ml incubated overnight at 4°C, 
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pH6 heat induced epitope retrieval, pH9 heat induced epitope retrieval, no 
retrieval) were tested and the anti-LPS antibody did not stain Ct inclusions in 
infected samples. However, the anti-MOMP antibody’s optimal concentration 
was 1 μg/ml with overnight incubation at 4°C. To visualise the primary 
antibody staining, Tyramide amplification system (Perkin Elmer, Cat. No 
SAT701B001EA for FITC, NEL745B001KT for Cy5) was used according to 
the manufacturer’s instructions. Cells were visualised using an LSM 710 
confocal microscope. 
3.2.4.3. DNA extraction and Ct plasmid copy assay 
analysis of Ct infected cells 
To elucidate whether Ct was multiplying in ESC, I used a Ct plasmid copy 
assay that utilised a standard curve to estimate the plasmid copies of Ct in the 
samples. This is a qPCR based method that detects the Ct Cryptic Plasmid 
Helicase (DnaB) gene that is found in 7-9 copies per bacterium. 
3.2.4.4. DNA extraction from ESC 
To extract DNA from infected cells, the MagMAX™ Total Nucleic Acid 
Isolation Kit (Ambion, Cat. No. AM1840) was used. 235 μl of lysis/binding 
solution were added in bead tubes. Cells were washed with PBS three times 
and scraped off using a cell scraper in 175 μl of PBS. The mixture was 
transferred into bead tubes containing magnetic zirconia beads that bind 
nucleic acids and vortexed for 15 minutes. Tubes were then centrifuged at 
8,000 g for 30 seconds to pellet the zirconia beads. 115 μl of each sample were 
moved to a processing plate and remaining samples were stored at -20°C. 65 μl 
of 100% isopropanol was added in each well and it was mixed for 1 minute. 20 
μl of Bead Mix were subsequently added and mixed for 5 minutes at a plate 
shaker. Binding beads that were holding the DNA were captured using a 
magnetic plate and washed twice with 150 μl of wash solution followed by two 
washes with 150 μl wash solution 2. Beads were dried by shaking for 2 minutes 
and 30 μl 65°C elution buffer and mixed for three minutes. The beads were 
captured and supernatant containing purified DNA was stored at -20°C. 
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3.2.4.5. Ct plasmid copy assay  
To assess whether Ct could proliferate in ESC the Chlamydia trachomatis 
Genesig Standard Kit (PrimerDesign, Cat. No Path-C.trachomatis-standard) 
was used. Using a standard curve of known concentration provided by the kit, I 
was able to do absolute quantification of Ct in DNA extracts from ESC cells. 
The qPCR protocol is described in 2.3.3 (TaqMan method) respectively. 
3.2.5. Human Chemokine Array 
To investigate changes in secreted chemokines from decidualised primary ESC 
in response to Ct infection, the Proteome Profiler™ Human Chemokine Array 
Kit (R&DSystems, Abingdon, UK, Cat. No. ARY017) was used with the help 
of Mrs June Stroud, MRC Centre for Inflammation Research. This proteomic 
assay is a membrane based antibody sandwich immunoassay that detects 33 
different chemokines, shown in Table 3.2. 
Table 3.2. Chemokines detected by the Proteome Profiler™ Human Chemokine Array 
Kit  
CCL1/I-309 CCL21/6Ckine CXCL8/IL-8 




CCL5/RANTES CCL28 CXCL11/I-TAC 
CCL7/MCP-3 Chemerin CXCL12/SDF-1 
CCL14/HCC-1/HCC-3 CX3CL1/Fractalkine CXCL16 
CCL15/MIP-1 delta/LKN-1 CXCL1/GRO alpha CXCL17/VCC-1 
CCL17/TARC CXCL4/PF4 IL-16 
CCL18/PARC CXCL5/ENA-78 Midkine 
CCL19/MIP-3 beta CXCL7/NAP-2 XCL1/Lymphotactin 
CCL20/MIP-3 alpha   
 
Samples used were pooled supernatants from three in-vitro Ct infected ESC 
and the manufacturer’s protocol was followed without deviation. Briefly, the 
membranes were blocked for one hour on a rocking platform. After several 
washes, sample/detection antibody mix was added on the membranes, 
overnight at 4°C. The next day the membranes were washed and Streptavidin-
HRP was added for 30 minutes, after which they were developed in X-ray film 
for 1, 3, 5 and 7 minutes. Each chemokine was represented in film (if present) 
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by a circle. Varying diameters corresponded to various concentrations of 
chemokines. Using ImageJ and Photoshop, the pixel density of each chemokine 
was estimated across all samples. 
3.2.6. Enzyme-linked Immunosorbent Assay 
3.2.6.1. Protocol of sandwich ELISA 
Sandwich ELISA was used to detect IGFBP-1 (R&DSystems, Cat. 
No.DY871), PRL (R&DSystems, Cat. No.DY682) and CXCL8 (R&DSystems, 
Cat. No. DY208). All ELISAs were used as per manufacturer’s instructions. . 
For more information regarding the reagents involved in this ELISA, see Table 
1.3. 
Clear flat-bottomed 96-well plates (Sigma, Cat. No. CLS3590) were coated 
with 100 μl per well of capture antibody diluted to working concentration in 
PBS. Plates were incubated overnight at room temperature. After incubation, 
the solution was aspirated, all wells were washed three times with wash buffer 
and the plate was blotted on a paper towel, a procedure that was repeated after 
every protocol step. Plates were blocked using blocking buffer for one hour 
during which a two-fold serial dilution standard curve and appropriate sample 
dilutions in reagent diluent were prepared. Standard curve dilutions were 
commencing from 2000 ng/μl. The wash step was repeated and 100 μl of 
sample or standard were added to each plate, along with appropriate negative 
controls, for two hours at room temperature on a plate rocker. Plates were 
again washed and detection antibody was added for two hours at 100 μl per 
well on a plate rocker. The antibody was then removed, and the wells were 
washed and incubated with Streptavidin-HRP solution for 12 minutes on a 
plate rocker. A final wash step was then performed and substrate, 3,3',5,5'-
Tetramethylbenzidine (TMB) was added in the wells under dark on a plate 
rocker. TMB is colourless but is converted to light blue by streptavidin, if it is 
present in each well. This was converted to yellow with the addition of 50 μl 
2M sulphuric acid, which also stopped the reaction. Optical density was 
measured immediately after, using a microplate reader at appropriate 
wavelengths, as specified by each manufacturer (Table 3.3). 
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Table 3.3. Concentrations of capture antibody, detection antibody, streptavidin-HRP and 
recipe of wash buffer, blocking buffer used in IGFBP-1, PRL and CXCL8 ELISAs. 
*Antibody concentration differed between ELISA kit batches. 
Reagent IGFBP-1 ELISA PRL ELISA CXCL8/IL8 
ELISA 
Wash buffer 0.05% Tween® 
20 in PBS 
0.05% Tween® 
20 in PBS 
0.05% Tween® 
20 in PBS 
Blocking buffer 5% Tween® 20 
in PBS 
1% bovine serum 
albumin (BSA) 
in PBS 
1% bovine serum 
albumin in PBS 
Capture 
antibody* 
as specified on 
bottle 
as specified on 
bottle 




as specified on 
bottle 
as specified on 
bottle 
as specified on 
bottle 
Reagent diluent 5% Tween® 20 
in PBS 
0.1% BSA and 
0.05% Tween® 
20 in PBS 
0.1% BSA and 
0.05% Tween® 
20 in PBS 
Streptavidin as specified on 
bottle 
as specified on 
bottle 




1:1 mixture of 
colour reagent A 
and B 
1:1 mixture of 
colour reagent A 
and B 
1:1 mixture of 
colour reagent A 
and B 
Stop solution 2N H2SO4 2N H2SO4 2N H2SO4 
 
Sample concentrations were calculated using MasterPlex® QT (Hitachi) 
software, courtesy of Dr Forbes Howie. 
3.2.7. Magnetic Luminex® Screening Assay 
The Luminex® Screening Assay (R&D Systems, Cat.No. LXSAHM) was used 
to detect CXCL12 and CXCL16 as per manufacturer’s instructions. 
Supernatants from Ct infected, UV-Ct treated and uninfected ESC originating 
from three patients were pooled and the assay membranes were incubated in 
these supernatants and following washes, Streptavidin-Horseradish Peroxidase 
and chemiluminescent detection reagents were added. The signal produced is 
in proportion to the amount of cytokine bound on the capture antibodies 
located on each membrane. Using an X-ray developer, the signal was 
visualised. To compare the quantity of each chemokine across the membranes, 
each chemokine was expressed as a % proportion of the average of three 
reference dots that are present on each membrane. 
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3.2.8. Trophoblast cell migration assays 
To analyse the migration potential of first trimester trophoblast cell line SW71 
in response to chemokines CXCL12, CXCL16, their combination and 
conditioned media from infected ESC and controls, a migration assay was 
designed. 
The minimal concentrations of CXCL12 and CXCL16 recombinant proteins 
(R&D systems, Cat. No. 350-NS/CF and 976-CX-025 respectively) were 
determined using the following scratch assay. Scratch assays are widely used to 
assess cell migration in in-vitro culture systems (Liang et al., 2007). SW71 
cells were plated at 105 in 12-well plates and left to rest for four hours. 
Subsequently, the media was changed to media containing 5 ng, 25 ng, 50 ng 
and 100 ng of each chemokine and their combination per ml. Using a 1 ml 
pipette tip, the well was scratched in the middle and pictures were taken using 
an Axiovert 200 Zeiss microscope at this point termed 0 hours. 30 hours later, 
the distance covered between cells on 30 points randomly chosen was counted 
using surface measure in ImageJ.  
Due to large variations observed in the scratch assay, a spheroid assay was 
developed to assess SW71 migration in response to chemokines and ESC 
conditioned media. Briefly, 105 SW71 cells were plated in round bottom non-
adhesive 96-well plates overnight. The following morning, the cell spheroids 
formed were transferred in 48-well plates (2 spheroids per well), that were 
containing 1ml of conditioned media, with and without chemokines as seen in 
Table 3.4. 30 hours later, the assay was stopped, the spheroids were 
photographed using an Axiovert 200. The migration are was defined as the one 
cell layer surface originating from an attached spheroid, excluding the area 
covered by the spheroid and was calculated using ImageJ. Each treatment was 
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Decidualised Ct infected 
300 μl 
200 μl 500 μl +/- 50 ng/ml CXCL12 
+/- 100 ng/ml CXCL16 
Decidualised UV-Ct treated 
300 μl 
200 μl 500 μl +/- 50 ng/ml CXCL12 
+/- 100 ng/ml CXCL16 
Decidualised uninfected 
300 μl 
200 μl 500 μl +/- 50 ng/ml CXCL12 
+/- 100 ng/ml CXCL16 
Non decidualised uninfected – 
300 μl 
200 μl 500 μl none 
RPMI control – 300 μl 200 μl 500 μl none 
DMEM control – 300 μl 200 μl 500 μl none 
 
3.2.9. Statistical analysis 
Statistical analysis was carried out using GraphPad Prism 6. Repeated 
measures non parametric ANOVA- Friedman’s test was used for all sample 
sets. By using a non parametric test it was assumed that the samples are not 
following a Gaussian distribution, as the sample size was not suitable for a 
normality test. Friedman’s test was selected as using a repeated-measures test 
(RM one way ANOVA) controls for experimental variability attributed to 
patient-to-patient response variations. Some factors not controlled for in the 
experiment will affect all the measurements from one subject equally, so they 
will not affect the difference between the measurements in that subject. By 
analyzing only the differences, therefore, a matched test controls for some of 
the sources of scatter. Furthermore, to compare specific groups when 
Friedman’s test showed a significant difference, Dunn’s method for non 
parametric multiple comparisons was used, as it allows for comparison of two 
particular groups by determining each rank from the entire data set (all groups), 
not just the two groups being compared. All graphs are representing mean with 
standard deviation (SD) of the data. 
Dr Ioannis Papastathopoulos, Chancellor’s Fellow at the University of 
Edinburgh’s School of Mathematics has reviewed the statistical analysis and 
approved it for analysis of the data presented in this chapter.  
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3.3. Results 
3.3.1. Ct stock viability and titration 
Two Ct stocks used for in-vitro experiments were produced as described in 2.1. 
Titration of stock was carried out using anti-LPS immunohistochemistry on 8-
well chamber slides containing HEP2 cells infected with multiplicities of 
infection (MOI) of Ct (10-1 to 10-7), as described in 2.1. Following thorough 
counting of all inclusions in dilutions 10-5 and 10-6, the titre of the first stock 
was estimated at 2.8 x 108 bacteria per ml of stock and the second stock 2 x 106 
bacteria/ml. A portion of this stock was UV-inactivated (UV-Ct, see paragraph 
2.1). Aliquots were transported from Moredun Institute to the QMRI according 
to safety regulations and were used for all experiments described in this chapter 
unless otherwise specified.  
CHX was used for Ct stock production as explained in 2.1. As it was shown 
not to be required for successful infection in-vitro and it is highly toxic for cells 
(as seen in Figure 3.1), all experiments in the present thesis were carried out 
without CHX. 
 
Figure 3.1. Cycloheximide (CHX) has a highly toxic effect on HeLa cells. (A) Significantly 
reduced numbers of uninfected HeLa cells were observed when CHX was included in their 
media. (B) Uninfected HeLa cells without CHX in their media. Both pictures were taken 96 
hours after plating. Scale bars equal 200 μm. 
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To confirm the viability of Ct stock after transfer and the successful UV-
inactivation of the Ct stock, HeLa cells were infected at MOI 1 for 96 hours 
and treated with UV-Ct at the same concentration. 
In cultures infected with viable Ct, visible inclusions were seen in Giemsa 
stained cells from 48 hours, with an exemplar image seen in Figure 3.2A and 
highlighted in Figure 3.2B.  
 
Figure 3.2. Ct inclusions in HeLa cells infected with MOI 1. Cells were stained with Giemsa 
48 hours post infection. (A) Staining revealed large Ct inclusions within infected HeLa cells, 
coloured purple darker than the cytoplasm with a grainy appearance. Several dead cells were 
also visible, as absorbing Giemsa stained them dark blue. (B) In the sketch corresponding to 
panel A, Ct inclusions are highlighted in green, dead cells in red and uninfected HeLa cells in 
blue. Scale bars equal 50 μm. 
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The number of cells containing inclusions increased over time. By 96 hours 
post infection, very few live HeLa cells remained in the wells and some 
inclusions were visible ( 
Figure 3.3A). In contrast, UV-Ct treated HeLa and uninfected controls 
proliferated as expected in a 96-hour cell culture ( 
Figure 3.3B,  
Figure 3.3C). Moreover, no inclusions were seen in cells cultured with UV-Ct at 
the same MOI as Ct over the same time course, indicating no infectious EBs 
remained after UV inactivation of the Ct stock.  
 
Figure 3.3. Ct infection of HeLa cells causes reduction in cell numbers and cell death. 
HeLa cells were infected with MOI 1 of Ct, then cells were fixed and stained with Giemsa 96 
hours post infection. (A) Ct inclusions (stained light purple) were visible in some cells.  
Uninfected live HeLa cells were scarce and there was a clear reduction in cell numbers, as well 
as many dead cells and cell debris (stained blue). (B) UV-Ct did not infect HeLa cells and their 
appearance resembled that of uninfected HeLa cells. (C) Uninfected HeLa cells cultured for 96 
hours proliferated and as a result high cell density was observed. Scale bars equal 200 μm. 
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3.3.2. Ct can directly infect human ESC  
Primary ESC were infected in 12-well plates with Ct serovar E at MOI 0.01, 
0.1, 1, 2 and 3. No visible inclusions were present in cells at MOI 0.01 and 
MOI 0.1 48 hours post infection and very few inclusions were seen at MOI 1, 
whereas ESC infected with MOI 2 and 3 showed similar numbers of inclusions 
following infection. The non infected non decidualised and decidualised ESC 
displayed no signs of infection however uninfected decidualised ESC were 
visibly enlarged and rounder as expected (Figure 3.4A, Figure 3.4B) whereas 
visible Ct inclusions were seen in cells infected at MOI 2, as well as dead cells 
and cell debris (Figure 3.4C). Decidualised ESC treated with UV-Ct were 
morphologically similar to uninfected decidualised ESC and displayed no signs 
of infection (Figure 3.4.D). No copies of Ct cryptic plasmid were detected in 
uninfected cells, as assessed using qPCR. UV-Ct treated ESC (which still 
contained bacterial DNA) had 2.5 x104 – 7.5 x104 plasmid copies per well. Ct 
infected wells contained 1.2 x106 – 3.3 x106 plasmid copies indicating that 
significant replication had occurred (Figure 3.4.E). Although the number of 
decidualised uninfected ESC was decreased compared to non-decidualised 
ESC, UV-Ct treated and Ct infected ESC samples contained similar numbers of 
cells compared to decidualised uninfected ESC (Figure 3.4.F). In infected wells, 
between 0.05% - 20% of ESC contained Ct inclusions (Figure 3.5). These 
conditions were used for all subsequent experiments. 
To visualise Ct more accurately, two anti-Ct antibodies were tested under 
various antigen retrieval conditions and primary antibody concentration as 
described in 3.4.2. Using the Tyramide amplification system for 
immunofluorescence, Ct inclusions were clearly stained in HeLa cells but ESC 
cells were autofluorescing when stained with Cy3 and FITC, thus imaging and 
detecting Ct inclusions was difficult. When using Cy5, detection of inclusions 
was possible in ESC. However, ESC were not surviving on glass coverslips 
longer than 72 hours, regardless of coverslip coating with Matrigel. 
Decidualised ESC had poor survival if trypsinised and replated. Ct infected 
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decidualised ESC proved to be particularly fragile and could not be transferred 
onto glass slides to perform immunofluorescence. Finally, as ESC were grown 
in 12-well plates, the cost of immunofluorescence was quite high and the 
available visualisation methods did not produce good quality images. 
Therefore, Giemsa stain was selected as the optimal staining method for 
visualising Ct infection in ESC.  
 
  
    85 
Figure 3.4. Ct can infect decidualised ESC. ESC were infected with Ct MOI 2 following an 
in-vitro decidualisation protocol. Non decidualised uninfected ESC, uninfected decidualised 
ESC and UV-Ct treated ESC were used as controls. 48 hours post infection DNA was collected 
for qPCR and cells were stained with Giemsa. Cell counts were conducted in 15 fields of view 
per well measuring 0.32 mm2 each. (A) Non decidualised uninfected ESC were elongated and 
thin. (B) Decidualised uninfected ECS became rounder and larger compared to non 
decidualised ESC. (C) Ct infected decidualised ESC displayed signs of infection and contained 
inclusions that were stained purple by Giemsa stain. The wells also contained dead cells and 
cell debris. (D) UV-Ct treated decidualised ESC did not contain inclusions and resembled 
uninfected decidualised ESC in appearance. (E) 25.000 – 75.000 Ct plasmid DNA copies were 
detected in UV-Ct treated ESC. Ct infected ESC had a significantly higher number of 
1.200.000 – 3.300.000 plasmid copies per sample, indicating proliferation of Ct only in 
infected cells (RM one-way ANOVA-Friedman’s test with Dunn’s multiple comparisons test, 
p=0.0094, n=4). (F) Cell counts on Giemsa stained ESC indicated that decidualised uninfected 
cells were significantly fewer compared to non-decidualised controls (RM one-way ANOVA-
Friedman’s test with Dunn’s multiple comparisons test, p= 0.0185, n=4). In contrast, UV-Ct 
treated cells and Ct infected cell numbers were similar to uninfected decidualised ESC. Scale 




Figure 3.5. Ct infects 0.05% - 18% of decidualised ESC 48 hours post infection. ESC were 
infected with Ct MOI 2 following an in-vitro decidualisation protocol, then were fixed 48 
hours post infection and stained with Giemsa stain. Cell counts were conducted in 15 fields of 
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3.3.3. Ct infection of human ESC results in defective 
decidualisation 
3.3.3.1. Ct infection did not affect decidualisation 
marker IGFBP1  
For decidualisation marker IGFBP1, both mRNA and protein were 
significantly upregulated in decidualised uninfected ESC compared to non 
decidualised controls (Figure 3.6A&B). However, no differences in IGFBP1 
levels were observed as a result of UV-inactivated Ct treatment or Ct infection 
(Figure 3.6A&B).  
 
Figure 3.6. Ct infection does not affect mRNA and protein levels of decidualisation 
marker IGFBP1. ESC were infected with Ct MOI 2 following an in-vitro decidualisation 
protocol. Non decidualised uninfected ESC, uninfected decidualised ESC and UV-Ct treated 
ESC were used as controls. 48 hours post infection mRNA and supernatants were collected for 
qPCR and ELISA tests respectively. (A) IGFBP1 mRNA levels were elevated in response to 
decidualisation signals as expected, however no difference was observed between decidualised 
Ct infected and UV-Ct treated or uninfected decidualised ESC (RM one-way ANOVA-
Friedman’s test with Dunn’s multiple comparisons test, p=0.0057, n=7). (B) Secreted IGFBP1 
protein concentration was not altered by Ct infection, however it was higher in decidualised 
ESC compared to non decidualised cells (RM one-way ANOVA-Friedman’s test with Dunn’s 
multiple comparisons test, p=0.044, n= 5). Graphs show the mean and standard deviation. 
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3.3.3.2. Ct infection affected decidualisation marker 
PRL  
Infection with Ct reduced the mRNA expression of the classic decidualisation 
marker PRL at mRNA but not protein levels in decidualised Ct infected ESC 
(Figure 3.7A&B). Decidualised uninfected ESC had increased levels of both 
PRL mRNA and protein compared to non decidualised ESC (Figure 3.7A&B). 
 
Figure 3.7. Ct infection of ESC reduces mRNA but not protein levels of decidualisation 
marker PRL. ESC were infected with Ct MOI 2 following an in-vitro decidualisation 
protocol. Non decidualised uninfected ESC, uninfected decidualised ESC and UV-Ct treated 
ESC were used as controls. 48 hours post infection mRNA and supernatants were collected for 
qPCR and ELISA tests respectively. (A) PRL mRNA was upregulated in response to 
decidualisation stimulus, whereas it was downregulated in infected decidualised cells 
compared to uninfected controls indicating the adverse effect of Ct infection on decidualisation 
(RM one-way ANOVA-Friedman’s test with Dunn’s multiple comparisons test, p=0.0009 and 
0.0151 respectively, n=7). (B) PRL protein levels were increased in decidualised non infected 
cells compared to non decidualised controls as expected (RM one-way ANOVA-Friedman’s 
test with Dunn’s multiple comparisons test, p=0.0044, n=5). However, PRL levels were not 
significantly different between Ct infected ESC compared to decidualised uninfected controls, 
(RM one-way ANOVA-Friedman’s test with Dunn’s multiple comparisons test, p>0.05, n=5). 
Graphs show the mean and standard deviation. 
3.3.4. Ct infection does not affect SGK1, VEGF, 
FOXO3A, HB-EGF but reduces EGF expression 
To further investigate the effect of Ct on other genes that have been identified 
as important to decidualisation, implantation or association with miscarriage 
(discussed in Chapter 1), the mRNA levels of SGK1, VEGF, FOXO3A, EGF 
and HB-EGF were investigated by qPCR. However, with the exception of 
reduced EGF mRNA levels in Ct infected decidualised ESC compared to 
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uninfected non decidualised controls, no change was observed in response to 
Ct infection in any of the above genes (Figure 3.8).  
 
Figure 3.8. Ct infection has no effect on SGK1, VEGF, FOXO3A, HB-EGF but reduces 
the levels of EGF mRNA. ESC were infected with Ct MOI 2 following an in-vitro 
decidualisation protocol. Non decidualised uninfected ESC, uninfected decidualised ESC and 
UV-Ct treated ESC were used as controls. 48 hours post infection mRNA was collected test the 
effect of Ct infection on VEGF, EGF, SGK1, FOXO3A and HB-EGF expression levels using 
qPCR. (A) SGK1 mRNA levels were not altered by Ct infection (RM one-way ANOVA-
Friedman’s test, p>0.05, n=7). (B) VEGF mRNA levels did not differ among all groups (RM 
one-way ANOVA-Friedman’s test, p>0.05, n=7). (C) FOXO3A mRNA expression levels 
remained unchanged (RM one-way ANOVA-Friedman’s test, p>0.05, n=7). (D) HB-EGF 
mRNA levels did not differ among the four groups (RM one-way ANOVA-Friedman’s test, 
p>0.05, n=7). (E) EGF mRNA levels were reduced in Ct infected ESC (RM one-way ANOVA-
Friedman’s test with Dunn’s multiple comparisons test, p=0.0389, n=7). Graphs show the 
mean and standard deviation. 
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3.3.5. Ct infected human ESC have an altered 
chemokine profile 
To assess the immune response of ESC to Ct infection, CXCL8 mRNA and 
protein levels were examined and a significant increase of this chemokine was 
observed in response to active Ct infection, however the levels of CXCL8 were 
not affected by decidualisation or exposure to UV-inactivated Ct (Figure 3.9).  
 
Figure 3.9. CXCL8 expression is induced by Ct infection. ESC were infected with Ct MOI 2 
following an in-vitro decidualisation protocol. Non decidualised uninfected ESC, uninfected 
decidualised ESC and UV-Ct treated ESC were used as controls. 48 hours post infection 
mRNA and supernatants were collected for qPCR and ELISA tests respectively. (A) CXCL8 
mRNA was upregulated in Ct infected decidualised ESC (RM one-way ANOVA-Friedman’s 
test with Dunn’s multiple comparisons test, p= 0.001, n=7). CXCL8 was not upregulated as a 
response to decidualisation or UV-Ct treatments alone. (B) CXCL8 protein secretion was 
increased in infected ESC but not in controls (RM one-way ANOVA-Friedman’s test with 
Dunn’s multiple comparisons test, p= 0.011, n=6). CXCL8 protein levels in decidualised ESC 
supernatants were not higher compared to non decidualised cells. All graphs show the mean 
and standard deviation. 
 
To investigate the effect of Ct infection on chemokine secretion by 
decidualised ESC, the levels of 31 secreted chemokines were examined by 
proteomic array in supernatants from decidualised uninfected and infected 
ESC. A pattern of differential expression between the cell types was observed 
(Figure 3.10).  
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Figure 3.10. Chemokine proteomic array of 31 chemokines on pooled cell supernatants 
indicated altered chemokine secretion from decidualised Ct infected compared to 
uninfected decidualised ESC. ESC were infected with Ct MOI 2 following an in-vitro 
decidualisation protocol. Non decidualised uninfected ESC were used as controls. 48 hours 
post infection supernatants were collected. The secretion levels of 31 chemokines in pooled 
supernatants from three patient samples were analysed on blot membranes. Each chemokine 
was represented by two dots. (A) Layout of each membrane with cytokines CXCL12 and 
CXCL16 highlighted in red and green respectively (B) Ct infected decidualised ESC secreted 
chemokine profile, demonstrating ESC secreted all 31 chemokines. (C) Uninfected 
decidualised ESC secreted chemokine profile is altered compared to Ct infected ESC. (n=1) 
 
Table 3.2 shows that four chemokines were upregulated and 15 downregulated 
in Ct infected decidualised compared to non infected ESC (threshold 5%). Of 
the chemokines known to be involved with early pregnancy, trophoblast 
invasion and/or genital infection CXCL12 and CXCL16 were both strongly 
downregulated in infected decidualised ESC, as were chemokines CCL7, 
CCL12 and Midkine whilst CXCL7, CXCL1 and XCL1 were strongly 
upregulated. 
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Table 3.5. Chemokine proteomic array showed altered chemokine secretion due to Ct infection in decidualised ESC. Results were calculated as % of the average 
of positive controls present in each membrane. Significant differences higher than 5% are highlighted in grey. Table contains information about the role of each 
chemokine in decidualisation, early pregnancy and association with miscarriage and Ct infection.  
Protein  % of positive control 
Decidualised 












14.90 19.43 -4.53 mRNA detected in the endometrium throughout the menstrual cycle and increased in early 




6.42 7.78 -1.36 Detected by immunohistochemistry in decidualised ESC and first trimester decidua, was 
shown to induce apoptosis in ESC and its receptors were increased in ESC from 
miscarriage (Sun et al., 2013). No information on association with Ct infection. 
CXCL16/ 
SRPSOX 
24.59 53.31 -28.72 Human trophoblasts recruited T lymphocytes and monocytes into decidua by secretion of 
CXCL16 in early pregnancy (Huang et al., 2008). CXCL16 also induces invasion and 
proliferation of first-trimester human trophoblast cells (Huang, Zhu, et al., 2006). No 




91.66 99.69 -8.03 Chemerin serum concentration was significantly higher in pregnant women in the 3rd 
trimester than in non-pregnant and pregnant women in the 1st trimester, whilst no 
differences were observed during the menstrual cycle (Garces et al., 2013).No information 
on miscarriage or association with Ct infection. 
ENA-78/ 
CXCL5 
10.67 14.48 -3.82 Elevated ENA-78 levels were associated with increased risk of miscarriage (Whitcomb et 
al., 2007). mRNA levels were increased in trachoma patients (Burton et al., 2011). No 
information on decidualisation. 
Eotaxin-3/ 
CCL2 
16.52 23.75 -7.23 IL-33 enhances proliferation and invasiveness of ESC by up-regulation of CCL2 and its 
receptor CCR2(Hu et al., 2014). No association between maternal circulation levels during 
the first trimester of CCL2 and miscarriage(Hannan et al., 2014). No information on 
association with Ct infection. 
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Protein  % of positive control 
Decidualised 












28.68 30.31 -1.63 Is expressed in maternal decidua and promotes human trophoblast invasion (Hannan et al., 
2006). No association between maternal circulation levels during the first trimester of 




94.17 66.23 27.94 Expressed in early pregnancy decidua (GCID:GC04P073869). Upregulated in women with 
antiphospholipid antibodies inducing a placental inflammatory response via the TLR-
4/MyD88 pathway, which in turn compromises trophoblast survival(Mulla et al., 2009). 




10.22 15.23 -5.01 Promotes human trophoblast invasion (Hannan et al., 2006). No information on miscarriage 
or association with Ct infection. 
I309/ CCL1/ 
TCA3 




98.02 100.15 -2.13 Promotes trophoblast invasion (Jovanović et al., 2010). Upregulated in women with 
antiphospholipid antibodies inducing a placental inflammatory response, which in turn 
compromises trophoblast survival(Mulla et al., 2009). No association of serum levels with 
miscarriage (Whitcomb et al., 2007). Induced by Ct infection (Natividad et al., 2009). 
IP-10/ 
CXCL10 
36.13 44.75 -8.62 Increased in decidua during the implantation window (Sela et al., 2013). Also reported to be 




8.70 13.58 -4.88 Increased levels in euthyroid women with autoimmune thyroiditis with recurrent 
miscarriage and compared to diabetics with successful pregnancy (Aktas et al., 2014). 
Secreted by progesterone primed primary endocervical epithelial cells infected with Ct 
(Wan et al., 2014). No information on decidualisation or early pregnancy. 
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Protein  % of positive control 
Decidualised 











46.07 23.09 22.98 Upregulated during implantation window (Lobo et al., 2004). No information on 




101.83 99.08 2.75 Localised in glandular epithelium and endothelial cells, not secreted by blastocyst during 
early implantation window (GCID: GC17P034255). Upregulated in women with 
antiphospholipid antibodies inducing a placental inflammatory response which in turn 
compromises trophoblast survival (Mulla et al., 2009). Elevated mRNA due to Ct infection 
(Molestina et al., 2000). 
IL-16/ LCF 20.71 36.59 -15.88 Expressed in decidua during the implantation window (GCID:GC15P081159). 




38.34 61.95 -23.61 Detected in plasma of women during 1st trimester of pregnancy but not altered in 
miscarriage cases (Hannan et al., 2014). Does not induce trophoblast migration (Hannan et 




31.95 46.88 -14.93 Detected on maternal stromal cells and increased in placentae from miscarriage cases 
(Freier et al., 2015). No information on association with Ct infection. 
MDK/MK/ 
Midkine 




10.27 17.56 -7.29 Associated with asymptomatic Ct infection in men (Hakimi et al., 2014).No information on 




10.44 18.14 -7.70 Secreted by ESC in response to hCG (Srivastava et al., 2013). Promotes trophoblast 
migration (Hannan et al., 2006). No association of serum levels with miscarriage 
(Whitcomb et al., 2007). Levels were not affected by Ct infection (Maxion and Kelly, 
2002). 
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Protein  % of positive control 
Decidualised 




















14.12 14.36 -0.24 Was shown to be increased due to Ct infection (Porcella et al., 2015). No information on 















15.85 25.42 -9.57 Increased in trachoma patients in response to Il-17 (Burton et al., 2011). No information on 
decidualisation, early pregnancy or miscarriage.  
PF4/ 
CXCL4 




34.42 25.36 9.07 Localised in endometrial stromal and endothelial cells during the implantation window and 
is not produced by the trophoblast (GCID:GC17M035871). No association of serum levels 
with miscarriage (Whitcomb et al., 2007).  
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Protein  % of positive control 
Decidualised 












15.12 94.86 -79.75 Associated with trophoblast invasion and implantation in primary stromal cells (Hanna et 
al., 2003; Zhou et al., 2008). There is also a study showing inhibition of CXCL12 due to 
cytomegalovirus infection that resulted in impaired migration and invasion of human 
extravillous cytotrophoblasts (Warner et al., 2012). Levels not altered in semen of men with 




17.75 30.25 -12.50 Induces trophoblast migration (Li et al., 2014). No information on decidualisation, 
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To validate the array results, qPCR and ELISA were used to measure changes 
in mRNA and protein levels of chemokines CXCL12 and CXCL16 as a result 
of infection with Ct. As seen in Figure 3.11A and Figure 3.11C, there were no 
significant differences in mRNA encoding CXCL12 and CXCL16. In contrast, 
infected ESC secreted significantly less CXCL12 and CXCL16 (Figure 3.11B, 
Figure 3.11D). CXR4 (the receptor for CXCL12) mRNA was significantly 
decreased in infected decidualised ESC (Figure 3.11E). However, CXCR6 (the 
receptor for CXCL16) mRNA was not affected by Ct infection (Figure 3.11F).  
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Figure 3.11. Ct infection alters innate immune response of decidualised ESC as measured 
by attenuated mRNA and protein levels of trophoblast invasion-associated chemokines 
CXCL12 and CXCL16. ESC were infected with Ct MOI 2 following an in-vitro 
decidualisation protocol. Non decidualised uninfected ESC, uninfected decidualised ESC and 
UV-Ct treated ESC were used as controls. 48 hours post infection mRNA and supernatants 
were collected for qPCR and ELISA tests respectively. (A) CXCL12 mRNA was not altered in 
response to infection (RM one-way ANOVA-Friedman’s test, p>0.05 n=7). (B) Reduction of 
secreted CXCL12 in Ct infected cell supernatants (RM one-way ANOVA-Friedman’s test with 
Dunn’s multiple comparisons test, p= 0.0267, n=4). (C) mRNA levels of CXCL16 were not 
altered (RM one-way ANOVA-Friedman’s test, p>0.05, n=7). (D) Decreased CXCL16 protein 
levels were measured in Ct infected ESC supernatants (RM one-way ANOVA-Friedman’s test 
with Dunn’s multiple comparisons test, p= 0.0078, n=4). (E) CXR4 mRNA, receptor of 
CXCL12, was increased only in infected cells (RM one-way ANOVA-Friedman’s test with 
Dunn’s multiple comparisons test, p=0.0267, n=7). (F) CXCR6, receptor of CXCL16 was not 
affected by Ct infection in mRNA level CXR4 mRNA, receptor of CXCL12, was increased 
only in infected cells (RM one-way ANOVA-Friedman’s test, p>0.05, n=7). Graphs show the 
mean and standard deviation. 
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3.3.6. Supernatants from Ct infected cells do not 
affect SW71 trophoblast cell line migration 
Since CXCL12 and CXCL16 are known to affect trophoblast migration (as 
discussed in Chapter 1), I hypothesised that decreased secretion of these two 
chemokines might affect trophoblast migration thus potentially impairing 
implantation. 
To test this hypothesis, SW71 first trimester trophoblast cells were treated with 
conditioned media from Ct infected ESC with and without recombinant 
CXCL12 and CXCL16. The optimal concentration of CXCL12 and CXCL16 
that can induce SW71 migration was calculated from a scratch assay was 
completed in triplicate as described in paragraph 3.2.8.  
SW71 spheroids were plated in 48-well plates and treated as seen in Table 3.4. 
There were no other significant differences in migration among all treatment 
groups (Figure 3.12A). Supernatants from primary decidualised ESC alone was 
not sufficient to induce migration of SW71 cells compared to media from non 
decidualised ESC (Figure 3.12B). Similarly, addition of recombinant CXCL12 
and CXCL16 did not affect trophoblast migration in cells treated with various 
conditioned media (Figure 3.12C, Figure 3.12D). However, when both 
CXCL12 and CXCL16 were both added in trophoblast spheroids treated with 
Ct infected conditioned media, cells expanded further away from the main 
spheroid body (Figure 3.12E). An example can be seen in Figure 3.12F. 
Further validation and troubleshooting of this experiment was not possible due 
to time restriction. 
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Figure 3.12. Supernatants from Ct infected ESC do not affect migration of trophoblast 
cell line SW71. ESC were infected with Ct MOI 2 following an in-vitro decidualisation 
protocol. Non decidualised uninfected ESC, uninfected decidualised ESC and UV-Ct treated 
ESC were used as controls. Supernatants were collected from ESC 48 hours post infection and 
added to SW71 spheroids. Recombinant CXCL12 and CXCL16 proteins were added either 
individually or combined in conjunction with ESC cell supernatants. 30 hours later the area 
between the main spheroid body (marked in red) and the outer ring of cells (marked in green) 
was measured to calculate migration. (A) SW71 migration distance was not different among 
decidualised uninfected and Ct infected ESC supernatants (RM one-way ANOVA-Friedman’s, 
p>0.05, n=3). (B) Supernatants from decidualised ESC did not induce increased migration (RM 
one-way ANOVA-Friedman’s test, p>0.05, n=3). (C) Addition of CXCL12 to SW71 media did 
not induce migration (RM one-way ANOVA-Friedman’s test, p>0.05, n=3). (D) Addition of 
CXCL16 to SW71 media did not induce migration (RM one-way ANOVA-Friedman’s test, 
p>0.05, n=3). (E) Trophoblast cells treated with Ct infection supernatant supplemented with 
CXCL12 and CXCL16 migrated more compared to controls (RM one-way ANOVA-
Friedman’s test with Dunn’s multiple comparisons test, p=0.047, n=3). (F) Representative 
image of expansion of trophoblast spheroids in response to Ct infected conditioned media 
combined with CXCL12 and CXCL16, indicated by the green line. Scale bar equals 200μm. 
Graphs show the mean and standard deviation. 
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3.4. Discussion 
The data presented in this chapter demonstrate that Ct can infect ESC and 
infection could impair decidualisation as it decreases the mRNA levels of 
decidualisation marker PRL and alters the secretion of chemokines CXCL12 
and CXCL16. 
It was previously believed that Ct can only infect epithelial cells (Buchholz and 
Stephens, 2006; Rasmussen et al., 1997; Rödel, Grosse, Yu, Wolf, Otto, 
Liebler-Tenorio, Forsbach-Birk, and Straube, 2011). I demonstrated for the 
first time that Ct can also infect and proliferate in ESC, the functional 
compartment of the endometrium that is responsible for decidualisation. It is 
therefore possible that ascending genital Ct infection might be a more 
complicated process than previously thought. Ct could breach the epithelial 
barrier of the endometrium and infect other cell types such as stromal cells, 
endothelial cells or glandular epithelial cells causing extended inflammation 
(endometrial structure reviewed in Chapter 1). Ct is known to cause 
endometritis, namely inflammation of the endometrium that is often 
asymptomatic, in non-pregnant women (Tait et al., 1997). Some studies have 
suggested an association of chronic endometritis with miscarriage and 
implantation failure (Cicinelli et al., 2014; McQueen et al., 2014). Data from 
animal studies indicate that in mice, C. abortus induces the murine equivalent 
of miscarriage likely due to decidual damage (Buendía et al., 1998). The effect 
of a Ct infected endometrial stromal compartment on gestation-related 
processes, such as decidualisation, might be a possible mechanism of Ct 
infection induced pregnancy complications.  
Using a novel in-vitro model of active Ct infection on ESC cells, I 
demonstrated that infection can impact ESC decidualisation by affecting 
expression of widely used decidualisation marker PRL. PRL is a key molecule 
of decidualisation, also thought to be involved in epithelial cell differentiation 
(Haines et al., 2009). Furthermore, PRL has been associated with angiogenesis, 
trophoblast cell growth and immune regulation during early pregnancy 
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(reviewed in Jabbour and Critchley, 2001). The PRL receptor (PRLR) has also 
been shown to increase cell proliferation (Olazabal et al., 2000). Given the 
crucial role of PRL during decidualisation and early gestation, it is possible 
that reduced PRL levels due to Ct infection might have a detrimental effect on 
a potential pregnancy. It is known that PRL mRNA and protein was expressed 
in some patients suffering from recurrent miscarriage and infertility but not in 
others (Garzia et al., 2004). Reduction of endometrial PRL has been linked 
recently to recurrent miscarriage (Salker et al., 2010). Finally, in rodent models 
decidual cell prolactin production has been shown to be critical for successful 
pregnancy (Bao et al., 2007). Although the exact mechanism remains 
unknown, reduction of PRL due to Ct infection might be a potential 
mechanism of Ct induced miscarriage. 
On the contrary, Ct infection did not affect the expression of IGFBP1 mRNA 
or protein. This could be attributed to the fact that infection occurred after ESC 
were decidualised and IGFBP1 is the first marker to be induced in high levels 
(Gellersen and Brosens, 2014b). It is therefore possible that at that stage of 
decidualisation, the impact of Ct infection on IGFPB1 was negligible. 
However, PRL is induced at a later stage and although IGFBP1 and PRL are 
similarly regulated by various transcriptional factors, there is one study to date 
that has reported slightly differential regulation (Buzzio et al., 2006). Buzzio et 
al. reported that FOXO1A and FOXO3A transcriptional factor silencing was 
sufficient to downregulate IGFBP1 but PRL levels were not affected, although 
overexpression of FOXO1 activated both molecules as expected (Buzzio et al., 
2006). However, my data demonstrated that FOXO3A mRNA was not affected 
by Ct infection in decidualised ESC (Figure 3.9C). This mechanism is 
therefore not likely to be responsible for the different effect of Ct infection on 
IGFPB1 and PRL observed in this model. Another possibility is that the ratio 
between FOXO1 and FOXO3A can impact upon decidualisation markers 
expression (Buzzio et al., 2006); examination of FOXO1 mRNA levels in 
further experiments is required to clarify this possibility. Alternatively, there 
may be yet more unknown mechanisms involved in induction of 
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decidualisation marker secretion, mechanisms that result in differential 
regulation of IGFBP1 and PRL in the presence of Ct infection.  
Ct infection had no effect on decidualisation and miscarriage-associated gene 
SGK1 and it’s downstream target FOXO3A, indicating that this is not a 
pathway that is likely to be affected by Ct infection of ESC. Furthermore, 
mRNA levels of proangiogenic factor VEGF and HB-EGF were similarly not 
altered. HB-EGF has been shown to mediate decidualisation and ESC survival 
(Chobotova et al., 2005); it therefore appears that Ct infection does not affect 
this decidualisation pathway. On the contrary, EGF mRNA was reduced in 
infected ESC compared to decidualised controls. A study reported that 
increasing concentration of EGF resulted in inhibition of cAMP induced in-
vitro decidualisation of ESC (Sakamoto et al., 2000). Since EGF mRNA was 
reduced by Ct infection, the impaired decidualisation observed in infected ESC 
is not likely to be mediated via EGF. Reduction of EGF could be the result of a 
mechanism attempting to compensate for the reduced PRL mRNA levels, 
however this requires further investigation. 
It would be very interesting to induce decidualisation on ESC infected with a 
lower MOI, allowing to experiment to be stopped at various time points after 
the onset of decidualisation, to investigate whether active infection would 
impair the process by decreasing PRL and/or IGFBP1 secretion. Unfortunately, 
it was not possible to conduct these experiments due to time restriction, 
however future studies could further explore the mechanism via which Ct 
infection impacts on decidualisation. 
Ct infection of ESC induces a strong innate immune response from the host, 
indicated by high levels of transcript and secreted CXCL8 in decidualised ESC. 
Several studies have already shown this in epithelial cells and cell lines such as 
HeLa cells, identifying NOD1 pattern recognition receptor as responsible for 
CXCL8 induction (Buchholz and Stephens, 2006, 2007, 2008; Cheng et al., 
2008). Importantly, CXCL8 recruits proinflammatory M1 macrophages (Xuan 
et al., 2015), thus tipping the M1/M2 balance in the fetomaternal interface 
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from M2 to M1, a fact recently shown to be associated with miscarriage 
(Brown et al., 2014; Guenther et al., 2012). Innate immune response of 
maternal decidua to active Ct infection during gestation could potentially have 
serious implications on pregnancy outcome. 
Furthermore, data presented in this study demonstrate that Ct infection changes 
the chemokine secretion profile in decidualised ESC. Interestingly, a reduction 
in the levels of CXCL12 and CXCL16 was observed. The reduction in protein 
expression in the culture supernatants cannot be attributed to increased 
receptor-ligand interactions as the receptor for neither chemokine showed 
increased expression. This observation may have relevance to the role of Ct in 
miscarriage because both CXCL12 and CXCL16 are known to promote 
trophoblast migration (Huang, Zhu, et al., 2006; Isozaki et al., 2013). 
Furthermore, reduced CXCL12 levels were shown to be the cause of decreased 
trophoblast migration as a result of human cytomegalovirus infection (Warner 
et al., 2012). Importantly, in a pituitary adenoma cell line it was shown that 
CXCL12/CXCR4 pathway activation resulted in increased PRL secretion, 
suggesting a potential link between reduced PRL and CXCL12 levels (Barbieri 
et al., 2007). It is possible that Ct infection could subsequently lead to 
defective trophoblast invasion due to lack of essential attractant signalling 
molecules secreted from maternal decidua, such as CXCL12 and CXCL16.  
To test this hypothesis, a trophoblast invasion assay was conducted using 
spheroid trophoblast SW71 cells treated with conditioned media from infected 
ESC and controls. Expansion of trophoblast SW71 cells from the central 
spheroid body was not hindered by conditioned media from Ct infected ESC or 
UV-Ct treated ESC. This could be due to the fact that ESC supernatants were 
mixed with trophoblast DMEM media and this might have reduced the impact 
on SW71 spheroids. However, when lack of both CXCL12 and CXL16 was 
compensated by supplementing recombinant chemokines in Ct infection media, 
trophoblast cells surprisingly migrated over a wider area compared to controls. 
This observation could be attributed to many factors. The chemokine array 
conducted in this study indicated highly secreted RANTES/CCL5 (regulated 
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on activation, normal T-cell expressed and secreted) and MCP1/ CCL2 
(monocyte chemotactic protein 1), chemokines that are also known to induce 
trophoblast migration (as seen in Table 3.5). A study showed that trophoblast 
cells migrated into media containing CXCL8, RANTES and MCP1 (James, 
Cartwright, et al., 2012). CXCL8 alone has been reported to induce trophoblast 
migration (Jovanović et al., 2010). It is thus possible that high levels of 
CXCL8, RANTES and MCP1 found in Ct infection conditioned media, when 
combined with additional CXCL12 and CXCL16 result in increased 
trophoblast migration. The complicated interactions between various cytokines 
and their pleiotropic action pose a particular challenge when trying to 
investigate the effect of infection on trophoblast migration. An interesting 
future experiment would be investigating the effect of a co-culture of Ct 
infected decidualised ESC and SW71 cells. If Ct infection hindered SW71 cell 
migration, the experiment could be repeated using primary first trimester 
trophoblast cells and analysis could result in identification of more factors 
involved in this process.  
Developing a novel in-vitro model of infection of decidualised ESC proved 
particularly challenging due to the difficulties of ESC cell culture. Each 
experiment lasted approximately two months as ESC are growing at a slow rate 
in cell culture and are quite sensitive. Several repetitions were required to 
establish the model, ensuring both successful decidualisation via secretion of 
decidualisation markers and successful infection with the presence of 
inclusions and CXCL8 secretion. A limitation of the present study was the 
quantification of Ct inclusions was conducted using observation of inclusion 
staining by Giemsa. Due to significant difficulties of immunohistochemical 
staining of Ct inclusions, the fixed cells could be fluorescently stained for Ct 
and results visualised to facilitate counting. For a more user-independent 
quantification, the automated snapshot function of an appropriate imaging 
program could be utilised to confirm unbiased selection of areas. The 
experiment could be further supported by a second individual independently 
counting infected cells, which unfortunately was not possible at this time.  
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In summary, my data suggest that Ct infection leads to defective endometrial 
stromal cell decidualisation and results in an altered immune response that 
could impact on trophoblast migration and immune cell recruitment. Future 
work to clarify the role of Ct infection on trophoblast invasion via CXCL12 
and CXCL16 dysregulation and immune cell recruitment in the endometrium 
due to altered chemokine profile could further our understanding of the 
mechanism of Ct-induced miscarriage.   
 
   106 
4. Chapter 4: The effect of Ct infection in a 
murine model of pregnancy  
4.1. Introduction and aims 
Studies indicate that during gestation presence of acute infection leads to 
premature labour (de la Maza et al., 1994; Pal et al., 1999). In a study by Pal et 
al. (Pal et al., 1999), Ct mouse pneumonitis (MoPn) biovar was used to infect 
BALB/c mice intravaginally at concentrations ranging between 101 and 107 
IFU during gestation in a model of acute infection. It was shown that high 
concentrations of MoPn EBs (106 or 107) led to premature pup delivery (Pal et 
al., 1999). Mice infected with lower concentrations mostly delivered at term 
and no differences were observed in pup weight, however weight 
measurements were not taken in prematurely delivered pups as they were 
cannibalized by their mothers upon delivery (Pal et al., 1999). This study had 
good methodology, thus the data presented appears to be reliable. Using the 
same MoPn biovar in an earlier study (de la Maza et al., 1994), it was shown 
that 6 weeks post intravaginal inoculation with 3x107 bacteria, C3H/HeN, 
C57BL/6N and BALB/cAnN mice were less fertile compared to controls as 
indicated by a reduction in the number of pregnant mice and total pup number 
per mouse (de la Maza et al., 1994). However, the methodology of this study is 
not described in detail and no statistical power calculation is given  (de la Maza 
et al., 1994). Another study (Pal et al., 2001) demonstrated that susceptibility 
of BALB/c, C3H, and C57BL/6 mice ranging from 5 to 14 weeks of age to 
intravaginal infection with various concentrations (104 - 107) of Ct pneumonitis 
serovar was shown to be age-dependant. Younger mice had higher number of 
IFU recovered per mouse, vaginal shedding lasted longer and following mating 
higher rates of infertility and a decrease in the number of embryos were 
observed in the infected young mice (Pal et al., 2001). The methodology of this 
study is however not described in detail. 
Additionally, vaginal infection with Ct serovars prior to gestation in mice can 
result in infertility (Igietseme et al., 2013). C57Bl/6 mice that were infected 
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twice with 105 IFU of Ct serovar L2 were infertile, an effect reversed by local 
caspase activity inhibition in a more clearly designed study by Igietseme et al 
(Igietseme et al., 2013).  
On the contrary, in a different study (Tuffrey et al., 1988) when TO mice were 
infected with 1x107 IFU of Ct serovar E during gestation, the number of fetuses 
was not altered and the bacteria failed to cross the foetal membranes. Placental 
colonisation was detected especially when the infection was intraperitoneal 
versus intravaginal or intravenous infection, however this outcome was not 
observed if the mice were infected prior to day 5 of gestation (Tuffrey et al., 
1988). This study is an old study and further details on the mouse strain used 
could not be obtained, a serious limitation of this study. Furthermore, it seems 
low numbers of mice were used as well as both intraperitoneal and intravaginal 
inoculation of Ct, however the experiments are not clearly described and that 
needs to be taken into consideration when interpreting the data. 
Despite their limitations, the majority of the above studies indicate that vaginal 
infection with Ct serovars prior to gestation in mice can result in infertility and 
during gestation presence of acute infection leads to premature labour. 
However, no study to date has examined the effect the effect of Ct serovar E 
past infection on mouse implantation, pregnancy and resorption, and 
embryonic growth. In addition, the mechanism(s) by which Ct could result in 
these adverse pregnancy outcomes remains unknown. 
The hypothesis of this chapter was that past Ct infection with serovar E in C3H 
mice can affect pregnancy outcomes.  
To address this hypothesis I aimed:  
1. To investigate the effect of past Ct serovar E infection in C3H mice on 
pregnancy outcomes including implantation rates, pregnancy resorption 
numbers, and embryonic growth  
2. To investigate the effect of past Ct serovar E infection in C3H mice on 
genes of importance to mouse gestation and embryonic growth  
 
   108 
4.2. Materials and methods  
All procedures were undertaken according to UK Home Office regulations 
after ethical review, under project license 60/3544 held by Professor Andrew 
Horne. 
4.2.1. Murine pregnancy Ct infection model 
C3H mice were selected as several studies have indicated they are susceptible 
to infection with Ct (Carmichael et al., 2013; Darville et al., 1997; de la Maza 
et al., 1994; Peterson et al., 1999). Assuming the null hypothesis that prior Ct 
infection has no effect on pregnancy rate, a 95% infection rate with Ct and a 
viable pregnancy rate of 95%, this study required 80 female (40 infected and 
40 sham infected) and therefore 12 male mice to achieve significant results. 
Due to time restrictions, from the first set of experiments (termination of 
pregnancy at e12 of gestation) 60 out of 80 mice in total were used in the 
experiment. Only preliminary experiments were conducted for the second set 
(termination of pregnancy at e14) due to time restrictions and 10 infected and 
10 sham infected animals were sacrificed. 
Mice were kept in a 12-hour light/dark cycle with humidity maintained at 55% 
and temperature between 20°C and 25°C. Food and water were available as 
required. Mice from C3H strain at seven weeks of age were used for all 
experiments and mice were housed in individually ventilated cage (IVC) 
conditions at a maximum of five mice per box. All experiments were 
performed in a Class II hood according to health and safety regulations of the 
BRR animal facility. 
4.2.2. Preparation of Ct stock for intravaginal 
inoculation 
Ct stock at a titre of 3x106 /ml was used and each mouse was inoculated 
vaginally with 105 EBs. Prior to inoculation, the bacterial stock was spun at 
5,000g for 5 minutes and subsequently re-suspended in Succinic acid, sodium 
phosphate monobasic monohydrate and glycine buffer (SPG) buffer at pH7 (for 
protocol see Table 4.1) at a final volume of 30 μl per mouse. Control C3H mice 
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were inoculated vaginally with 30 μl of SPG buffer that did not contain any Ct 
(sham infection). Prior to vaginal inoculation, the mice were anaesthetised 
using 4% isofluorane for 30 seconds.  
Table 4.1. SPG buffer recipe. 
Component Concentration Company and Cat. No 
Sucrose 250 mM Sigma, Cat. No S0389 
Sodium Phosphate 10 mM Sigma, Cat. No 342483 
L-glutamate 5 mM Sigma, Cat. No G1251 
Sterile water volume as required Baxter, Cat. No 
BHL2F7113CS 
 
4.2.3. Mouse model protocol  
The following protocol was used: 
 
Figure 4.1. In-vivo murine model of past Ct infection.  
Day 0: Control mice received intravaginal injection of 30μl SPG buffer. Case mice received 
30μl of SPG buffer containing 105 Ct each.  
Day 1: All mice were vaginally swabbed to test for Ct presence.  
Day 8: All mice were vaginally swabbed to test for Ct presence. 
Day 18: All mice were vaginally swabbed to test for Ct presence. 
Day 24: All mice were vaginally swabbed to test for Ct presence. 
Day 30: All mice were mated and checked for plugs daily until pregnancy was established. 
Mice that remained unplugged over three consecutive cycles (3x4-day-cycles) were removed 
from the male mice and culled when each experiment was finished. 
e12-e14 of gestation: pregnant mice were culled at appropriate time points as required for each 
experiment. 
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4.2.4. Timed mouse mating 
C3H mice were mated 30 days post infection. For timed mating, each male was 
housed in an individual cage and was allocated a maximum of two females. 
Vaginal plug checks of breeding females were undertaken each morning before 
10 am to allow accurate calculation of their gestation stage. The day of plug 
discovery was designated e1 of gestation. 
4.2.5. Testing for presence of Ct infection 
To ensure that the mice were infected, vaginal FLOQswabs (COPAN floc 
technologies, Cat. No 518CS01) were collected and subsequently tested for 
evidence of Ct infection at the Microbiology lab of the Royal Infirmary of 
Edinburgh by Mike Shepherd using Abbott RealTime Ct/NG Amplification 
Reagent Kit (Abbot, Cat. No 08L07-091). Mice were immobilized by hand and 
swabbed vaginally without anaesthesia.  
4.2.6. Tissue collection and processing  
Mice were killed by a schedule 1 method. 
The uterus was removed from each pregnant mouse post-mortem. The number 
of live pups and non viable pups (resorption sites) was recorded. Each embryo 
and placenta was morphologically observed to identify potential 
malformations. Embryonic and placental weights were recorded immediately 
after dissection using a scale by one observer. All measurements were recorded 
on paper and subsequently imported in Excel. 
Embryonic and placental weight data were available for 12/19 non infected 
mice, 15/16 Ct exposed mice and 7/9 Ct infected mice at e12 as they were not 
initially included in the measured outcomes of this study and therefore not 
recorded. 
Tissue samples from each uterus, placenta and embryo were collected in 
RNAlater (ThermoFisher Scientific, Cat.No AM7021) to study mRNA levels 
of genes of interest. RNA samples were stored at -80oC following a 24-hour 
incubation period in RNAlater.  
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4.2.7. Statistical analysis 
Statistical analysis was carried out using GraphPad Prism 6. Normality was 
assessed using Kolmogorov Smirnoff tests. Where data was not normally 
distributed, the Kruskal-Wallis non-parametric test was used to analyse the 
data. This was followed by Dunn’s multiple comparison’s test as it allows for 
comparison of two particular groups by determining each rank from the entire 
data set (all groups), not just the two groups being compared. If the data was 
normally distributed, a parametric ordinary one-way ANOVA (Brown-
Forsythe test) was used to determine if there were any significant differences. 
This was followed by the Bonferroni’s post-hoc test for comparison among 
groups if any significant differences were indicated by the ANOVA test. All 
graphs show mean and standard deviation of the data. 
Dr Ioannis Papastathopoulos, Chancellor’s Fellow at the University of 
Edinburgh’s school of mathematics, reviewed the statistical analysis and 
approved it for analysis of the data presented in this chapter.  
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4.3. Results 
 
4.3.1. Natural history of Ct infection in the 
exposed cohort of mice 
As seen in Table 4.2, none of the control mice tested positive for Ct one day 
post infection but all mice inoculated with Ct tested positive. Seven days later, 
20 of 40 case mice remained positive for Ct and these mice were considered 
‘Ct infected’. The remaining case mice were considered ‘Ct-exposed’ (n=20). 
All mice tested negative for Ct 18 and 24 days post-infection, indicating that 
infected mice cleared the infection in maximum three weeks time.  
Table 4.2. Vaginal swab test for Ct infection results from C3H mouse experiments. 
 Number of mice  






swab test  
Positive 
swab test 
Swab day 1 40 0 0 40 
Swab day 8 40 0 20 20 
Swab day 18 40 0 40 0 
Swab day 24 40 0 40 0 
 
4.3.2. Pregnancy outcomes of Ct infection in 
the exposed cohort of mice 
Mice were killed at e12 and e14 of gestation as calculated based on vaginal 
plug detection. An example of a pregnant mouse uterus at e12 can be seen in 
Figure 4.2A. Resorptions, namely pups that are no longer viable and are 
subsequently absorbed by the mouse uterus (Passey et al., 1999), were 
classified as “early” when at the time of dissection it was not possible to 
distinguish the embryonic tissue from the placenta (Figure 4.2B) and as “late” 
if the distinction was clear (Figure 4.2C). From here onwards, with the term 
“resorption” both early and late resorptions are included and normally 
developed pups are named “NDev”. The experiment was conducted on 60 out 
of 80 mice for e12 and 20 out of 80 mice for e14 due to time restrictions. 
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Figure 4.2. C3H mouse uterus, resorption and embryos at e12 of gestation. (A) Uterus with 
normally developed (NDev) pups and pups that were no longer viable, namely resorptions. (B) 
In utero resorption and live pup. (C) Dissected resorption placenta and embryo (left) and live 
embryonic and placental tissue (right). Ruler in cm. 
As some mice were not successfully mated, in a total of five experiments, the 
outcomes were 23 out of 40 control “non infected” mice. 18 negative cases or 
“Ct-exposed” and 12 out of a total of 40 positive cases termed “Ct infected” 
mice (Table 4.3). Embryonic and placental weight data were available for 
12/19 non infected mice, 15/15 Ct exposed mice and 7/9 Ct infected mice at 
e12 as they were not initially included in the outcomes of this study and 
therefore not recorded. 
Table 4.3. Number of C3H mice per non infected, Ct exposed and Ct infected group, 
classified by gestation age at day of termination. 



















e12  9 8 19 15 9 
e14  4 6 4 3 3 
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4.3.3. Past Ct infection does not affect 
implantation rate, or resorption or pup 
numbers  
The total number of implantation sites was calculated per mouse (live pups 
plus resorption sites), similar levels of total implantation sites per mouse were 
demonstrated (Figure 4.3A).  
 
 
Figure 4.3. Past Ct infection of C3H mice does not impact on implantation and pregnancy 
outcome at e12 of gestation. C3H mice were intravaginally inoculated with Ct or sham 
infected and mated 30 days post infection. They were classified as Ct infected if they presented 
with infection 8 days post inoculation, Ct exposed if they cleared the infection by day 8 and 
controls (non infected mice). (A) Ct infection did not alter total embryo implantation site 
numbers per mouse, therefore not affecting the implantation rate of the mice (ordinary one-way 
ANOVA, p>0.05, n=9-19 mice per group). (B) Past Ct infection and exposure to Ct did not 
affect pup or resorption numbers (ordinary one-way ANOVA, p>0.05, n=9-19 mice per group). 
Graphs show mean and standard deviation. 
 
Furthermore, the number of normally developed pups and resorptions did not 
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4.3.4. Past Ct infection does not affect 
placental or embryo weight at e12 
 
Figure 4.4. Past Ct infection does not affect the average embryonic and placental weight 
of e12 pups. C3H mice were intravaginally inoculated with Ct or sham infected and mated 30 
days post infection. They were classified as Ct infected if they presented with infection 8 days 
post inoculation, Ct exposed if they cleared the infection by day 8 and controls (non infected 
mice). (A) No difference was observed in the average e12 embryo weight among all groups 
(ordinary one-way ANOVA, p>0.05, n=7-15 mice per group). (B) The average e12 placental 
weight was not affected by Ct infection or exposure to Ct (ordinary one-way ANOVA, p>0.05, 
n=7-15 mice per group). Graphs show mean and standard deviation. 
 
The average weight of embryos and placenta per mouse did not differ among 
the three groups (Figure 4.4). When examining each pup as an individual 
independent unit, data shows the weight of each pup and placenta was not 
altered due to exposure to Ct or presence of Ct infection on e12 (Figure 4.5A, 
Figure 4.5B). The embryo to placenta ratio per mouse was also not different 
among the three groups (Figure 4.5C). 
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Figure 4.5. Past Ct infection of C3H mice does not affect embryonic and placental weight 
at e12 of gestation. C3H mice were intravaginally inoculated with Ct or sham infected and 
mated 30 days post infection. They were classified as Ct infected if they presented with 
infection 8 days post inoculation, Ct exposed if they cleared the infection by day 8 and controls 
(non infected mice). (A) No change in embryonic weight was observed (ordinary one-way 
ANOVA, p>0.05, n=49-98 pups). (B) Placental weight did not differ among all groups 
(Kruskal-Wallis test, p>0.05, n=49-98 pups). (C) Embryo to placenta ratio was not altered due 
to exposure to Ct or Ct infection (ordinary one-way ANOVA, p>0.05, n=7-15 mice). Graphs 
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4.3.5. Past Ct infection does not affect 
implantation rate, pup or resorption numbers 
at e14 
At e14 no differences were observed on the number of normally developed 
pups and resorptions or total implantation sites among non infected, Ct exposed 
and Ct infected mice (Figure 4.6A, Figure 4.6B). 
 
 
Figure 4.6. Past Ct infection does not impact on C3H mice implantation and pregnancy 
outcome at e14 of gestation. C3H mice were intravaginally inoculated with Ct or sham 
infected and mated 30 days post infection. They were classified as Ct infected if they presented 
with infection 8 days post inoculation, Ct exposed if they cleared the infection by day 8 and 
controls (non infected mice). (A) The number of implantation sites did not differ among all 
groups (Kruskal-Wallis test, p>0.05, n=3-4 mice). (B) Similar numbers of NDev pups and 
resorption sites per mouse were observed at e14 (Kruskal-Wallis test, p>0.05, n=3-4 mice). 
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4.3.6. Past Ct infection reduces embryo and 
placenta weight at e14  
 
When examining the average embryo and placenta weight per dam, no 
differences were observed among Ct infected, Ct exposed and non infected 
dams at e14 as seen in Figure 3.7. 
 
Figure 4.7. Past Ct infection does not affect neither the average embryonic nor the 
average placental weight of e14 C3H mice pups. C3H mice were intravaginally inoculated 
with Ct or sham infected and mated 30 days post infection. They were classified as Ct infected 
if they presented with infection 8 days post inoculation, Ct exposed if they cleared the infection 
by day 8 and controls (non infected mice). (A) No change in average embryonic weight was 
observed among all groups (Kruskal-Wallis test, p>0.05, n=3-4 mice). (B) The average 
placental weight did not differ among all groups. (Kruskal-Wallis test, p>0.05, n=3-4 mice). 
Graphs show mean and standard deviation. 
 
The weight of e14 embryos from Ct infected mothers was reduced compared to 
non infected pups (mean of 0.1138g compared to a mean of 0.1219g, Figure 
4.8A). Similarly, placentae from Ct infected mice weighed less than those from 
non infected controls (a mean of 0.06828g compared to a mean of 0.07598g, 
Figure 4.8B). On the contrary, the embryo/placenta ratio of individual mice did 
not differ among groups (Figure 4.8C).  
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Figure 4.8. Ct past infection of C3H mice results in reduced embryonic and placental 
weight of e14 C3H pups. C3H mice were intravaginally inoculated with Ct or sham infected 
and mated 30 days post infection. They were classified as Ct infected if they presented with 
infection 8 days post inoculation, Ct exposed if they cleared the infection by day 8 and controls 
(non infected mice). (A) Reduction in embryonic weight of e14 pups was measured in Ct 
infected embryos compared to non infected control mice (Kruskal-Wallis test with Dunn’s 
multiple comparison’s test, p=0.034, n=23-26 pups). (B) Similarly, placentae of pups from Ct 
infected mice weighed less than non infected controls (ordinary one-way ANOVA with 
Bonferroni’s multiple comparison’s test, p=0.0019, n=23-26 pups). (C) No difference was 
observed in the embryo/placenta ratio per mouse among all groups (Kruskal-Wallis test, 
p>0.05, n=3-4 mice). Graphs show mean and standard deviation. 
 
4.3.7. Ct infection induces Prlr, Cxcl16 and Egf 
expression in e12 mouse uterus surrounding 
resorption sites but does not alter Cxcl12 or 
their respective receptor expression levels 
To investigate potential changes in my genes of interest for this study, the 
levels of on Prl, Cxcl12, Cxcl16, Egf and their receptors were examined 
(Figure 4.9). The mRNA levels of Prlr, Cxcl16 and Egf were elevated in 
uterine tissue in proximity to mouse resorption implantation sites in Ct infected 
mice. In contrast, Prl, Cxcl12, Cxcr4 and Cxcr6 were not affected by past Ct 
infection.  
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Figure 4.9. Past Ct infection on does not affect the mRNA levels of Prl and Cxcl16 but 
alters the expression levels of Prlr, Cxcl12, Cxcr4, Cxcr6 and Egf in the uterus at e12 of 
C3H mouse gestation. C3H mice were intravaginally inoculated with Ct or sham infected and 
mated 30 days post infection. They were classified as Ct infected if they presented with 
infection 8 days post inoculation, Ct exposed if they cleared the infection by day 8 and controls 
(non infected mice). (A) The mRNA of Prl was not altered among all groups (Kruskal-Wallis 
test, p>0.05, n=5-7 mice). (B) Prlr mRNA was increased in resorption sites of Ct infected C3H 
mice compared to resorptions of non infected mice (Kruskal-Wallis test with Dunn’s multiple 
comparisons test, p=0.0052, n=5-7 mice). (C) Cxcl12 expression levels were not altered among 
all groups (Kruskal-Wallis test, p>0.05, n=5-7 mice). (D) mRNA levels of Cxcr4, receptor of 
Cxcl12 chemokine, remained unchanged among all groups (Kruskal-Wallis test, p>0.05, n=5-7 
mice). (E) Cxcl16 mRNA was increased in resorption sites of Ct infected mice (Kruskal-Wallis 
test with Dunn’s multiple comparisons test, p=0.0061, n=5-7 mice). (F) In contrast, mRNA for 
Cxcl16 receptor Cxcr6 remained unchanged (Kruskal-Wallis test, p>0.05, n=5-7 mice). (G) Egf 
messenger RNA was also upregulated in Ct infected mice resorptions (Kruskal-Wallis test with 
Dunn’s multiple comparisons test, p=0.0049, n=5-7 mice). Graphs show mean and standard 
deviation. 
 
To summarise, pregnancy outcomes including implantation rate and pregnancy 
or resorption numbers remained unchanged in Ct exposed and Ct infected mice 
compared to non infected controls at e12 and e14 of gestation. Embryonic and 
placental weight of Ct infected mice was similar to controls on e12 however a 
reduction was observed on e14 of gestation. Prl, Cxcl12, Cxcr4 and Cxcr6 
mRNA levels were not affected by past Ct infection, whereas Prlr, Cxcl16 and 
Egf where elevated in uterine tissue in proximity to mouse resorption 
implantation sites in Ct infected mice compared to tissue near normally 
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4.4. Discussion 
This study demonstrates that Ct infection, cleared prior to pregnancy, reduces 
embryonic and placental weight at e14 but has no effect on implantation or pup 
resorption rates in a murine model of pregnancy. Furthermore, changes in 
gestation related genes Prlr, Cxcl16 and Egf indicate possible mechanisms that 
might be responsible for Ct induced adverse pregnancy outcomes in mice. 
There are few models of ascending Ct infection in the mouse female 
reproductive tract (Gondek et al., 2012; Pal et al., 1994; Swenson et al., 1983) 
and even fewer models of ascending infection leading to adverse pregnancy 
outcomes (Igietseme et al., 2013; de la Maza et al., 1994; Pal et al., 1999, 
2001; Tuffrey et al., 1988). In my model using Ct serovar E, vaginal 
inoculation with 105 IFU of Ct was sufficient to induce ascending and 
subsequent uterine infection in C3H mice that was cleared 18 days post 
infection in all mice. This could be a useful model to study processes and 
pathways related to early pregnancy that are affected by serovar E, the human 
sexually transmitted Ct serovar. 
The number of total implantation sites per mouse was not altered following 
exposure to Ct indicating no effect of past Ct infection on implantation. 
Similarly, no differences were observed in the number of live embryos or 
resorptions at both e12 and e14 gestational days. Although the experiments 
were not completed due to time restrictions, it is likely that past Ct infection 
does not alter implantation rates or fertility in C3H mice. However, infertility 
has been induced by the MoPn serovar (in high IFU doses, such as 106 and 107, 
Carmichael et al., 2013). Serovar E has been shown to be less potent 
pathogenic factor in mice compared to other Ct serovars such as D and F in 
C3H mice (Carmichael et al., 2013). Although my results indicate that it is not 
likely that past infection with serovar E results in infertility, future experiments 
utilizing higher IFU for serovar E infection and comparison with MoPn serovar 
infection should be carried out to further investigate this hypothesis. 
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The average embryonic and placental weight per mouse was not affected by Ct 
infection or exposure to Ct at e12 of gestation. Similarly, in preliminary 
experiments at e14 of gestation, no difference was observed when the average 
pup and placental weight was examined per dam. However, Ct infection was 
shown to decrease placenta and embryonic weight at e14 but not e12 if each 
embryo was considered an individual value. Some published studies have 
analysed gestational parameters by regarding each embryo and placenta as an 
individual value (Constância et al., 2002; Mu et al., 2008), whereas others 
either analysed the mean weight per dam or analysed the data both ways 
(Cosselman et al., 2012; Hubbard et al., 2013). Both ways of analysing the data 
are valid, however they highlight the need of further experiments to investigate 
the potential link between past Ct infection and IUGR. 
Although these were preliminary experiments, this is the first murine model to 
demonstrate that past maternal infection with Ct infection could potentially 
lead to IUGR. IUGR has been induced in other mouse models with a maternal 
low-protein diet and hypercholesterolemia (Bhasin et al., 2009). In the absence 
of maternal malnutrition, insufficient vascularisation as a result of abnormal 
vessel development in Vegf-/- mice caused IUGR (Carmeliet et al., 1996). Nitric 
oxide synthase knockout (eNOS-/-) mice display suboptimal uterine artery 
function and placental nutrient transport is impaired leading to IUGR (Kusinski 
et al., 2012). Insulin-growth factor II (IgfII) depletion has been shown to 
induce reduction of placenta weight that also results in IUGR (Constancia et 
al., 2002). It would be interesting to determine whether Ct infection leads to 
IUGR through any of these pathways in future experiments utilising the mouse 
model of infection and gestation developed in this study. 
It was surprising that Prlr and Egf transcripts were upregulated in uterine tissue 
of mouse resorption in Ct infected mice. There are no data available regarding 
pathogenic roles of excess Prlr or Egf. It is known however that Prl-/- and Prlr-/- 
mouse models display serious reproductive failure phenotypes including 
impaired fertilisation, implantation failure and abnormal mammary gland 
development (Bao et al., 2007; Horseman et al., 1997; Lucas et al., 1998; 
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Ormandy et al., 1997). Furthermore, reduced Prl and Egf protein levels have 
been associated to placental induced IUGR by several studies in mice (Ain et 
al., 2005; Cellini et al., 2004; Kamei et al., 1999; Rab et al., 2013). Taking into 
consideration that elevated mRNA levels do not necessarily result in increased 
protein levels, it is possible that the mRNA levels of Prlr are increased in an 
attempt to compensate for reduced protein levels due to the past Ct infection. 
This suggests a potential effect of Ct in post-translational regulation of these 
critical genes and requires further investigation. 
Finally, the role of Cxcl16 during mouse gestation is completely unknown and 
the presence of mRNA on gestational day e12 is a novel finding. As Cxcl16 is 
affected by Ct infection in a pattern similar to Prlr and Egf, it is likely that it is 
also involved in mouse gestation similarly to its role in human gestation, 
including recruitment of immune cells and interaction with trophoblast cells or 
maternal decidua. It would be very interesting to explore the role of Cxcl16 
utilising a knock-out mouse model, with and without Ct infection during 
gestation. 
A limitation of the current study is that weight data were not available for all 
dams at e12 as this was not an outcome initially included in the study aims. 
Future studies should be planned in great detail in advance and include 
embryonic and placental weight measurements. Furthermore, due to time 
restrictions, the experiments presented in this study are preliminary and should 
be repeated until a sufficient sample number is reached, as established in the 
statistical power calculation of this study.  
In future studies of past Ct infection utilising the current C3H model of 
gestation, it would be very interesting to investigate whether the growth 
restriction is continued till labour and whether the labour onset is premature or 
not. Moreover, another study could be designed to explore whether the effect 
of antibiotic treatment of Ct infection could prevent any of the above 
complications in a future gestation.  
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This study demonstrated that past Ct infection not only reduced embryonic and 
placental growth on e14 pups but also attenuated the expression levels of 
gestation related genes Prlr, Cxcl16 and Egf. These findings require further 
investigation initially using the murine model and further evaluation in 
humans, as they may highlight a previously unknown effect of past Ct infection 
to gestation and provide a link between infection, IUGR and potentially other 
adverse pregnancy outcomes such as premature labour and reduced birth 
weight.  
 
   126 
5. Chapter 5: Interim study analysis: 
association between Ct infection and 
miscarriage 
5.1. Introduction and aims  
Active Ct infection is defined as ‘current’ infection and is detected by PCR of a 
cervical swab (Centers for Disease Control and Prevention., 2014) although 
historically this was done by the less sensitive method of tissue culture 
(Centers for Disease Control and Prevention., 2014; Sozio and Ness, 1998). 
Persistent Ct infection is defined as infection that is still active for a minimum 
of 6 months up to 5 years after initial diagnosis (Meijer et al., 2005; Morré et 
al., 2002). Past Ct infection, which has been either treated using antibiotics or 
spontaneously cleared, can be diagnosed by proxy via detection of anti-Ct IgG 
antibodies in serum (Baud et al., 2011). Several ELISAs based on the detection 
of antibodies against Ct antigen MOMP are commercially available at the 
moment such as the MEDAC ELISA plus, the Savyon Sero Ct-IgG ELISA and 
the Anilabsystems IgG EIA (Wills et al., 2009b). A newly developed ELISA 
targeting antibodies against the Pgp3 protein of the Ct plasmid was shown to 
be the most sensitive assay when detecting past Ct infection (Horner et al., 
2013; Wills et al., 2009c). 
Active infection was shown to be associated with miscarriage in a study of 66 
women with spontaneous miscarriage (Vigil et al., 2002). In this study (Vigil et 
al., 2002), 21% (14 of 66) were Ct infected compared with 8.9% (23 of 59) of 
women with full-term pregnancies (p<0.05). The percentage increased to 
68.8% (22 of 32) when both parents were infected.  
Conversely, other studies have reported no association between active Ct 
infection and miscarriage (Baud et al., 2011; Grönroos et al., 1983; Munday et 
al., 1984; Sozio and Ness, 1998). In a study of 145 women with miscarriage 
and 261 controls (Baud et al., 2011), Ct was detected in 4% (5 of 145) of 
placentae from women with miscarriage and 0.7% (18 of 261) of control 
women with healthy pregnancies, however no difference was observed in the 
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prevalence of active Ct infection between women with miscarriage and 
controls (p=0.026). Baud et al. (Baud et al., 2011) more recently conducted a 
statistically powered study, with defined patient recruitment criteria for both 
cases and controls and examined for the presence of Ct infection in women and 
placentae using sensitive methods (ELISA and PCR), therefore this study is of 
high quality. In a separate study (Sozio and Ness, 1998), the proportion of 
women with Ct infection was 3.8% (2 of 52) among spontaneous miscarriage 
cases and 8.5% (5 of 59) controls under 22 weeks of gestation, therefore the 
researchers reported no increased risk of miscarriage due to Ct. In another 
prospective study (Munday et al., 1984), 241 pregnant women, 76 women 
miscarried and Ct was detected in the cervix of one woman in the study using 
cell culture followed by Giemsa stain, leading the authors to believe there was 
no association between Ct and miscarriage. In a study by Grönroos et al. 
(Grönroos et al., 1983), detection of IgG and IgA Ct antibodies by 
radioimmunoassay in sera and cervical secretions of 189 women with 
threatened miscarriage, showed no difference in Ct prevalence among women 
that subsequently delivered a healthy baby compared to women that 
miscarried. Further details of these studies are shown in Table 5.1. 
Several studies have been published in support of the association of past Ct 
infection with miscarriage, with Ct prevalence ranging between 11%-69% in 
miscarriages compared to 2-7% in healthy pregnant controls (Arsovic et al., 
2014; Baud et al., 2011; Licciardi and Grifo, 1992; Wilkowska-Trojniel et al., 
2009). In one study (Arsovic et al., 2014), 10 of 54 women with miscarriage 
were shown to have persistent Ct infection. Arsovic et al. (Arsovic et al., 
2014), suggest an association between persistent Ct infection and miscarriage, 
however a limitation of this study is these cases were compared only against 
patients with tubal infertility and not uninfected healthy pregnant women 
(Arsovic et al., 2014). In another study (Baud et al., 2011), 145 women with 
miscarriage and 261 controls, a positive association of past Ct infection with 
miscarriage was observed. The prevalence of Ct antibodies was 15.2% (2 of 
145) in women with miscarriage compared to 7.3% (19 in 261) in controls 
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(p=0.018, Baud et al., 2011). Furthermore, in an observational study of 4,920 
women with genital tract infections (Kortekangas-Savolainen et al., 2012), 
Kortekangas-Savolainen et al., have suggested that late complications can 
occur in Ct infected pregnant women. Moreover, Wilkowska-Trojniel et al. 
(Wilkowska-Trojniel et al., 2009) observed the prevalence of Ct antibodies in 
11.28% (9 of 76) patients with one spontaneous miscarriage compared to 2.2% 
(1 of 46) of 2nd and 3rd pregnancy trimester controls (p=0.029). In an older 
study of 195 miscarriage cases (Feist et al., 1999), 4.1% (8 of 195) patients 
were seropositive for Ct and none of the placenta sections examined were 
infected with the bacterium. This study examined no controls (Feist et al., 
1999). Finally, 69.0% (20 of 29) women with miscarriage were found to be 
positive for Ct antibodies compared to 23.7% controls (9 of 38, p<0.001) or 
25.6% of women who did not become pregnant (20 of 78, p<0.001) after IVF 
(Licciardi et al., 1992). In contrast, a number of older studies have disputed the 
association of past Ct infection and miscarriage (Coste et al., 1991; Feist et al., 
1999). In a case control study (Coste et al., 1991) comprising of 279 
miscarriage and 279 control cases, previous miscarriage, ethnic origin, 
maternal age above 30 at time of conception but not Ct infection were 
highlighted as significant risk factors to miscarriage. Additionally, a different 
study (Feist et al., 1999) examined 195 placental samples from miscarriage 
cases where examined using anti-Ct LPS antibody and were all negative. In the 
same study, serum samples from 187 patients were tested for detection of anti-
Ct antibodies by microimmunofluorescence. Serological findings indicated that 
only 8 patients had had past Ct infection (Feist et al., 1999). Finally, Paukku et 
al. (Paukku et al., 1999) examined 72 recurrent miscarriage patients and 132 
controls using serum Ct IgG and IgA ELISA to detect Ct infection and reported 
no association between Ct and miscarriage. This paper appears to have 
contradictory statements, as the microimmunofluorescence data the authors 
also presented in the paper demonstrated a higher prevalence of Ct infection 
antibodies in the control group. This was also openly criticised also in a letter 
to the same journal (Witkin, 2000). Further details of these studies and their 
limitations are shown in Table 5.1. 
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To summarise, the evidence supporting an association of Ct with miscarriage is 
inconsistent. This can be attributed to poor sensitivity of older detection assays 
and the inability of assays that detect current infection to detect past infection. 
Moreover, many of the above studies have been poorly designed, with some 
having unequal group sizes or missing a control patient population.  
I therefore set out to investigate the association of lifetime exposure to genital 
Ct infection with miscarriage using a novel ELISA that detects antibodies to 
the Pgp3 protein of Ct plasmids with more sensitivity than widely used 
commercial assays (Wills et al., 2009a). The Pgp3 antigen is unique to Ct, 
eliminating cross-reactivity with antibodies to other Chlamydia species such as 
C.pneumoniae, a major weakness of previous serological tests (Wills et al., 
2009a). A well-powered case-control study to investigate whether past Ct 
infection is a risk factor for miscarriage (for further details see sections 5.2.1). 
The hypothesis of this study was that past Ct infection is associated with 
increased risk of miscarriage.  
To address this hypothesis I aimed:  
1. To compare the detection of past Ct infection  
2. To investigate whether lifetime exposure to Ct is associated with 
increased risk of miscarriage  
3. To investigate the prevalence of active Ct infection in women 
presenting with miscarriage. 
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Table 5.1. Analysis of studies investigating the role of past and active Ct infection and miscarriage.       
Study Pregnancy 
complication 
Case population Control population Type of 
infection 














Active infection: cell culture from 
cervical swab and IgA 
radioimmunoassay on cervical and 






Less reliable due to 
lack of control 





1st and 2nd 
trimester 
miscarriage 
76 women with 
spontaneous 
miscarriage 
under 28 weeks 
of gestation 
149 women whose 




Active infection: cell culture 
detection using GIEMSA stain 















between the ages 
of 14 and 40 with 
miscarriage up to 
22 weeks of 
gestation  








DNA testing on urine samples 






Limitation is the 






66 women with 
history of one or 
more 1st trimester 
spontaneous 
miscarriages 
259 women with 








Immunofluorescence on cervical 





More reliable study 
although the much 
smaller size of the 




















Active: cell culture, DNA probe 







with case group 
much smaller 
compared to 
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Study Pregnancy 
complication 
Case population Control population Type of 
infection 











120 women aged 
19-44 years with 
miscarriage 
history 
46 women, in the 2nd 
and 3rd trimester with 
normal pregnancy, no 
history of miscarriage 





Active: PCR of endocervical swabs 
Past: serum IgG and IgA detection 







is the smaller 
sample size of the 
control group 








consulting for an 
acute 
miscarriage.  
261 women attending 
the labour ward with 








Active: PCR of endocervical 
swabs,  
Past: serum IgG and IgA using 
Ridascreen ELISA 







More reliable study 
using sensitive 
detection methods 
despite the smaller 








54 women with 
spontaneous 
miscarriage 





Serum samples: ELISA on IgG and 








is the small sample 
size of both groups 















Serum samples: ELISA on IgG and 







small sample size 










between 15 and 
44 years with 
miscarriage 
279 women 15 - 44 
years, giving birth in 
the same hospitals on 


























on unspecified Ct antibodies on 
serum. Immunohistochemistry, 




Less reliable due to 
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5.2. Materials and Methods  
5.2.1. Statistical power of study  
This is a large study of women with miscarriage with sufficient power to estimate the 
Ct population attributable risk in miscarriage (300 women in the miscarriage group 
and 300 women in the control group). Past Ct infection seroprevalence of 20% in the 
control group and 40% in women with miscarriage is anticipated based on literature 
review and pilot work (Baud et al., 2010; Lyytikäinen et al., 2008). The study has 
over 99% power to demonstrate an association between Ct exposure and miscarriage. 
It will have 86% power to detect a dose response effect of Ct titre, if 35% of the 
estimated 60 pregnant Ct positive controls have a high titre compared with 60% of the 
expected 120 miscarriage Ct positive population. With 300 women who have 
miscarried and 300 women with normal pregnancies, this will allow estimation of 
exposure within the miscarriage group (95% CI) 34.5%- 45.8% and 15.7%-25.1% 
within the control group respectively.  
5.2.2. Study participants  
All women gave written informed consent to the study, which was approved by the 
Scotland Ethics committee (REC reference number: 12/SS/0098). 
Women who attended the Pregnancy Support Centre of the Royal Infirmary of 
Edinburgh with a miscarriage that had been confirmed with an ultrasound scan were 
recruited. These women were aged between 16 and 45 years old with no history of 
HIV. The miscarriages were all within the first 12 weeks of pregnancy.  
Details of age, ethnicity, patient reported number of previous episodes of Ct, height 
and weight, medical history, current medication and current Ct infection status 
(cervical swab tested by Abbott RealTime CCOt/NG Amplification Reagent Kit, 
Abbot, Cat. No 08L07-091, and/or results obtained from the clinic notes if taken as 
part of routine clinical care) were collected for each patient. Additionally, birth 
weight (grams) of the baby was recorded for control patients. 
Patients in the control group were recruited from the Edinburgh Tissue Biobank and 
the Obstetric Triage Department at the Royal infirmary. The Edinburgh Tissue 
Biobank database folders were checked for eligible patients. Inclusion criteria 
included were between 15 and 45 years old, had no history of miscarriage or stillbirth 
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in previous pregnancies, no history of HIV, and were in their third trimester of their 
current pregnancy when approached. If information regarding history of Ct infection 
was recorded in the Biobank database, it was recorded. Details of age, ethnicity, 
patient reported number of previous episodes of Ct, height and weight, medical 
history, current medication were also recorded. However, routine Ct PCR swab test 
was not conducted by the Biobank at the time of recruitment. Serum samples were 
retrieved from the Biobank and analysed. The same inclusion criteria were used for 
women approached at the Obstetric Triage Department at the Royal infirmary, 
however a Ct PCR swab test was also conducted during recruitment in addition to 
serum sample collection. 
5.2.3. Ct antibody detection in serum samples 
5.2.3.1. Pgp3 indirect ELISA assay  
Samples were analysed for evidence of past Ct infection by Dr Gillian Wills as 
published in (Wills et al., 2009a) in Professor Myra McClure’s laboratory (Jefferiss 
Trust Laboratories, Wright-Fleming Institute, Imperial College London). This assay 
was selected as it is the most sensitive and specific assay compared to the most widely 
used anti-MOMP ELISAs (Wills et al., 2009c).  
Briefly, immunosorb 96-well microtitration plates were coated with Pgp3 protein for 
1 h at 37°C (20 ng per well in 100 mM sodium carbonate buffer, pH 9.6). The bound 
protein was washed with PBST-B (PBS, pH 7.2, containing 0.05% Tween 20), 
blocked with 200 μl of 1% Hammersten casein in PBST-B for 2 h at 37°C, and 
washed three times. All sera were then assayed in duplicate at a 1:100 dilution in the 
blocking buffer. After 1 h at 37°C, the bound protein and antibody were washed three 
times, and 100 μl of an HRP-labelled goat anti-human antibody (Fc fragment) diluted 
1:8,000 was added. After 1 h at 37°C, unbound antibody was removed by six washes 
with PBST-B; then 100 μl TMB solution was added, and the mixture was incubated 
for 10 min at 25°C. The reaction was stopped with 50 μl 2 M H2SO4, and absorbance 
was read at 450 nm. Readings were corrected for background by subtracting the 
average absorbance of two (blank) wells with no serum. 
5.2.4. RIDASCREEN® Chlamydia IgG/IgM assay 
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The second Ct detection assay used was the RIDASCREEN® Chlamydia IgG/IgM 
kit, used in the study by in the study by Baud and colleagues (Baud et al., 2011), R-
biopharm, Cat. no: KGM3101). 
The kit was used according to the manufacturer’s protocol. Briefly, 100 μl sample 
buffer was added into each of the microwells followed by 5 μl sample or control. The 
plate was mixed on a plate mixer and incubated for 45 minutes at 37 °C in an 
incubator. The wells were emptied into a waste container containing hypochlorite 
solution for disinfection. Then the plate was blotted onto absorbent paper in order to 
remove the residual moisture and washed 5 times using 300 μl diluted wash buffer 
each time. Subsequently, 100 μl of the streptavidin conjugated- IgG was added and 
incubated at 37 °C for 30 minutes. Following 5 washes, 100 μl of substrate were 
added to each well and incubated at room temperature for 20 minutes. The reaction 
was stopped by adding 50 μl stop reagent and the absorbance was measured at 450 
nm (reference wavelength 620 nm). 
5.2.5. Statistical analysis 
Statistical analysis was carried out by the Chi square test (used to test for a 
relationship between two groups of categorical values), Mann-Whitney test (used to 
test for a relationship between two groups of continuous values) and Fisher’s exact 
test (is used to analyse contingency tables with two nominal variables). The GraphPad 
Prism 6 software was used with the guidance of my study collaborator Dr Paddy 
Horner (Consultant Senior Lecturer in the School of Social and Community Medicine 
at the University of Bristol and expert in statistical analysis and modelling) (Horner et 
al., 2013; Wills et al., 2009c).   
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5.3. Results  
 
5.3.1. Demographic characteristics of study 
participants 
During January 2013–November 2015, a total of 199 women with miscarriage 
(‘miscarriage group’) were recruited to my study at the Pregnancy Support Centre of 
the Royal Infirmary of Edinburgh. 141 ‘control’ women were prospectively recruited 
from the Obstetric Triage Department at the Royal Infirmary of Edinburgh (‘control 
group’) and the Edinburgh Tissue Biobank.  
I personally identified 130 eligible control patients from the Edinburgh Tissue 
Biobank and recruited 10 patients from the Obstetric Triage Department at the Royal 
infirmary. Furthermore, I personally recruited 58 women at the Pregnancy Support 
Centre of the Royal Infirmary of Edinburgh.  
Due to difficulties with recruitment, I did not achieve the target set out in my sample 
size calculation and I therefore present an interim analysis. Recruitment is on-going 
by the Horne group and the target of 300 women in each group should be achieved by 
2017. 
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Figure 5.1. Case-control study recruitment was not completed till July 2015. (A) The target of 300 
women in the control group was not reached by May 2016, a total of 199 women were recruited. (B) 
Similarly, 141 of 300 women of the control group were recruited. 
 
 
As shown in Table 5.2, the groups did not significantly differ in age, as the average 
was 32.87 years of age for the control group and 36.62 for the miscarriage group. 
Similarly, no differences were observed in weight, height or body mass index (BMI) 
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between both groups. Ethnicity was a parameter that differed between groups, as 
more participants in the control group were of “unknown/other” ethnicity (9,3% 
compared to 0% whereas in the miscarriage group the majority of participants were 
Caucasian (95.5% compared to 87.9% in the control group). 
Table 5.2. Study participants displayed no difference in demographics including age, weight, 
height, smoking status and body mass index (BMI), however a difference was observed in the 
ethnicity between the control and miscarriage group. 








Age (years) Mean± Std. dev. 32.87 ± 
5.419 
32.62 ± 5.816 0.9506* 
 




70.18 ± 17.42 0.2131* 
 

















Smoker (%) 13 (9.6%) 21 (10.7%) 0.6720** 
 Ex smoker (%) 27 (19.9%) 46 (23.4%) 
Never smoked 
(%) 
96 (70.6) 130 (66%) 
Ethnicity Caucasian (%) 123 (87.9%) 190 (95.5%) < 0.0001** 
Black (%) 3 (2.1%) 3 (1.5%) 
Asian (%) 1 (0.7%) 6 (4%) 
Other/Unknown 
(%) 
13 (9.3%) 0 (0%) 
*Mann-Whitney test, **Chi square test 
 
Detailed statistical parameters can be found in Appendix 3. 
 
 
5.3.2.  Pgp3 ELISA detected more patients exposed 
to Ct than RIDASCREEN Chlamydia IgG ELISA 
Using the RIDASCREEN ELISA to detect past infection, 12 women with miscarriage 
and ten women from the control group were found to be seropositive for past Ct 
infection. However, using the Pgp3 ELISA 36 women with miscarriage and 31 
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women from the control group were positive for the Pgp3 antigen, indicating past Ct 
infection (Figure 5.2). 
 
Figure 5.2. The Pgp3 ELISA detected more women that had been exposed to past Ct infection 
compared to the RIDASCREEN ELISA. Serum samples were collected from 36 versus 12 patients 
in the miscarriage group and 31 compared to 10 in the control group. Past Ct infection was detected 
using an in-house ELISA assay detecting antibodies against Ct cryptic plasmid protein Pgp3 and a 
commercially available ELISA detecting anti-Ct LPS antibodies. 
 
5.3.3. No association with miscarriage and past Ct 
infection (based on interim analysis) 
Past Ct infection was detected by both the Pgp3 and the commercially available anti-
LPS ELISA. 31 women from the control group and 36 women from the miscarriage 
group were seropositive for Pgp3, whereas 96 and 124 respectively were 
seronegative. Using the commercially available IgG LPS ELISA on the same 
samples, 12 women from the control group where positive with 113 negatives and 10 
women from the miscarriage group were positive whilst 113 were negative (Table 
5.3). 
 
Table 5.3. Interim analysis of 141 serum samples from women with normal pregnancies and 199 
women with miscarriage demonstrates no association between past Ct infection and miscarriage. 
Past Ct infection was detected in serum samples using an in-house ELISA assay detecting antibodies 
against Ct cryptic plasmid protein Pgp3 and a commercially available ELISA detecting anti-Ct LPS 
antibodies. In the control group, 31 participants tested positive and 96 tested negatively for past Ct 
infection, whereas in the miscarriage group 36 were seropositive and 124 were seronegative as detected 
by the Pgp3 assay.  
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(n=141) (n=199)  
Pgp3 result Positive 31 36 0.7790** 







Positive 12 10 0.8240** 




**Chi square test 
 
 History of past Ct infection was reported by 4 women of the control group and 17 
women with miscarriage, with 17 women from the control group and 182 women 
from the miscarriage group reporting no previous Ct diagnosis. Information on history 
of Ct infection was not available for 120 women from the control group retrieved 
from the Biobank. 
Taking into account the self-reported history of past infection and the past Ct 
infection seroprevalence data from the Pgp3 assay, it is evident that several women 
had been exposed to Ct in the past without ever been diagnosed. More specifically, 
out of 31 seropositive women in the control group, only 4 reported past Ct diagnosis, 
whereas in the miscarriage group more women had received a diagnosis as 17 out of 
36 seropositive patients reported history of Ct infection (p=0.0034). 
 
5.3.4. Active Ct infection was not detected in any of 
the study participants  
 
None of the 14 women from the control group and 177 women from the miscarriage 
group was infected with Ct at the time of enrolment. The remaining 129 women of the 
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control group were not tested for active infection as the serum samples had been 
collected previously by Edinburgh tissue Biobank (Table 5.4). 
Table 5.4. Active Ct infection was not detected in any of the study participants. Participants were 
tested for active Ct infection at the time of enrolment in the study by PCR (Abbott RealTime Ct/NG 
Amplification Reagent Kit) on a cervical swab sample the participants collected themselves. This was 
not possible for control samples retrieved from the Edinburgh tissue Biobank, thus only 14 patients 
were tested and found seronegative. In the miscarriage group, none of the 177 women tested were 
diagnosed with active Ct infection. 




Positive 0 0 









To summarise, interim analysis of the samples from this study to date indicates that 
past Ct infection is not associated with miscarriage. If this holds true for the 
completed dataset, this is a very important public health message.  
The Pgp3 assay is more sensitive than other commercially available ELISAs (Wills et 
al., 2009a). As I have demonstrated, the Pgp3 ELISA detected more cases of past Ct 
infection compared to the RIDASCREEN Chlamydia IgG assay used by Baud and 
colleagues in the most recent study showing an association between Ct and 
miscarriage (Baud et al., 2011), however a study on samples with known history of Ct 
infection is required to establish the difference in sensitivity of these two ELISAs. 
With a total of 340 participants from both the miscarriage and control groups, the 
present study has a sample size larger than most studies published on the association 
between past and active Ct infection and miscarriage (Arsovic et al., 2014; Coste et 
al., 1991; Feist et al., 1999; Grönroos et al., 1983; Munday et al., 1984; Paukku et al., 
1999; Sozio and Ness, 1998; Wilkowska-Trojniel et al., 2009). The interim analysis 
suggests no association between past Ct infection and miscarriage, a result that, if 
confirmed upon study completion, contradicts several published studies (Arsovic et 
al., 2014; Baud et al., 2011; Licciardi and Grifo, 1992; Wilkowska-Trojniel et al., 
2009), whilst adding to those arguing against past Ct infection being a risk factor for 
miscarriage (Coste et al., 1991; Feist et al., 1999). It is likely that upon completion of 
the study the lack of association will be proved given the statistical power of the 
present study, thus clarifying that lifetime exposure to Ct is not a risk factor for 
miscarriage.  
An important factor that must be taken into consideration is that this study has 99% 
power to detect the association between Ct and miscarriage provided the prevalence 
of past Ct infection is 20% in the control group and 40% in the miscarriage group. 
Preliminary data indicate that the difference in Ct prevalence is not as high as 20% 
between the two groups. Although the study is still on-going, it is possible that a far 
larger scale study may be required to have sufficient power to establish an association 
between Ct and miscarriage. 
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Maternal weight and obesity, defined as body mass index (BMI) >=28, as well as 
smoking status were not associated with miscarriage. Obesity has been identified as a 
risk factor for miscarriage (Boots and Stephenson, 2011). The results reported in the 
present interim analysis could be attributed to similar weight, height and BMI 
distribution between the two groups, leading to no association between BMI and 
miscarriage. Furthermore, published systematic review of 98 studies has demonstrated 
that active smoking during pregnancy, including passive smoking, increased the risk 
of miscarriage (Pineles et al., 2014). However, similarly to BMI, smoking status was 
not associated with miscarriage in my analysis and a similar pattern of smokers, ex 
smokers and non smokers was observed among both groups.  
An important outcome from the interim analysis was that no active Ct infection was 
detected in any of the women in the miscarriage group so it is not going to be possible 
to come to any conclusion on active infection from this study. A past study on 
pregnant women in England has reported prevalence ranging from 0.08% to 2.1% in 
adult women 25-44 years old (Price et al., 2014). Similar prevalence statistics have 
been reported across Europe, ranging between 1.7% and 17% (Rours, Duijts, et al., 
2011; Wilson et al., 2002). Crucial to prevalence of the disease is country of origin as 
prevalence rates are higher in developing countries (27% in Saudi Arabia (Ashshi et 
al., 2015), 23% (Patel et al., 2010)and 29.8% in India (Yasodhara et al., 2001), and 
10.9-12.5% in Argentina (Golijow et al., 2005)). Furthermore, younger women are at 
higher risk of Ct infection and detection rates in pregnant adolescents have been 
reported as high as 37% (Hardy et al., 1984). In my sample set, zero prevalence 
reflects on Ct testing policies in Scotland that have been applied to young women 17-
24 years old and have resulted in 21% reduction of Ct cases (Looker et al., 2015) as 
well as the fact that the average age of both groups was 32 years old, suggesting a 
population of women at a lower risk of Ct infection (Adams et al., 2004; Price et al., 
2014). It is also possible that women who wish to become pregnant are more 
conscious of their health and ask to get tested if they think they might be at risk. It is 
therefore likely that potential infections might have been treated at the time of 
recruitment. As Ct prevalence rates are higher in developing countries, risk of adverse 
pregnancy outcomes due to past Ct infections might be more relevant in developing 
countries, highlighting the importance of the conduction of2 a statistically powered 
study in these areas. 
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The recruiting process for this study proved particularly challenging. Abiding by the 
schedule of each patient visit can be time consuming, as appointments can be delayed. 
This could result in missing patients if appointments occur in parallel in different 
departments. Furthermore, many patients did not consent to discussing the study or 
refused to participate after discussion. Another important factor was the lack of 
eligible patient samples from the Edinburgh Tissue Biobank for inclusion in my 
study. Another limitation of the Edinburgh Tissue Biobank samples was the lack of 
past Ct infection medical history information and current infection tested at the time 
of recruitment, as this was not a process normally undertaken by the Biobank. This 
resulted in a need for additional recruitment of patients attending their elective C-
section appointments at the Triage for the control group of this study.  
Recruitment to this study should be completed by 2017 and detailed statistical 
analysis will be followed by publication of the findings that will contribute to a better 
understanding of Ct infection and risk of miscarriage.  
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6. Chapter 6: General discussion 
In the present thesis three questions were addressed:  
1. Does Ct infection impact upon decidualisation and chemokine secretion? 
2. Does past Ct infection cause adverse pregnancy outcomes in a murine 
pregnancy model? 
3. Is past Ct infection associated with miscarriage in humans?  
The hypothesis was that Ct can infect ESC that undergo decidualisation. Ct infection 
could result in suboptimal decidualisation and attenuated chemokine secretion, which 
could negatively impact on a potential implantation. Furthermore, I hypothesised that 
there is a causal relationship between past Ct infection and adverse pregnancy 
outcomes including increased number of pup resorptions and IUGR in a murine 
model of pregnancy. Finally, drawing parallels between the mice and humans, I 
postulated that past Ct infection could be a risk factor for miscarriage. 
6.1. The role of the endometrium in Ct infection 
and adverse pregnancy outcomes  
The fetomaternal microenvironment during decidualisation and early pregnancy is a 
result of complex interactions between various cell types of the mother and the fetus. 
Consequently, any disruption of this delicate balance may lead to adverse pregnancy 
outcomes. As demonstrated in Chapter 3, Ct can infect not only the endometrial 
luminal epithelium but also the stromal cells. Furthermore, it can disrupt 
decidualisation as measured by reduced levels of decidualisation marker PRL, without 
affecting the high mRNA and protein levels of the other important decidualisation 
marker, IGFBP1. 
PRL is a key molecule for gestation and decidualised, with a well characterised role, 
and reduced PRL secretion has been linked to recurrent miscarriage (Salker et al., 
2010). In contrast, the role of PRL in IUGR remains unclear. It has been shown that 
mRNA and protein levels of decidualisation marker IGFBP-1 and leptin were 
elevated in IUGR placentae compared to placentae from normal birth weight babies, 
whereas PRL levels were found to be similar between the two groups (Struwe et al., 
2010).Interestingly, the same group detected elevated levels of IGFBP-1, leptin and 
PRL levels in the periphery and intermediate zone of IUGR placentae compared to 
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normal birth weight control placentae, demonstrating that sampling area is crucial for 
accurate quantification of proteins of interest (Tzschoppe et al., 2010).  
As demonstrated in Chapter 4, within a controlled experimental environment where 
the only variable is Ct infection of dams a month prior to mating, it is evident that 
past Ct infection did not cause increased resorption and did not evidently affect 
pregnancy up to e12 of gestation. However, preliminary experimental data collected 
by examination of individual pups at e14 have shown that Ct infection causes an 
apparent reduction in fetal size, indicating IUGR. Prl is expressed during the first half 
of mouse gestation and it is downregulated from e10 onwards (Barkley et al., 1978; 
Mednick et al., 1980), similar to the pattern observed during human gestation (Rigg et 
al., 1977). It was therefore not unexpected that the mRNA levels of Prl (Figure 4.9) 
were barely detected in the whole uteri examined in my mouse model. This does not 
necessarily mean that it has no role in contributing to IUGR caused by Ct infection in 
a mouse model of gestation. Future experiments are needed to investigate changes in 
Prl protein and mRNA levels during the early mouse gestation, namely at the stage 
corresponding to early decidualisation of the in-vitro experiments.  
Another largely unexplored field is the role of the immune system in IUGR. More 
specifically, there is no information on the role of CXCL12 and CXCL16 in IUGR 
development. A recent study has reported raised levels of interleukin-6, CXCL8 and 
interleukin-18 in IUGR new born babies compared to healthy babies, indicating that 
inflammation might be associated with IUGR (Krajewski et al., 2014). Moreover, 
increased umbilical artery CCL16 levels were associated with IUGR and preterm 
preeclampsia (Mäkikallio et al., 2012). I showed that CXCL12 and CXCL16 were 
reduced in-vitro in decidualised ESC infected with Ct (Figure 3.11) whereas CXCL8 
was elevated (Figure 3.9). As the role of maternal decidua is critical during early 
gestation, this could be a potential mechanism via which Ct infection could result in 
IUGR. A study utilising a proteomic array on babies and mothers with IUGR 
compared to healthy babies and mothers could identify more cytokines involved in 
IUGR pathogenesis and thus contribute to clarifying factors responsible for this 
adverse pregnancy outcome. 
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6.2. The role of past Ct infection in IUGR 
The role of active Ct infection in IUGR has not been firmly established, although 
most studies indicate that it can have a causative effect (Germain et al., 1994; 
Investigators of the John Hopkins Study of Cervicitis and Adverse Pregnancy, 1989; 
Vedmedovska et al., 2010). The complexity of mechanisms associated with adverse 
pregnancy outcomes has been furthermore demonstrated by the several risk factors 
associated with IUGR such as smoking, high BMI and drug use among others 
(reviewed in Suhag, A & Berghella, 2013). Therefore, a future study should account 
for all the above factors in order to elucidate whether Ct is a risk factor for IUGR. 
In this study, mRNA levels of Prl and Egf were upregulated in uterine tissue of mouse 
resorption in Ct infected mice indicating that past Ct infection might affect gestation 
related pathways. . Contrary to expectations none of the gene changes reported in a 
2010 microarray analysis of mice uteri in an IUGR model induced by the human 
pathogen Campylobacter rectus infection (Bobetsis et al., 2010) were observed here, 
which highlights the possibility that different pathogens could impact upon different 
pathways whilst resulting to similar outcome. In a study of IUGR, induced by 
dexamethasone in rats, in addition to the placental prolactin family genes, the insulin-
like growth factor-II and the Akt signalling pathway were dysregulated (Ain et al., 
2005). Due to attenuated expression of Akt/ protein kinase B, increased apoptosis was 
observed from placentae of IUGR mothers, partially explaining the reduced placental 
size observed (Ain et al., 2005). Insulin growth factor 1 (IGF1) mutation was shown 
to be responsible for growth retardation of a 15-year old boy (Woods et al., 1996). 
The role of IGF1 in IUGR is further supported by another reported case of IUGR in a 
female patient (Wallborn et al., 2010). It is therefore important for future experiments 
with the in-vivo model to further investigate these genes as potential targets.  
An interesting question raised is the mechanism via which past Ct infection results in 
permanent uterine damage that could affect future pregnancies. It is has been well 
established that Ct can regulate the transcription of host cell genes to promote its 
multiplication and protect itself from the host organism’s immune system (Nicholson 
et al., 2003). An emerging new field is examining the effect of infections on the 
epigenetic regulation of genes, called “patho-epigenetics” (Minárovits, 2009). The 
field of epigenetics examines the effect of DNA methylation, mainly at gene 
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promoters and enhancers that results in gene silencing, post-translational 
modifications of histone proteins, and RNA-based silencing on the phenotype of an 
individual (Riddihough and Zahn, 2010). Epigenetic alterations have been proven to 
be involved in disease development, including cancer and schizophrenia (Kanwal and 
Gupta, 2012; Van Vliet et al., 2007). Emerging data indicates that some viral and 
bacterial infections can attenuate epigenetic modifications resulting in abnormal 
phenotype that could lead to disease development (reviewed in Bierne et al., 2012; 
Minárovits, 2009). Helicobacter pylori infection of gastric mucosal cells was shown 
to increase methylation of several genes such as p16, resulting in increased risk of 
gastric cancer (Maekita et al., 2006). Infection with intracellular Listeria 
monocytogenes but not non-invasive Listeria innocua altered the epigenetic 
modifications of CXCL8 promoter, resulting in increased CXCL8 by HUVEC cells, 
however it did not affect IFN-γ (Opitz et al., 2006; Schmeck et al., 2005). No 
research to date is available on whether Ct infection can alter the epigenome of 
infected cells and whether this alterations could be lingering after the infection has 
been cleared, thus impairing normal cell function. This is an interesting new 
parameter of the potential long term health effects of bacterial infections that should 
be further investigated in the future. 
6.3. Investigating the role of past and current Ct 
infection in adverse pregnancy outcomes  
Upon completion of sample collection for the case control study, analysis of the 
results will elucidate the role of past Ct infection and miscarriage. Secondary 
outcomes of the study will include prevalence of current Ct infection in women of 
reproductive age in Scotland and association of factors such as maternal BMI and 
smoking status with miscarriage. Interim analysis of the data suggests no association 
of past Ct infection with miscarriage, an outcome that coincides with the findings 
from the in-vivo mouse model.  
The role of maternal infections in the development of IUGR has not been elucidated. 
It is postulated that infections including C.pneumoniae and Cytomegalovirus are an 
important risk factor to development of preeclampsia, a condition that includes 
complications such as premature labour and IUGR (von Dadelszen and Magee, 2002). 
The association between IUGR and past Ct that was indicated by data from the in-
    
 148 
vivo model presented in Chapter 4 could potentially be addressed by examining the 
birth weight and placental weight of embryos born from control women enrolled in 
the study. However, as this study has not been statistically powered to answer this 
question, a new appropriately designed case control study should be carried out. It is 
vital to take into consideration in the design of such a study important risk factors for 
IUGR development, such as maternal malnutrition and socioeconomic status 
(reviewed in Suhag, A & Berghella, 2013). 
Past and active Ct infection has been linked to female infertility, more specifically 
tubal factor infertility (Brunham et al., 1985; Mania-Pramanik et al., 2012; Patton et 
al., 1994). If the lack of association between past Ct infection and miscarriage is 
confirmed when the present study analysis is complete, this will indicate that although 
some women may have fertility problems as a result of exposure to Ct infection, 
women can be reassured that if they do have a normal uterine pregnancy there is no 
evidence of an adverse outcome. 
6.4. Future studies  
Sample collection for the case control study should be completed by the end of 2017. 
Statistical analysis of the results will be followed by publication of the findings. 
Future experiments utilising the in-vivo Ct infection model, in addition to further 
elucidation the role of past Ct infection in IUGR as suggested in Chapter 4, could 
focus on exploring the mechanism via which this effect is taking place. Molecules 
such as leptin, interleukin-6, CXCL8 and interleukin-18 that have been highlighted by 
other studies could be targets of interest. However, another future step could be a 
large-scale proteomic or mRNA array that could potentially reveal pathways affected 
by Ct infection that have never previously been identified. Sample sets could include 
pregnant mice with active infection and past infection, with and without antibiotic 
treatment at early and later gestational time points. This could lead not only to 
important discoveries regarding the role of past and active Ct infection in gestation, 
but also reveal potential implications to the general health of the mother. 
The role of many PRR receptors such as the NOD family of receptors in gestation is a 
new field of scientific interest (Abrahams, 2011). NOD1 and NOD2 are expressed in 
first trimester trophoblast cells and their activation may induce a proinflammatory 
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response (Costello et al., 2007). Another member of the NOD family, NALP3 was 
also shown to be expressed in trophoblast cells (Mulla et al., 2013). Inflammasome-
dependent caspase-1 activation (via NALP3 and ASC) was shown to induce Ct 
intracellular growth (Abdul-Sater et al., 2009). This could potentially have 
detrimental effect in establishing Ct infection in the decidua and placenta and is a 
direction that future experiments both in-vitro and in-vivo could explore.  
Moreover, a study in epigenetic changes such as changes in DNA methylation and 
histone modification in infected ESC could be a clue as to how does past Ct infection 
have long lasting effects. Similarly, this could be explored in uterine samples from the 
mouse model.  
As active Ct infection in pregnancy is recognised to be a risk factor for adverse 
pregnancy outcomes, an optimised in-vitro model of trophoblast invasion could be 
used to ascertain whether active Ct infection can impact on trophoblast cell migration. 
This could be conducted in parallel with studies in mice that could focus on active 
maternal infection and onset of gestation and placentation.  
Finally, the efficacy of antibiotic treatment in preventing adverse consequences of Ct 
infection could be explored both in-vivo and in-vitro. An interesting set of 
experiments could focus on key targets highlighted by the above studies and whether 
antibiotic treatment can reverse the attenuated expression/ regulation of genes of 
interest. If this hypothesis were to be proven true, the importance of diagnosis and 
treatment of Ct infection would be particularly highlighted. 
6.5. Conclusions of PhD 
In summary, the data presented in this thesis suggests that Ct has the capability to 
infect the stromal compartment of the endometrium and infection could result in 
suboptimal decidualisation as reduced mRNA and protein levels of the 
decidualisation marker PRL were observed in Ct infected ESC in-vitro. Furthermore, 
infection altered chemokine secretion of decidualised ESC in-vitro, thus attenuating 
levels of chemokines essential for normal implantation. The role of past Ct infection 
in causing miscarriage was investigated in a mouse model, however the number of 
resorptions did not differ between control and Ct infected mice. Importantly, the 
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embryonic and placental weight of pups of Ct infected dams was reduced compared to 
controls, a consequence that could lead to IUGR later during gestation.  
Though it may be the case that already exposed women may be at a higher risk of 
pregnancy complications, quick diagnosis and effective treatment could result in 
minimising the risk for a future pregnancy. The current study indicates that it is 
preferable to maintain vigilance and prophylactic policies as a precaution whilst 
future research efforts should be focused on elucidating key issues that remain 
unknown regarding the role of Ct infection in pregnancy.  
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7. Appendix 1  
The following paper based on Chapter 3 has been accepted for publication in 
Scientific Reports. 
Chlamydia trachomatis infection of human endometrial stromal cells induces defective 
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Miscarriage affects ~20% of pregnancies and maternal infections account for ~15% of early 1 
miscarriages. Chlamydia trachomatis (Ct) has been associated with miscarriage but the 2 
underlying mechanisms are unknown. Successful implantation requires endometrial stromal 3 
cell (ESC) decidualisation. Maintenance of pregnancy requires angiogenesis, establishment of 4 
the correct cellular milieu and trophoblast invasion, all of which involve the action of 5 
chemokines. Our objective was to determine whether Ct infection impacts upon ESC 6 
decidualisation and chemokine secretion. Human primary ESC were decidualised in-vitro, 7 
infected with Ct serovar E, and changes in expression of genes of interest were measured 8 
using RT-PCR, proteomic array and ELISA. We demonstrate for the first time that Ct can 9 
infect and proliferate in ESC. Expression of the decidualisation marker prolactin was 10 
decreased in Ct-infected ESC at both mRNA and protein levels. Ct infection altered the 11 
chemokine profile of decidualised ESC as shown by proteomic array. Chemokines CXCL12 12 
and CXCL16, important for trophoblast invasion, were analysed further and expression was 13 
reduced in infected decidualised cells at mRNA and protein levels. Our data indicate that Ct 14 
infection of ESC impairs decidualisation and alters chemokine release. These findings at least 15 
partially explain how Ct infection could result in adverse pregnancy outcomes. 16 
 17 
Word count: 198/200 18 
 19 
  20 




A miscarriage is defined as the spontaneous loss of a pregnancy during the first 24 weeks of 23 
gestation and occurs in approximately 20% of clinically recognised pregnancies1. 24 
Miscarriages are associated with considerable physical and psychological morbidity. Bleeding 25 
due to miscarriage can lead to haemodynamic shock and death and the emotional response to 26 
miscarriage can include depression and anxiety1. Approximately, 50% of early miscarriages 27 
are attributed to fetal chromosomal abnormalities, however, the underlying cause in other 28 
cases is often undefined. A number of infections have also been linked to miscarriage and 29 
infections are thought to account for 15% of early and 66% of late miscarriages (reviewed 30 
in1). Several studies have been published regarding the association of pelvic Chlamydia 31 
trachomatis (Ct) infection with miscarriage, with Ct prevalence ranging between 11%-69% in 32 
miscarriages compared to 2-7% in healthy pregnant controls2–6. The mechanisms underlying 33 
this association between Ct infection and miscarriage are unknown, though a recent study 34 
suggests Ct may interfere in essential early pregnancy inflammatory processes7. 35 
The development of a successful pregnancy depends upon maternal receptivity during the 36 
implantation window. This is largely established during decidualisation, the process whereby 37 
the stromal cells of the endometrium undergo structural and morphological changes to 38 
prepare for possible embryo implantation. Secretion of appropriate chemokine signals by 39 
decidual cells contributes to the recruitment of predominantly anti-inflammatory leukocyte 40 
subpopulations necessary for pregnancy maintenance8, and prevents recruitment of potentially 41 
damaging T lymphocytes9. The maternal immune response to miscarriage associated 42 
infections can have detrimental effects on pregnancy maintenance, a characteristic example of 43 
which is seen when malaria pathogens are detected in the placenta (reviewed in1). 44 
Furthermore, chemokines not only recruit and impact on immune cells but are also involved 45 
in trophoblast invasion and angiogenesis during early pregnancy10. 46 
Both undifferentiated and decidualised endometrium has been shown to be altered compared 47 
to normal pregnancies11 in women with spontaneous miscarriage. Impaired decidualisation, 48 
measured by a reduction in the decidualisation marker prolactin (PRL) in the endometrium, 49 
has been associated with recurrent miscarriage12 and in rodent models decidual cell prolactin 50 
production has been shown to be critical for successful pregnancy13. Infection can markedly 51 
change the chemokine profile to recruit pro-inflammatory cell subsets.  52 
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It is well established that Ct infects endometrial epithelial cells14–16, however the effect of Ct 53 
infection on endometrial stromal cell function and decidualisation is yet undetermined and 54 
may have a role in the association of Ct infection with miscarriage. Ct is known to cause 55 
endometritis, namely inflammation of the endometrium that is often asymptomatic, in non-56 
pregnant women17. Data from animal studies indicate that in mice, C. abortus induces the 57 
murine equivalent of miscarriage without fetal harm, likely due to decidual damage18. In 58 
cattle C. psittaci associated chronic endometritis is a recognized cause of infertility (strain 59 
now known as Chlamydia pecorum)19. To our knowledge, no study to date has identified why 60 
Ct can cause endometritis in women or how infection of the stromal compartment of the 61 
endometrium might alter the function of human endometrial stromal cells. We therefore 62 
aimed to determine whether Ct can infect human endometrial stromal cells (ESC) and 63 
examine the effect of Ct infection on decidualisation and chemokine secretion in an in-vitro 64 
model.  65 
Results 66 
 67 
Ct can directly infect human endometrial stromal cells (ESC)  68 
 69 
Primary ESC (n=4) were infected in 12 well plates with Ct serovar E at a multiplicity of 70 
infection (MOI) of 0.01, 0.1, 1, 2 and 3. No visible inclusions were present in cells at MOI 71 
0.01 and MOI 0.1 48 hours post infection and few inclusions were seen at MOI 1 (data not 72 
shown). The non-infected ESC and ESC treated with UV-inactivated Ct at MOI 2, displayed 73 
no signs of infection (Figure 1A, B, C) whereas visible Ct inclusions were seen in cells 74 
infected at MOI 2 (Figure 1, D, E). No copies of Ct cryptic plasmid were detected in 75 
uninfected cells, as assessed using qPCR. ESC exposed to UV-inactivated Ct (which still 76 
contained bacterial DNA) had 2.5 x104 – 7.5 x104 plasmid copies per well. Ct infected wells 77 
contained 1.2x106 – 3.3 x106 plasmid copies indicating that significant replication had 78 
occurred (Figure 1F). Although the number of decidualised uninfected ESC was decreased 79 
compared to non-decidualised ESC, UV-treated and Ct infected ESC samples contained 80 
similar numbers of cells compared to decidualised uninfected ESC (Figure 1G). In infected 81 
wells, between 0.05% - 20% of ESC contained chlamydial inclusions (Supplementary Figure 82 
1). These conditions were used for all subsequent experiments. Cells infected at MOI 3 83 
appeared similar to those infected at MOI 2 (equivalent to 4x105 organisms per well, 84 
supplementary Figure 2). 85 
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 86 
Ct infection of human ESC results in defective decidualisation 87 
 88 
Infection with Ct, but not treatment with UV-inactivated Ct, reduced the expression of the 89 
classic decidualisation marker prolactin (PRL) at both mRNA (Figure 2A) but not protein 90 
levels (Figure 2B) in decidualised Ct infected ESC. Similarly, exposure of decidualised ESC 91 
to either 200 or 100 µg/ml lipopolysaccharide (LPS) derived from either, Escherichia coli (E. 92 
coli) or Salmonella enterica serotype Minnesota (S. Minnesota) also failed to inhibit the of 93 
prolactin secretion (Supplementary figure 2). Decidualised uninfected ESC had increased 94 
levels of both PRL mRNA and protein compared to non decidualised ESC.  95 
 96 
Ct-infected human ESC have an altered chemokine profile 97 
 98 
To investigate the effect of Ct infection on chemokine secretion by decidualised ESC, the 99 
levels of 31 secreted chemokines were examined by proteomic array in supernatants from 100 
decidualised uninfected and infected ESC. All of the chemokines on the array were detected 101 
and a pattern of preferential expression between infected and uninfected cells was seen 102 
(Figure 3). Supplementary table 1 shows that four chemokines were upregulated and 17 103 
downregulated in Ct infected decidualised compared to non-infected ESC (cutoff 5%). Of the 104 
chemokines known to be involved with early pregnancy, trophoblast invasion and/or genital 105 
infection CXCL12 and CXCL16 were both strongly downregulated in infected decidualised 106 
ESC, as were chemokines CCL7, CCL12 and Midkine whilst CXCL7, CXCL1 and XCL1 107 
were strongly upregulated (see Supplementary table 1 for further details). To validate the 108 
array results, qPCR and ELISA were used to measure changes in mRNA and protein levels of 109 
chemokines CXCL12 and CXCL16 as a result of infection with Ct. As seen in Figures 4A 110 
and C, there were no significant differences in mRNA encoding CXCL12 and CXCL16. In 111 
contrast, infected ESC secreted significantly less CXCL12 and CXCL16 (Figure 4B, D). 112 
CXR4 (the receptor for CXCL12) mRNA was significantly decreased in infected decidualised 113 
ESC (Figure 4E). In contrast, CXCR6 (the receptor for CXCL16) mRNA was not affected by 114 
Ct infection (Figure 4F).   115 
 116 




Herein, we demonstrate for the first time that Ct can infect and proliferate in human 119 
endometrial stromal cells (ESC) and that active infection impairs decidualisation and alters 120 
the secretion of chemokines.  121 
 To our knowledge, all previous studies have only explored the effect of Ct on epithelial cells 122 
of the female reproductive tract20–22, however as we have demonstrated here Ct can also infect 123 
and affect the function of ESC. In light of this novel finding, we propose that ascending 124 
genital Ct infection might be a more complicated process than previously thought, as Ct could 125 
breach the epithelial barrier of the endometrium and infect other cell types such as stromal 126 
cells, endothelial cells or glandular epithelial cells (endometrial structure reviewed in1) 127 
causing extended inflammation. Infection with Ct has been reported to cause endometritis and 128 
some studies have suggested an association of chronic endometritis with miscarriage and 129 
implantation failure23,24. The effect of a Ct infected endometrial stromal compartment on 130 
gestation-related processes, such as decidualisation, might at least partially explain infection 131 
related adverse pregnancy outcomes.  132 
Using an in-vitro model, we demonstrated that Ct infection attenuates ESC decidualisation. 133 
Furthermore, in the current model active Ct infection, but not exposure to either UV-134 
inactivated organisms or to purified E. coli or S. Minnesota LPS, caused a reduction in 135 
mRNA but not protein levels of the widely used phenotypic decidualisation marker, PRL. 136 
PRL protein levels may not be altered due to the infection occurring after ESC decidualisation 137 
however a reduction of mRNA potentially indicates impaired decidualisation capability of Ct 138 
infected ESC. PRL is a key factor in the process of decidualisation and is thought to also be 139 
involved in epithelial cell differentiation, implantation, angiogenesis, trophoblast cell growth 140 
and immune regulation during early pregnancy25. We believe this observation is important 141 
because a reduction of endometrial PRL has been linked recently to recurrent miscarriage12.  142 
Furthermore, we show that Ct infection changes the chemokine secretion profile in 143 
decidualised ESC. Interestingly, we observed a reduction in the levels of CXCL12 and 144 
CXCL16. The reduction in protein expression in the culture supernatants cannot be attributed 145 
to increased receptor-ligand interactions as the receptor for neither chemokine showed 146 
increased expression. We believe that this may have relevance to the role of Ct in miscarriage 147 
because these cytokines are known to promote trophoblast migration26–28. It is possible that 148 
that infection could therefore lead to defective trophoblast invasion due to lack of essential 149 
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attractant signalling molecules secreted from maternal decidua, such as CXCL12 and 150 
CXCL16.  151 
Our findings are also important because decidualised endometrium from spontaneous and 152 
recurrent miscarriages have been reported to have different immune cell profiles compared to 153 
viable pregnancies, including increased levels of uterine natural killer cells (uNK) and 154 
macrophages29,30. Dysregulated chemokines due to Ct infection, as indicated in our array, 155 
could therefore also impact on the population of immune cells at the feto-maternal interface 156 
by altering immune cell recruitment. 157 
In summary, our data suggest a novel mechanism through which infection leads to defective 158 
endometrial stromal cell decidualisation, resulting in an altered immune response that could 159 
impact upon trophoblast migration and immune cell recruitment. Future work to clarify the 160 
potential role of Ct and other bacterial infections upon trophoblast invasion via CXCL12 and 161 
CXCL16 dysregulation and immune cell recruitment in the endometrium due to altered 162 
chemokine profile could further our understanding of this potential mechanism of infection 163 
associated miscarriage.   164 
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Materials and methods 165 
Subjects 166 
Ethical approval for this study was obtained from the Lothian Research Ethics Committee 167 
(LREC10/S1402/59). Informed written consent obtained from all patients and all of the 168 
methods were carried out in accordance with the approved guidelines. Human endometrial 169 
stromal cells (ESC) were collected after informed written consent from women undergoing 170 
hysterectomy for benign gynaecological conditions. Only samples from women in the 171 
proliferative phase of the menstrual cycle (cycle staging determined by the last menstrual 172 
period and measurement of serum estradiol and progesterone levels) were selected for further 173 
experiments. The tissue was dissociated using enzymatic digestion with 1mg/ml of 174 
collagenase type IV for two hours at 37°C, (Sigma C5138), followed by mechanical 175 
breakdown using a 70μm and subsequently 40μm filter (Falcon, Corning, Cat. No 352350 and 176 
352340 respectively). Single cells were plated in RPMI 1640 media (Sigma, Cat. No. R0883) 177 
supplemented with 10% heat inactivated foetal calf serum (HIFCS, Gibco, Cat. No 178 
10082139), 1% L-glutamine (Sigma, Cat. No G-7513) and 1% Penicillin/ Streptomycin 179 
(Sigma, Cat. No. P4333).  180 
 181 
Primary human endometrial stromal cell (ESC) culture  182 
Prior to any treatments, cells were transferred to phenol red-free RPMI 1640 (Sigma, Cat. No 183 
R7509) containing 10% charcoal stripped fetal calf serum (CSFCS, prepared in house from 184 
FCS), 1% L-glutamine and 0.5% gentamycin (Sigma, Cat. No. G1272) for 48 hours prior to 185 
use. The antibiotic gentamycin was used instead of the standard penicillin/ streptomycin 186 
regimen, because it does not inhibit Ct growth31. Cells were maintained at 37°C and 5% CO2. 187 
Treatments were completed in duplicate per experiment and were repeated on 4 (for initial 188 
chlamydial growth experiments) or 6 (prolactin/ chemokine expression) times using cells 189 
derived from different patients on each occasion. 190 
 191 
In-vitro decidualisation 192 
To assess the effects of chlamydial infection on the decidualisation of primary endometrial 193 
stromal cells, an in-vitro decidualisation method previously described was used32. Cells were 194 
trypsinised, spun for 3.5 minutes at 800rpm and resuspended phenol red-free RPMI 1640 with 195 
10% CSFCS. They were then plated at 105 cells per well of a 12-well plate for a minimum of 196 
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24 hours. Before the decidualisation protocol commenced, cells were serum starved in 2% 197 
CSFCS medium for 24 hours, supplemented as previously described. The cells were treated 198 
with 10-6M progesterone (Sigma, Cat. No. P0130) and 8-Bromo-adenosine 3’-5’-cyclic 199 
monophosphate (cAMP, Sigma, Cat. No. A9501) at a final concentration of 0.1 mg/ml. The 200 
medium was changed every 48 hours over a six-day period (supplementary table 2).  201 
 202 
 203 
Ct elementary bodies (EBs) growth and purification 204 
Chlamydia trachomatis (Ct) serotype E stock was produced in HEp2 cells using well 205 
established protocols.  Sub-confluent flasks of HEp2’s were inoculated with Ct. Infected cells 206 
were cultured for 48-72 hours in Iscove’s Modified Dulbecco’s Medium (IMDM, Life 207 
Technologies, Paisley, UK) supplemented with 2% heat inactivated fetal calf serum (FBS) and 208 
1 µg/ml cycloheximide (Sigma, Cat. No C4859) (PAA laboratories Ltd, Yeovil, Somerset, UK), 209 
until high numbers of mature inclusions were observed by optical microscopy. The cell 210 
monolayers were disrupted with glass beads and the medium containing cell debris was 211 
briefly sonicated  (Vibracell, Sonics & Materials, Connecticut, USA) and centrifuged at 50 x g 212 
for 5 minutes at 4°C to remove intact cells. The supernatant was removed and centrifuged at 213 
12,000 x g using a J-LITE JLA-16.250 rotor (Beckman Coulter Ltd. High Wycombe, UK). The 214 
pellet was resuspended by sonication in Tris/KCL and 25ml of inoculum were layered onto 215 
10ml 40% Gastrografin® (Bayer plc, Berkshire, UK) and centrifuged at 20,000 rpm at 4°C for 216 
45 minutes SW 32Ti rotor on Optima L-90K ultracentrifuge (Beckman Coulter Ltd). The pellet 217 
was re-suspended into 1ml Tris/KCL and layered onto discontinuous gradient (54%, 44%, 218 
34% Gastrografin®) and centrifuged at 20, 000 rpm at 4°C for two hours. The interface 219 
between the 44% and 54% layers, containing the EBs was carefully removed. The EBs were 220 
washed by resuspension in 10ml Tris KCL and centrifugation at 20, 000 rpm at 4°C for a 221 
further 45 minutes, to remove residual traces of Gastrografin®. The final pellet was 222 
resuspended by sonication in 10 ml of Chlamydia Transport Medium (218mM Sucrose, 223 
3.76mM KH2P04, 7.1mM K2HP04, 4.9mM L-glutamic acid, 10% FBS, 0.05 mg/ml 224 
Gentamycin, 0.1mg/ml Streptomycin, 150U/ml Nystatin). and the aliquots stored at -80OC. 225 
UV inactivation of Ct elementary bodies 226 
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To UV inactivate Ct EB’s, 500 l of inoculum was exposed to 2J UV-C. The successful 227 
inactivation of Ct was confirmed by cell culture of HeLa cells with UV inactivated bacteria 228 
for 96 hours without the presence of any inclusions.  229 
 230 
Titration of Ct stock 231 
To determine the titre of the Ct stock, HEp2 cells were plated at 105 per well of 8 well glass 232 
chamber slides, infected with serial tenfold dilutions of Ct inoculum (Multiplicity of infection 233 
[MOI] 1 – 10-8) and cultured for 48 hours. The cells were fixed in ice-cold acetone for 5 234 
minutes, left to air dry and stored at -20°C. After thawing, the slides were rehydrated in PBS 235 
and incubated with the primary antibody (C. abortus LPS, Santa Cruz Biotechnology, Cat. 236 
No. 13/4) for 1 hour at room temperature. Following PBS washes, the slides were incubated 237 
with a fluorescein isothiocyanate (FITC)-conjugated anti-mouse antibody (Sigma) for 60 238 
minutes at room temperature in a light-tight humidity chamber. Slides were mounted using 239 
ProLong® Gold Antifade Mountant with DAPI (lifeTechonologies, Cat. No. P36930). The 240 
total number of inclusions per well was counted at serial dilutions 10-5-10-7 and the titre of 241 
stock was calculated. 242 
 243 
Ct infection of decidualised ESC 244 
ESC were seeded at 12-well plates and decidualised as described above. On day 6 of the 245 
protocol, ESC were infected with Ct MOI 0.01, 0.1, 1, 2 and 3 or UV-Ct at the same MOI for 246 
48 hours prior to sample collection. To determine whether decidualisation of ESC was 247 
affected by exposure to lipopolysaccharide (LPS) from other bacterial species, decidualised 248 
ESC isolated from a further five subjects were exposed to LPS from either E. coli or S. 249 
Minnesota (both Invivogen) (each at 200μg/ml and 100μg/ml) for 48 hours prior to sample 250 
collection. 251 
RNA extraction, quantification and quality assessment  252 
To assess changes in expression levels of genes of interest, total RNA extraction was 253 
performed Using the RNeasy® Micro kit (Qiagen, Crawley, UK, Cat. No. 74004) following 254 
the manufacturer’s protocol. 255 
 256 
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Real time PCR 257 
 258 
All reactions were carried out in 384 well plates at a final reaction volume of 10μl per sample, 259 
as seen in supplementary table 3. The samples were mixed by repeat pipetting and centrifuged 260 
in a mini plate spinner (Applied Biosystems, Warrington, UK) at 1000g for 20 seconds to 261 
remove any bubbles. A standard curve of cDNA made from standardised placenta RNA 262 
(Ambion, Cat.No AM7950) was used on every plate to ensure comparability among all plates. 263 
All primers were predesigned KiCqStart® SYBR® Green Primers (Cat. No. KSPQ12012). 264 
PCR conditions were an initial step of 3 min at 95°C, followed by 40 cycles of 5s at 95°C, 265 
15s at 60°C and a final disassociation step consisting of 15s at 95°C, 15s at 60°C and finally 266 
15s at 95°C. 267 
 268 
DNA extraction from ESC 269 
To extract DNA from infected cells, the MagMAX™ Total Nucleic Acid Isolation Kit 270 
(Ambion, Cat. No. AM1840) was used according to the manufacturers’ protocol.  271 
 272 
Ct plasmid copy assay  273 
To assess whether Ct could proliferate in ESC the ‘Chlamydia trachomatis Genesig Standard 274 
Kit’ (PrimerDesign, Cat. No Path-C.trachomatis-standard) was used. A standard curve of 275 
known concentration provided by the kit was used to absolutely quantify Ct plasmid copy 276 
numbers in DNA extracts from ESC cells using qPCR.  277 
 278 
Human Chemokine Array 279 
Proteome Profiler™ Human Chemokine Array Kit (R&DSystems, Abingdon, UK, Cat. No. 280 
ARY017) was used.  Samples were pooled supernatants from ESC cultures and the 281 
manufacturer’s protocol was followed without deviation. The data are expressed as 282 
percentage of positive control of each membrane and pixel density was measured using 283 
ImageJ. 284 
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 285 
Enzyme-linked Immunoabsorbant Assay (ELISA) 286 
The sandwich ELISA was used to detect PRL (R&DSystems, Cat. No.DY682) protein 287 
concentrations as per manufacturer’s instructions. Sample concentrations were calculated 288 
using MasterPlex® QT (Hitachi) software.  289 
 290 
Magnetic Luminex®Screening Assay 291 
The Luminex®Screening Assay (R&D Systems,Cat.No. LXSAHM) was used to detect 292 
CXCL12 and CXCL16 as per manufacturer’s instructions. 293 
 294 
Statistical analysis 295 
Statistical analysis was carried out using GraphPad Prism 6. Friedman’s non parametric test 296 
was used for all sample sets. The “n” number corresponds to individual patients.  297 
Repeated measures non parametric ANOVA- Friedman’s test was used for all sample sets. By 298 
using a non parametric test it was assumed that the samples are not following a Gaussian 299 
distribution, as the sample size was not suitable for a normality test. Friedman’s test was 300 
selected as using a repeated-measures test (RM one way ANOVA) controls for experimental 301 
variability attributed to patient-to-patient response variations. Some factors not controlled for 302 
in the experiment will affect all the measurements from one subject equally, so they will not 303 
affect the difference between the measurements in that subject. By analyzing only the 304 
differences, therefore, a matched test controls for some of the sources of scatter. Furthermore, 305 
to compare specific groups, Dunn’s method for non parametric multiple comparisons was 306 
used, as it allows for comparison of two particular groups by determining each rank from the 307 
entire data set (all groups), not just the two groups being compared. However, the absolute 308 
value of the difference between the mean rank of the groups being compared is entered into 309 
the calculation of the z ratio. All graphs are representing mean with standard deviation (SD) 310 
of the data. 311 
 312 
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Figure 1. Ct infects decidualised ESC. ESC were infected with Ct MOI 2 following an in-vitro decidualisation protocol. Non decidualised uninfected 
ESC, uninfected decidualised ESC and UV-Ct treated ESC were used as controls. 48 hours post infection DNA was collected for qPCR and cells were 
stained with Giemsa. Cell counts were conducted in 15 fields of view per well measuring 0.32 mm2 each.  (a) Non decidualised uninfected ESC were 
elongated and thin. (b) Decidualised uninfected ECS became rounder and larger compared to non decidualised ESC. (c) Ct infected decidualised ESC 
displayed signs of infection and contained inclusions that were stained purple by Giemsa stain (highlighted by green circles). (d) UV-Ct treated 
decidualised ESC did not contain chlamydial inclusions and resembled uninfected decidualised ESC in appearance. (e) 25.000 – 75.000 Ct plasmid 
DNA copies were detected in UV-Ct treated ESC. Ct infected ESC had a significantly higher number of 1.200.000 – 3.200.000 plasmid copies per 
sample, indicating proliferation of Ct only in infected cells (RM one-way ANOVA-Friedman’s test with Dunn’s multiple comparisons test, p=0.0094, 
n=4). (f) Cell counts on Giemsa stained ESC indicated that decidualised uninfected cells were significantly fewer compared to non-decidualised 
controls (RM one-way ANOVA-Friedman’s test with Dunn’s multiple comparisons test, p= 0.0185, n=4). In contrast, UV-Ct treated cells and Ct 
infected cell numbers were similar to uninfected decidualised ESC. Scale bars equal 200μm. Graphs show the mean and standard deviation. 
 
 
Figure 2. Ct serovar E infection of ESC results in suboptimal decidualisation of ESC. (a) PRL mRNA is upregulated in response to decidualisation 
stimulus, whereas it is downregulated in infected decidualised cells compared to uninfected controls (n=5, One way ANOVA Friedman’s test with 
Dunn’s multiple comparisons test, p=0.0009 and 0.0151 respectively). (b) PRL protein levels are increased in decidualised non infected cells compared 
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to non decidualised controls as expected (n=5, One way ANOVA Friedman’s test with Dunn’s multiple comparisons test, p=0.0044). Reduction of PRL 
is observed only in cells infected by Ct compared to decidualised controls, indicating the adverse effect of Ct infection on decidualisation (n=5, One 
way ANOVA Friedman’s test with Dunn’s multiple comparisons test, p=0.028). Each circle/square represents an individual patient. 
 
 
Figure 3. Chemokine proteomic array of 31 chemokines on pooled cell supernatants from Ct infected and uninfected decidualised cells. Each 
chemokine is represented by a dot. (a) Ct infected decidualised ESC secreted chemokine profile, demonstrating ESC secrete all 31 chemokines. (b) 
Uninfected decidualised ESC secreted chemokine profile that is altered compared to Ct infected ESC. (n=3) 
 
 
Figure 4. Innate immune response of decidualised ESC to Ct infection. The innate response was determined by measurement (at an mRNA and 
protein level) of trophoblast invasion-associated chemokines CXCL12 and CXCL16. (a-b). CXCL12 mRNA was not altered in response to infection, 
however there was a reduction in protein levels in cell supernatants (n=4, One way ANOVA Friedman’s test with Dunn’s multiple comparisons test, p= 
0.0267). (c-d) Similarly, there was less secreted CXCL16 protein observed only in infected cells however no change in mRNA levels (n=4, One way 
ANOVA Friedman’s test with Dunn’s multiple comparisons test, p= 0.0078). (e) CXR4 mRNA, receptor of CXCL12, was increased only in infected 
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cells (n=7, One way ANOVA Friedman’s test with Dunn’s multiple comparisons test,, p=0.0267). f. CXCR6, receptor of CXCL16 does not seem to be 
affected by Ct infection in mRNA level. Each circle/square represents an individual patient. 
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8. Appendix 2 
The following review was published at Human Reproduction update, with open 
access and is reproduced here with permission from the editor. 
Giakoumelou, S. et al. The role of infection in miscarriage. Hum. Reprod. 
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9. Appendix 3 
Detailed interim study statistical analysis: 












Mean 32.87 32.62 
Median 34 34 
Std. deviation 5.419 5.816 
Weight 
(kg) 




Mean 70.84 70.18 
Median 67 65.7 
Std. deviation 13.76 17.42 
Height 
(cm) 




Mean 164.8 165.2 
Median 164.5 165 
Std. deviation 5.785 6.619 




Mean 26.22 25.72 
Median 24.66 24 
Std. deviation 5.374 6.024 
Ethnicity Caucasian (%) 123 (87.9%) 190 (95.5%) < 0.0001 
(Chi square 
test) 
Black (%) 3 (2.1%) 3 (1.5%) 
Asian (%) 1 (0.7%) 6 (4%) 
Other/Unknown 
(%) 
13 (9.3%) 0 (0%) 
Smoking 
status  
Smoker (%) 13 (9.6%) 21 (10.7%) 0.6720 
(Chi square 
test) 
Ex smoker (%) 27 (19.9%) 46 (23.4%) 
Never smoked 
(%) 
96 (70.6) 130 (66%) 
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PGP3 result Positive 31 36 0.7790 
(Chi square 
tests) 
Negative 96 124 
Not yet tested 25 40 
LPS Elisa* 
result 
Positive 12 10 0.8240 
(Chi square 
test) 
Negative 113 113 




Yes  4 17  
 No 17 182 
Unknown 120 0 
Current Ct 
infection 
Positive 0 0  
 Negative 14 177 
Unknown 126 15 
* RIDASCREEN® Chlamydia IgG, Cat no: KGM3101 
 
 
